
<html lang="en"     class="pb-page"  data-request-id="58e3f429-182c-44da-8f1b-2fac140443e7"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01572;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists" /></meta><meta name="dc.Creator" content="Maria João  Matos" /></meta><meta name="dc.Creator" content="Santiago  Vilar" /></meta><meta name="dc.Creator" content="Saleta  Vazquez-Rodriguez" /></meta><meta name="dc.Creator" content="Sonja  Kachler" /></meta><meta name="dc.Creator" content="Karl-Norbert  Klotz" /></meta><meta name="dc.Creator" content="Michela  Buccioni" /></meta><meta name="dc.Creator" content="Giovanna  Delogu" /></meta><meta name="dc.Creator" content="Lourdes  Santana" /></meta><meta name="dc.Creator" content="Eugenio  Uriarte" /></meta><meta name="dc.Creator" content="Fernanda  Borges" /></meta><meta name="dc.Description" content="Adenosine receptors participate in many physiological functions. Molecules that may selectively interact with one of the receptors are favorable multifunctional chemical entities to treat or decele..." /></meta><meta name="Description" content="Adenosine receptors participate in many physiological functions. Molecules that may selectively interact with one of the receptors are favorable multifunctional chemical entities to treat or decele..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 18, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01572" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01572" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01572" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01572" /></link>
        
    
    

<title>Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01572" /></meta><meta property="og:title" content="Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0006.jpeg" /></meta><meta property="og:description" content="Adenosine receptors participate in many physiological functions. Molecules that may selectively interact with one of the receptors are favorable multifunctional chemical entities to treat or decelerate the evolution of different diseases. 3-Arylcoumarins have already been studied as neuroprotective agents by our group. Here, differently 8-substituted 3-arylcoumarins are complementarily studied as ligands of adenosine receptors, performing radioligand binding assays. Among the synthesized compounds, selective A3 receptor antagonists were found. 3-(4-Bromophenyl)-8-hydroxycoumarin (compound 4) displayed the highest potency and selectivity as A3 receptor antagonist (Ki = 258 nM). An analysis of its X-ray diffraction provided detailed information on its structure. Further evaluation of a selected series of compounds indicated that it is the nature and position of the substituents that determine their activity and selectivity. Theoretical modeling calculations corroborate and explain the experimental data, suggesting this novel scaffold can be involved in the generation of candidates as multitarget drugs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01572"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01572">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01572&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01572&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01572&amp;href=/doi/10.1021/acs.jmedchem.9b01572" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2577-2587</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01561" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01526" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Optimization of Coumarin hA<sub>3</sub> Adenosine Receptor Antagonists</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Maria João Matos</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria João Matos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal</div><div class="loa-info-affiliations-info">Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>For M.J.M.: phone, +34 881814936; E-mail, <a href="/cdn-cgi/l/email-protection#1d707c6f747c77727c72337e726f6f78747c6d747369725d686e7e33786e"><span class="__cf_email__" data-cfemail="543935263d353e3b353b7a373b2626313d35243d3a203b142127377a3127">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#701d110219115e1d11041f033016135e05005e0004"><span class="__cf_email__" data-cfemail="036e62716a622d6e62776c704365602d76732d7377">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Jo%C3%A3o++Matos">Maria João Matos</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3470-8299" title="Orcid link">http://orcid.org/0000-0002-3470-8299</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Santiago Vilar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Santiago Vilar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Santiago++Vilar">Santiago Vilar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Saleta Vazquez-Rodriguez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Saleta Vazquez-Rodriguez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Saleta++Vazquez-Rodriguez">Saleta Vazquez-Rodriguez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sonja Kachler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sonja Kachler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sonja++Kachler">Sonja Kachler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karl-Norbert Klotz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karl-Norbert Klotz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmacology and Toxicology, University of Würzburg, 97078 Würzburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karl-Norbert++Klotz">Karl-Norbert Klotz</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3553-3205" title="Orcid link">http://orcid.org/0000-0003-3553-3205</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michela Buccioni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michela Buccioni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Medicinal Chemistry Unit, University of Camerino, 62032 Camerino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michela++Buccioni">Michela Buccioni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Giovanna Delogu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Giovanna Delogu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Life Sciences and Environment—Section of Pharmaceutical Sciences, University of Cagliari, 09124 Cagliari, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Giovanna++Delogu">Giovanna Delogu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0307-1544" title="Orcid link">http://orcid.org/0000-0003-0307-1544</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lourdes Santana</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lourdes Santana</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lourdes++Santana">Lourdes Santana</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eugenio Uriarte</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eugenio Uriarte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</div><div class="loa-info-affiliations-info">Instituto de Ciencias Químicas Aplicadas, Universidad Autónoma de Chile, 7500912 Santiago, Chile</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eugenio++Uriarte">Eugenio Uriarte</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Fernanda Borges</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fernanda Borges</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal</div></div><span class="conrtib-corresp"><strong>*</strong>For F.B.: phone, +351 220402560; E-mail, <a href="/cdn-cgi/l/email-protection#c5a3a7aab7a2a0b685a3a6ebb0b5ebb5b1"><span class="__cf_email__" data-cfemail="c3a5a1acb1a4a6b083a5a0edb6b3edb3b7">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fernanda++Borges">Fernanda Borges</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1050-2402" title="Orcid link">http://orcid.org/0000-0003-1050-2402</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01572&amp;href=/doi/10.1021%2Facs.jmedchem.9b01572" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2577–2587</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 18, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 September 2019</li><li><span class="item_label"><b>Published</b> online</span>18 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01572" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01572</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2577%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaria%2BJo%25C3%25A3o%2BMatos%252C%2BSantiago%2BVilar%252C%2BSaleta%2BVazquez-Rodriguez%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D5%26contentID%3Dacs.jmedchem.9b01572%26title%3DStructure-Based%2BOptimization%2Bof%2BCoumarin%2BhA3%2BAdenosine%2BReceptor%2BAntagonists%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2587%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01572"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">927</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01572" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;João Matos&quot;},{&quot;first_name&quot;:&quot;Santiago&quot;,&quot;last_name&quot;:&quot;Vilar&quot;},{&quot;first_name&quot;:&quot;Saleta&quot;,&quot;last_name&quot;:&quot;Vazquez-Rodriguez&quot;},{&quot;first_name&quot;:&quot;Sonja&quot;,&quot;last_name&quot;:&quot;Kachler&quot;},{&quot;first_name&quot;:&quot;Karl-Norbert&quot;,&quot;last_name&quot;:&quot;Klotz&quot;},{&quot;first_name&quot;:&quot;Michela&quot;,&quot;last_name&quot;:&quot;Buccioni&quot;},{&quot;first_name&quot;:&quot;Giovanna&quot;,&quot;last_name&quot;:&quot;Delogu&quot;},{&quot;first_name&quot;:&quot;Lourdes&quot;,&quot;last_name&quot;:&quot;Santana&quot;},{&quot;first_name&quot;:&quot;Eugenio&quot;,&quot;last_name&quot;:&quot;Uriarte&quot;},{&quot;first_name&quot;:&quot;Fernanda&quot;,&quot;last_name&quot;:&quot;Borges&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;2577-2587&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01572&quot;},&quot;abstract&quot;:&quot;Adenosine receptors participate in many physiological functions. Molecules that may selectively interact with one of the receptors are favorable multifunctional chemical entities to treat or decelerate the evolution of different diseases. 3-Arylcoumarins have already been studied as neuroprotective agents by our group. Here, differently 8-substituted 3-arylcoumarins are complementarily studied as ligands of adenosine receptors, performing radioligand binding assays. Among the synthesized compounds, selective A3 receptor antagonists were found. 3-(4-Bromophenyl)-8-hydroxycoumarin (compound 4) displayed the highest potency and selectivity as A3 receptor antagonist (Ki = 258 nM). An analysis of its X-ray diffraction provided detailed information on its structure. Further evaluation of a selected series of compounds indicated that it is the nature and position of the substituents that determine their activity and selectivity. Theoretical modeling calculations corroborate and explain the experimental data, suggest&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01572&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01572" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01572&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01572" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01572&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01572" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01572&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01572&amp;href=/doi/10.1021/acs.jmedchem.9b01572" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01572" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01572" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01572%26sid%3Dliteratum%253Aachs%26pmid%3D31738058%26genre%3Darticle%26aulast%3DMatos%26date%3D2020%26atitle%3DStructure-Based%2BOptimization%2Bof%2BCoumarin%2BhA3%2BAdenosine%2BReceptor%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D5%26spage%3D2577%26epage%3D2587%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (5)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/jmcmar.2020.63.issue-5/20200312/jmcmar.2020.63.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Adenosine receptors participate in many physiological functions. Molecules that may selectively interact with one of the receptors are favorable multifunctional chemical entities to treat or decelerate the evolution of different diseases. 3-Arylcoumarins have already been studied as neuroprotective agents by our group. Here, differently 8-substituted 3-arylcoumarins are complementarily studied as ligands of adenosine receptors, performing radioligand binding assays. Among the synthesized compounds, selective A<sub>3</sub> receptor antagonists were found. 3-(4-Bromophenyl)-8-hydroxycoumarin (compound <b>4</b>) displayed the highest potency and selectivity as A<sub>3</sub> receptor antagonist (<i>K</i><sub>i</sub> = 258 nM). An analysis of its X-ray diffraction provided detailed information on its structure. Further evaluation of a selected series of compounds indicated that it is the nature and position of the substituents that determine their activity and selectivity. Theoretical modeling calculations corroborate and explain the experimental data, suggesting this novel scaffold can be involved in the generation of candidates as multitarget drugs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/5"><issue-title>Women in Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Adenosine acts as a common control of several cellular functions.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This purine regulates fundamental pathophysiological activities through four receptor subtypes (A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Adenosine is the endogenous, nonselective agonist which remains shortly in the human body, while inosine (its metabolite), being metabolized by adenosine deaminase, weakly interacts with the A<sub>3</sub> receptor.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><div class="NLM_p">Adenosine receptors are GPCR (G protein-coupled receptors) that are being described as potential therapeutic targets for a wide range of pathologies.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> From cancer to brain diseases, these receptors are involved in immunological and inflammatory conditions.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> There is a huge variety of chemicals designed as adenosine receptor ligands, both directly acting as agonists, antagonists, and indirect modulators.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Regadenoson (CVT-3146) was proposed as selective A<sub>2A</sub> agonist. This molecule has been playing an interesting role inducing stress for imaging techniques in cardiology.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Istradefylline (KW-6002) was approved in Japan for Parkinson’s disease. This xanthine derivate proved to be a strong A<sub>2A</sub> antagonist.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">The increasing knowledge on the structure and mechanisms of A<sub>3</sub> receptor has given fundamental pieces of evidence to validate it as a promising therapeutic target.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This enables a rational design on robust A<sub>3</sub> selective antagonists as therapeutic solutions for several diseases.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Recent reports manifest an important role for A<sub>3</sub> receptor in mediating adenosine function at the central nervous system.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> A<sub>3</sub> receptors are also described as inducers of strong anti-inflammatory activity in animal models.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> These particular effects aroused our attention because our group has been active in the research of age-related pathologies, in particular, vascular, inflammatory, and neurodegenerative diseases.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p">On the basis of the background of our research group regarding differently substituted coumarins as potential adenosine receptor ligands<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref21">(16−21)</a> and in the potential of some of these compounds as neuroprotectors and enzymatic inhibitors related to neurodegenerative disorders (i.e., acetylcholinesterase, butyrylcholinesterase, and monoamine oxidase B), in this work, we report a group of coumarins bearing a wide variety of substituents as modulators of adenosine receptors. In particular, the revealing achievements of our last work on the interesting activity of 8-substituted 3-arylcoumarins (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) have been the inspiration for the progression of this study.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Design, synthesis, pharmacological evaluation, docking calculations, and structure–activity relationship exploration of a family of 8-substituted 3-arylcoumarins, were performed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previous results from the group on the potential of 8-substituted 3-arylcoumarins as adenosine ligands at adenosine 7TM receptors. (A) Three 8-(2-oxopropoxy)-3-arylcoumarins with different affinity profiles. (B) Hypothetical binding mode for 8-(2-oxopropoxy)-3-(<i>p</i>-tolyl)coumarin in the hA<sub>3</sub> protein pocket (template for the hA<sub>3</sub> homology model: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a>). Color code: pale-orange, micromolar range; red, nanomolar range.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Molecules <b>1</b>–<b>27</b> were prepared based on the synthetic strategies described in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A. In general, these compounds were obtained by a classic Perkin (compounds <b>1</b>–<b>3</b>, <b>5</b>–<b>14</b>, <b>16</b>, and <b>17</b>) and Perkin–Oglialoro (compounds <b>18</b>–<b>22</b>) reactions. Further hydrolysis of the ethoxy (compounds <b>4</b> and <b>15</b>) and acetoxy derivatives (compounds <b>23</b>–<b>27</b>) allowed the obtention of the hydroxyl derivatives.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22−25)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Scheme of the synthetic methodologies: (a) DCC, DMSO, 110 °C, 24 h; (b) HI, AcOH, Ac<sub>2</sub>O, reflux, 3 h; (c) CH<sub>3</sub>CO<sub>2</sub>K, Ac<sub>2</sub>O, reflux, 16 h; (d) HCl, MeOH, reflux, 3 h. (B) Molecular structure of compound <b>4</b>, showing the atom-numbering scheme used in the X-ray study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><i>ortho</i>-Hydroxybenzaldehydes reacted via Perkin condensation with the corresponding arylacetic acids and <i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide (DCC) acting as dehydrating agent to obtain compounds <b>1</b>–<b>3</b>, <b>5</b>–<b>14</b>, <b>16</b>, and <b>17</b>. Afterward, the ethoxy derivatives <b>3</b> and <b>14</b> gave the respective compounds <b>4</b> and <b>15</b> by acidic hydrolysis in the presence of hydriodic acid (HI) 57%, acetic acid (AcOH), and acetic anhydride (Ac<sub>2</sub>O).</div><div class="NLM_p">Acetoxy-3-arylcoumarins <b>18</b>–<b>22</b> were prepared via Perkin–Oglialoro condensation. Following its traditional methodology, <i>ortho</i>-hydroxybenzaldehydes and arylacetic acids reacted for 16 h, at reflux temperature, in the presence of potassium acetate (CH<sub>3</sub>CO<sub>2</sub>K) and acetic anhydride (Ac<sub>2</sub>O). Under these mild conditions, concomitant acetylation of the hydroxyls and closure of the pyrone ring occur. The hydrolysis of the acetoxy compounds was then carried out using aqueous hydrochloric acid (HCl) and methanol (MeOH), at reflux temperature, for 3 h. This reaction allowed obtaining hydroxyl substituted 3-arylcoumarins <b>23</b>–<b>27</b>.</div><div class="NLM_p last">The structural analyses of compound <b>4</b> by X-ray crystallography (CCDC number 1937910)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> corroborated the NMR information. This molecule is a coumarin derivative with a <i>p</i>-bromophenyl at position 3 of the coumarin and a hydroxyl at position 8, as represented in the scheme (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). The dihedral angle formed by both planes of the 3-arylcoumarin scaffold (∼36.6 ± 2.1°) may reveal some important information on the possible binding pose of compound <b>4</b> to the receptor, being typical of these family of molecules.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In addition, the C3—C13 bond length is typical from the 3-arylcoumarins 1.483 Å. This length is coincident with the one reported for the 3-phenylcoumarin, crystallized by our research group.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Also, coumarin’s planarity is corroborated by the torsion angles between its carbon atoms. Besides the interest in organic chemistry and structural elucidation, the deep structural knowledge of a molecule can be a significant tool for the understanding of its potential affinity and/or selectivity for particular receptors. All the details of the synthetic methodologies and characterization of the studied molecules are presented in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> of this manuscript.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Pharmacological Study</h3><div class="NLM_p">The affinity of the newly described coumarins for the A<sub>1</sub>, A<sub>2A</sub>, and A<sub>3</sub> adenosine receptors was evaluated using a protocol based on radioligand binding. A functional assay (inhibition of agonist-stimulated adenylyl cyclase activity) was performed to assess the affinity for the A<sub>2B</sub> receptor.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> All the details are included in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. A<sub>1</sub>, A<sub>2A</sub>, and A<sub>3</sub> adenosine receptors binding data is represented in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. All the studied molecules became inactive against the A<sub>2B</sub> receptor (IC<sub>50</sub> > 30 μM, data not shown).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>K</i><sub>i</sub> Values for the Binding Affinity of Compounds <b>1</b>–<b>27</b> and Reference Compounds for Human A<sub>1</sub>, A<sub>2A</sub>, and A<sub>3</sub> Receptors Expressed in Chinese Hamster Ovary (CHO) Cells<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">hA<sub>1</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hA<sub>2A</sub> (μM)</th><th class="colsep0 rowsep0" align="center">hA<sub>3</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">22.1 (18.0–27.1)</td><td class="colsep0 rowsep0" align="center">55.0 (36.4–83.1)</td><td class="colsep0 rowsep0" align="center">22.5 (14.0–36.3)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>60</td><td class="colsep0 rowsep0" align="center">3.93 (2.57–6.01)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">Br</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">Br</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center"><b>0.258</b><b>(0.143–0.468)</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">5.32 (3.68–7.68)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">13.7 (9.55–19.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">16.6 (10.5–26.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">9.05 (6.05–13.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">14.8 (9.34–23.3)</td><td class="colsep0 rowsep0" align="center">42.1 (33.6–52.7)</td><td class="colsep0 rowsep0" align="center">17.0 (11.2–25.7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">16.6 (10.2–26.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">25.9 (17.7–38.0)</td><td class="colsep0 rowsep0" align="center">13.6 (12.3–15.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">>60</td><td class="colsep0 rowsep0" align="center">32.9 (20.5–53.0)</td><td class="colsep0 rowsep0" align="center">9.82 (7.90–12.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">14.7 (8.74–24.6)</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">14.3 (7.79–26.4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">59.1 (57.1–61.2)</td><td class="colsep0 rowsep0" align="center">8.02 (6.90–9.32)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">5.06 (3.89–6.57)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">6.93 (5.76–8.33)</td><td class="colsep0 rowsep0" align="center">35.7 (27.9–45.8)</td><td class="colsep0 rowsep0" align="center">6.86 (5.86–8.03)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">8.56 (6.90–10.6)</td><td class="colsep0 rowsep0" align="center">21.1 (16.6–26.8)</td><td class="colsep0 rowsep0" align="center">5.17 (4.85–5.50)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">6.14 (3.24–11.6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">64.4 (49.0–84.6)</td><td class="colsep0 rowsep0" align="center">22.0 (12.5–38.7)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">OCOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">23.4 (14.5–37.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">4.62 (4.24–5.04)</td><td class="colsep0 rowsep0" align="center">42.3 (36.5–49.1)</td><td class="colsep0 rowsep0" align="center">5.09 (3.40–7.60)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">2.40 (1.95–2.95)</td><td class="colsep0 rowsep0" align="center">12.1 (9.69–15.2)</td><td class="colsep0 rowsep0" align="center">3.85 (3.04–4.89)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">12.5 (10.3–15.4)</td><td class="colsep0 rowsep0" align="center">55.3 (45.3–67.4)</td><td class="colsep0 rowsep0" align="center">9.16 (7.12–11.8)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">6.20 (5.11–7.53)</td><td class="colsep0 rowsep0" align="center">14.0 (10.1–19.5)</td><td class="colsep0 rowsep0" align="center">23.6 (16.8–33.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">OH</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">6.28 (5.26–7.49)</td><td class="colsep0 rowsep0" align="center">25.5 (21.2–30.5)</td><td class="colsep0 rowsep0" align="center">8.50 (7.47–9.67)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">theophylline</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">6.77 (4.07–11.3)</td><td class="colsep0 rowsep0" align="center">1.71 (1.02–2.90)</td><td class="colsep0 rowsep0" align="center">86.4 (73.6–101)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values are geometric means of three experiments and are given in μM with 95% confidence intervals. Numbers in brackets are the numerical value of the standard uncertainty.</p></div></div></div><div class="NLM_p">On the basis of previous results from our group, and on the potent A<sub>3</sub> receptor affinity of some of the described compounds,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> a novel family of coumarin-containing compounds was investigated. Their specific framework formed by an aryl ring attached to position 3 and a substitution pattern at positions 7 and/or 8 was analyzed for their capability to modulate the affinity for adenosine receptor subtypes. Different chemical features were attached to the phenyl ring at position 3, based on their physicochemical properties. Substituents from different quadrants of the Craig plot were explored. In addition, the substitution by alkyl or alkoxy groups was studied. Finally, the difference between the presence of acetoxy and/or hydroxy substituents at 7 and/or 8 positions of the coumarin scaffold was explored in detail. The effect of these substitutions on the binding and the level of selectivity for the receptors was studied and compared. From our analysis, no affinity for the A<sub>2B</sub> receptor was observed (<i>K</i><sub>i</sub> > 30 μM, data not shown).</div><div class="NLM_p">The structural variety on the studied series allowed us to obtain different affinity profiles for the analyzed adenosine receptors. Selective A<sub>3</sub> ligands, A<sub>2A</sub>/A<sub>3</sub> or A<sub>1</sub>/A<sub>3</sub> dual ligands, or nonselective (A<sub>1</sub>/A<sub>2A</sub>/A<sub>3</sub>) ligands were obtained. The analysis of the results allowed us to have a detailed perspective on structure–activity relationships. In general, compounds without attached groups on the 3-phenyl moiety are not selective, presenting affinity for the three adenosine receptors (compounds <b>1</b>, <b>10</b>, <b>18</b>, <b>19</b>, <b>23</b>, and <b>24</b>). This profile is independent of the nature of the 8 substitution (ethoxy, methyl, acetoxy) or even with substitutions at both 7 and 8 positions (compound <b>19</b>). These results are accordant with those obtained in our previous study.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> 8-(2-Oxopropoxy)-3-phenylcoumarin (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A) has reported affinity for three of the studied receptors in the low micromolar range (<i>K</i><sub>i</sub> A<sub>1</sub> = 10.4 μM, <i>K</i><sub>i</sub> A<sub>2A</sub> = 16.1 μM, and <i>K</i><sub>i</sub> A<sub>3</sub> = 7.1 μM).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In the present study, compound <b>24</b> shows similar affinity for the three adenosine receptors (<i>K</i><sub>i</sub> A<sub>1</sub> = 2.4 μM, <i>K</i><sub>i</sub> A<sub>2A</sub> = 12.1 μM, and <i>K</i><sub>i</sub> A<sub>3</sub> = 3.9 μM). In addition, compound <b>24</b> proved to be a better adenosine receptor ligand than theophylline, our reference compound, which is in clinical use to prevent and treat respiratory dysfunctions caused by asthma, emphysema, chronic bronchitis, and other lung diseases.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Besides being an A<sub>2B</sub> receptor antagonist, theophylline is also a nonselective phosphodiesterase inhibitor. The profile of our A<sub>1</sub>/A<sub>2A</sub>/A<sub>3</sub> compounds may be very interesting thinking about multifactorial conditions, as lung ischemia–reperfusion injury, likewise some xanthines, typical adenosine ligands.</div><div class="NLM_p">When the scaffold presents a substituent at position 8 and another one at <i>para</i> position of the 3-aryl moiety, independently of the nature of the substituent at positions 8 (ethoxy, hydroxy, methyl, or methoxy) or 3 (<i>p</i>-methylphenyl, <i>p</i>-bromophenyl, or <i>p</i>-methoxyphenyl), the compounds tend to be strong and selective A<sub>3</sub> ligands (compounds <b>2</b>, <b>4</b>, <b>11</b>, and <b>17</b>). This data expands our previously results.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The nanomolar affinity of compound <b>4</b> for the <i>h</i>A<sub>3</sub> receptor is about 2.5 times higher than that of our earlier reported 8-(2-oxopropoxy)-3-(<i>p</i>-tolyl)coumarin (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> So far, this is the best compound from all our research on the potential of coumarins as adenosine receptor ligands. In both cases, position 8 presents electron donating groups. This characteristic can be important to increase the activity and A<sub>3</sub> selectivity. In addition, it seems that the size of the atom/group at position 8 plays an important role on the activity as well.</div><div class="NLM_p">Another relevant relationship between the structure and the measured activity was observed for the series presenting 2- or 3-substitutions at the 3-aryl ring (<i>meta</i> and <i>para</i> positions). Compounds <b>13</b>, <b>14</b>, and <b>21</b> have affinity for both A<sub>2A</sub> and A<sub>3</sub>, and compound <b>15</b> has affinity for A<sub>1</sub> and A<sub>3</sub> receptors. The only example of a disubstituted compound at <i>ortho</i>/<i>para</i> positions (compound <b>8</b>), proved to be A<sub>3</sub> receptor selective (<i>K</i><sub>i</sub> A<sub>3</sub> = 16.6 μM).</div><div class="NLM_p">Finally, the inclusion of substituents at both 7 and 8 positions of the coumarin ring (both acetoxy and hydroxy groups), independently of the substituents on the 3-aryl ring, tend to give potent nonselective ligands (compounds <b>19</b>, <b>24</b>, <b>25</b>, and <b>27</b>). All these compounds have affinity for the A<sub>1</sub>, A<sub>2A</sub>, and A<sub>3</sub> adenosine receptors in the low micromolar range. Compounds <b>20</b> and <b>22</b> are the exception, being selective for the A<sub>3</sub> receptor.</div><div class="NLM_p">Finally, our most active and selective hA<sub>3</sub> compounds were functionally tested using the GloSensor cAMP assay, which consists in a biosensor technology.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The methodology is detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>, and the binding information is shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Antagonist Activities of <b>2</b>, <b>4</b>, <b>5</b>, and <b>17</b> at the hA<sub>3</sub> Adenosine Receptor<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hA<sub>3</sub> (IC<sub>50</sub> μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>2</b></td><td class="colsep0 rowsep0" align="center">18.4 (10.5–26.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4</b></td><td class="colsep0 rowsep0" align="center">3.1 (1.7–4.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5</b></td><td class="colsep0 rowsep0" align="center">29.5 (17.7–41.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17</b></td><td class="colsep0 rowsep0" align="center">25.3 (15.5–31.1)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The values are given in μM with 95% confidence intervals in parentheses.</p></div></div></div><div class="NLM_p">Cell-based functional assays showed that compounds <b>2</b>, <b>4</b>, <b>5</b>, and <b>17</b> behave as hA<sub>3</sub> receptor antagonists, being able to counteract NECA-inhibited cAMP accumulation.</div><div class="NLM_p last">In a homogeneous family of 27 compounds, it can be clearly observed a pattern of affinity based on the structures (positions and nature of the substituents) that allows new structure–affinity relationship understanding.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Molecular Docking</h3><div class="NLM_p">We studied the most active molecule within the designed family using docking calculations in the hA<sub>3</sub> receptor to establish the key residues and important interactions between the ligand and the protein. Our research group previously generated the hA<sub>3</sub> protein structure by homology modeling (general details are described in Methods).<a onclick="showRef(event, 'ref21 ref32'); return false;" href="javascript:void(0);" class="ref ref21 ref32">(21,32)</a> We docked compound <b>4</b> to the hA<sub>3</sub> with Glide standard precision (SP).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> We followed a similar protocol already described in previous studies<a onclick="showRef(event, 'ref21 ref32'); return false;" href="javascript:void(0);" class="ref ref21 ref32">(21,32)</a> and validated in the hA<sub>2A</sub> protein for which there are some crystal structures available in the PDB. As an example, the root-mean-square deviation (RMSD) comparing ligands theoretical with cocrystallized conformations in the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UZC">3UZC</a> crystal structures<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> was 0.69 and 1.90.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Molecular docking simulations presented a binding pose for compound <b>4</b> in the hA<sub>3</sub> pocket that pointed the 3-aryl portion toward the bottom and the benzene of the coumarin toward the surface (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). Compound <b>4</b> showed a pose in the hA<sub>3</sub> that presented some resemblance with the cocrystallized ligands ZM241385 and T4E in the <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UZC">3UZC</a> hA<sub>2A</sub> crystal structures (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b). The hydroxyl substituent at position 8 along with the carbonyl group are hypothesized to be important for the anchoring with the studied protein and established two hydrogen bonds with the residue Asn250, interacting via its amide (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>c). The equivalent residue in the hA<sub>2A</sub> (Asn253) showed also an important role in ligand interaction in crystallographic and mutagenesis studies.<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a> The benzopyrone moiety is proposed to establish aromatic π–π stacking interactions with Phe168 residue of the second extracellular loop.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) General view of the hA<sub>3</sub> receptor bound to compound <b>4</b>. (b) Comparison of the cocrystallized conformations for the compounds (carbons in green) in the hA<sub>2A</sub> [<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a> (left) and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UZC">3UZC</a> (right)] with the binding mode observed by docking in hA<sub>3</sub> for compound <b>4</b> (pink carbons). Both proteins, hA<sub>2A</sub> and hA<sub>3</sub>, were superimposed. (c) Hypothetical binding mode in the hA<sub>3</sub> determined for compound <b>4</b> along with relevant residues in ligand interaction. Hydrogen bonds are colored in yellow. For clarity, protein ribbons were partially omitted. Template for the hA<sub>3</sub> homology model: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We extended the ligand–protein interaction analysis to per residue energy contributions (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). The total energy is obtained from different contributions considering Coulomb, van der Waals, and H-bond energies. Residues Asn250, Phe168, Ile268, Leu246, Leu264, and Leu90 have the highest contribution in the ligand–protein recognition. Hydroxyl group at position 8 seems to be important for the interaction with residue Asn250, and it could be the explanation for the high activity displayed by compound <b>4</b>. The bromine substituent at <i>para</i> position of the 3-aryl moiety could be also a suitable substituent for the protein interaction. Compound <b>23</b>, structurally similar to compound <b>4</b> but with no substitution in the 3-aryl ring showed a similar binding mode but with lower Coulomb/van der Waals contributions with the residues close to the 3-aryl (see <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). The bromine substituent caused a slight increase in the interaction with residues Leu90, Ser271, and His272 compared to the 3-aryl ring without substituent (compound <b>23</b>). Moreover, we calculated the favored hydrophobic and hydrophilic areas inside the hA<sub>3</sub> protein pocket. The surfaces were generated taking into account the residues located in a radius of 5 Å from the ligand. The hydroxyl substituent presented at 8 position of the coumarin system and the oxygen atoms part of the pyrone system are placed in polar areas, whereas the coumarin and the 3-aryl scaffold are placed in a hydrophobic area (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>c). The bromine atom is buried in a deep hydrophobic area that can favor the interaction with the protein. In fact, besides hydrophobic interactions with residues Trp243 and Leu90 (also shown by compound <b>23</b>), we detected additional hydrophobic interactions with residues Val65 and Val61. The bromine atom does not interact through halogen bonds with the protein, but its hydrophobic nature is well suited for the hydrophobic surrounding residues. Our proposed binding mode explains the high affinity of compound <b>4</b> for hA<sub>3</sub> receptor. Our results agree with previous studies focused on adenosine receptors,<a onclick="showRef(event, 'ref21 ref32 ref34 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref21 ref32 ref34 ref35 ref36 ref37">(21,32,34−37)</a> in which residues as Asn250 and Phe168 were also reported as important in ligand–protein recognition.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Residue contribution to the interaction with ligand <b>4</b> (including van der Waals, Coulomb, and hydrogen bond energies). (b) Differences in the residue contribution of compounds <b>4</b> and <b>23</b>. Bromine substitution in the 3-aryl ring (compound <b>4</b>) causes a higher Coulomb/van der Waals contribution in nearby residues. (c) Hydrophobic (white) and hydrophilic (red) areas inside the hA<sub>3</sub> with the binding mode detected for compound <b>4</b> (isovalues of −0.5 and −4.87 for hydrophobic and hydrophilic surfaces, respectively). The 8-hydroxyl is placed in the hydrophilic area while the 3-aryl scaffold is placed in the hydrophobic one (template for the hA<sub>3</sub> homology model: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a>). (d) Dihedral angle energy plot for compound <b>4</b> extracted from conformational analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The results provided by the docking calculations are aligned with the X-ray structure of compound <b>4</b> (RMSD = 0.16 Å). As the analysis of the conformational preorganization of the compound could provide some insights in drug design,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> we performed a comparative structural study in terms of energetic stabilization around the dihedral angle C(2)–C(3)–C(13)–C(18) between the 3-aryl ring and the coumarin scaffold in compound <b>4</b>. The dihedral angle was rotated in 5° increments during the conformational analysis. Compound <b>4</b> showed two optimal energetic areas with values for the dihedral angle from −140° to −40° and from 40° to 140°. The described X-ray crystallized structure and the docking pose showed values of 145.4° and −152.1° for the dihedral angle. It has been reported that in many cases the bioactive ligand conformation is not correspondent with the global minimum energy conformer as both protein and ligand can reorganize their atomic coordinates to optimize complementarity.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> For compound <b>4</b>, the X-ray and the docking conformation are close to the global minimum energy structure. The dihedral angle energy plot for compound <b>4</b> is shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>d, with the values obtained in docking and X-ray studies.</div><div class="NLM_p">Compound <b>4</b> showed hA<sub>3</sub> activity and no affinity for the other adenosine subtypes. We performed additional molecular docking simulations in the hA<sub>2A</sub> crystallized structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a> to explain the affinity decrease for compound <b>4</b>. Molecular docking with no crystallographic water molecules in the hA<sub>2A</sub> binding region yielded a binding mode deeply buried in the cavity (see <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a). The displacement of water in the pocket could have a positive or negative impact in ligand binding affinity and enthalpy/entropy of the system.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The 4-bromophenyl scaffold of compound <b>4</b> with hydrophobic characteristics is placed in the polar area occupied by the water in the hA<sub>2A</sub>. This scaffold has not the potential to establish similar hydrogen bonds to the hydrogen bonding network described by the water molecules. As a hypothesis, the global process could be energetically unfavorable reducing the activity of compound <b>4</b> in hA<sub>2A</sub>. Nevertheless, the docking with crystallographic water molecules in the hA<sub>2A</sub> cavity showed a pose for compound <b>4</b> that binds a shallower area of the pocket and disrupts key interactions with some residues located deeper in the cavity, such as Asn253 (see <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b). The disruption of the binding mode explained for compound <b>4</b> in the hA<sub>3</sub> could be responsible for the low activity detected in hA<sub>2A</sub>. In fact, compound <b>4</b> showed a different residue profile binding in the hA<sub>3</sub> and hA<sub>2A</sub>, with a clear reduction in the interaction energy between the ligand and Asn253, a key residue in the interaction between compound <b>4</b> and the hA<sub>3</sub> (see <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Superposition of the binding poses for compound <b>4</b> observed by docking in hA<sub>3</sub> (ligand in pink carbons) and hA<sub>2A</sub> (ligand in orange carbons). (a) Hypothetical binding mode of compound <b>4</b> buried in an area of multiple crystallographic water molecules in the hA<sub>2A</sub> (although water molecules are shown in red/white mesh, the docking was performed with no water in the cavity). This hypothetical pose would need to displace the mentioned waters. (b) Hypothetical binding mode of compound <b>4</b> in a shallower area close to the extracellular loops in the hA<sub>2A</sub> (docking performed considering the water molecules presented in the protein pocket). Disruption of the binding mode detected for compound <b>4</b> in hA<sub>3</sub> (carbons in pink) could be the cause of lack of affinity in the hA<sub>2A</sub>. (c) Key residues in ligand recognition in the hA<sub>3</sub> that are not conserved in both hA<sub>2A</sub> and hA<sub>1</sub> subtypes. Other residues that differ in the hA<sub>3</sub>, hA<sub>2A</sub>, and hA<sub>1</sub> subtypes are Leu264, Met270, and Thr270, respectively, not represented in the figure due to clarity reasons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The residue Leu90 in the hA<sub>3</sub> that established key interactions with the 4-bromophenyl of compound <b>4</b> is substituted by Val84 and Val87 in the hA<sub>2A</sub> and hA<sub>1</sub>, respectively, although those residues present similar hydrophobic characteristics. However, some of the residues located in the extracellular domain of the hA<sub>3</sub> are not present in the other subtypes, which can be also an important factor to explain the selectivity. Residues such as Gln167 with polar properties, Val169, Ile253, and Leu264 with hydrophobic characteristics are substituted in the hA<sub>2A</sub> by the corresponding hydrophobic Leu167, the negative charged and hydrophilic Glu169, Thr256 with hydrophilic properties, and the hydrophobic Met270. The subtype hA<sub>1</sub> contains some residues, as Glu170, Glu172, Thr270, and Thr257 with hydrophilic properties more suitable for the interaction with polar substituents. <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>c shows important residues in ligand recognition in the hA<sub>3</sub> that are not conserved in both hA<sub>2A</sub> and hA<sub>1</sub> subtypes. The chemical characteristics of the residues can affect the entrance of the designed ligand in the pocket as well as the accommodation in the binding cleft and favor the selectivity against the hA<sub>3</sub>.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">3-Arylcoumarins proved to be an attractive scaffold for the development of multitarget molecules. In particular, 8-substituted compounds are promising molecules as novel antagonists of adenosine receptors, presenting different affinity and selectivity profiles. An extensive overview of our experimental data helped to conclude that both affinity and/or selectivity profiles of the new molecules against adenosine receptors could be modified taking into account the characteristics of the substituents at positions 3, 7, and 8 of the coumarins. Compound <b>4</b> (3-(4-bromophenyl)-8-hydroxycoumarin) appeared as the best compound within this study and all the molecules developed by our group so far. Its structure was corroborated by X-ray crystallography, revealing that this coumarin derivative presents a <i>p</i>-bromophenyl substituent at 3 position, presenting a hydroxyl group attached to position 8 as well. This last substituent proved to be fundamental for the interaction with Asn250 residue, and it could be the answer to explain the high affinity showed by this antagonist. The substituents on the 3-aryl ring are also important for this selectivity pattern. On the other hand, compound <b>24</b> proved to display the highest affinity on three receptors, being a better ligand than the reference compound, theophylline. This series offers the possibility to better understand important clues to modulate the interactions with adenosine receptors. Compound <b>24</b> can be the inspiration for the design of multifunctional compounds with interest in multifactorial conditions, and compound <b>4</b> can be the inspiration for the development of new coumarins as strong and selective A<sub>3</sub> antagonists.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> General Remarks</h4><div class="NLM_p last">Starting materials and reagents were obtained from commercial suppliers (Sigma-Aldrich) and were used without further purification. Melting points (mp) are uncorrected and were determined with a Reichert Kofler thermopan or in capillary tubes in a Büchi 510 apparatus. <sup>1</sup>H NMR (300 MHz) and <sup>13</sup>C NMR (75.4 MHz) spectra were recorded with a Bruker AMX spectrometer using CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as solvent. Chemical shifts (δ) are expressed in parts per million (ppm) using TMS as an internal standard. Coupling constants <i>J</i> are expressed in hertz (Hz). Spin multiplicities are given as s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet). Mass spectrometry was carried out with a Hewlett-Packard 5988A spectrometer. Elemental analyses were performed by a PerkinElmer 240B microanalyzer and are within ±0.4% of calculated values in all cases. The analytical results document ≥98% purity for all compounds. Flash chromatography (FC) was performed on silica gel (Merck 60, 230–400 mesh); analytical TLC was performed on precoated silica gel plates (Merck 60 F254). Organic solutions were dried over anhydrous sodium sulfate. Concentration and evaporation of the solvent after reaction or extraction was carried out on a rotary evaporator (Büchi Rotavapor) operating under reduced pressure.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> General Procedure for the Synthesis of 3-Phenylcoumarins (<b>1</b>–<b>3</b>, <b>5</b>–<b>14</b>, <b>16</b>, and <b>17</b>)</h4><div class="NLM_p last">A solution of 2-hydroxybenzaldehyde (7.34 mmol) and the corresponding phenylacetic acid (9.18 mmol) in dimethyl sulfoxide (15 mL) was prepared. <i>N</i>,<i>N</i>′-Dicyclohexylcarbodiimide (11.46 mmol) was added, and the mixture was heated in an oil bath at 110 °C for 24 h. Ice (100 mL) and acetic acid (10 mL) were added to the reaction mixture. After keeping it at room temperature for 2 h, the mixture was extracted with ether (3 × 25 mL). The organic layer was extracted with sodium bicarbonate solution (50 mL, 5%) and then water (20 mL). The solvent was evaporated under vacuum, and the dry residue was purified by FC (hexane/ethyl acetate 9:1).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> General Procedure for the Synthesis of Hydroxy-3-phenylcoumarins (<b>4</b> and <b>15</b>)</h4><div class="NLM_p last">A solution of <b>3</b> or <b>14</b> (0.50 mmol) in acetic acid (5 mL) and acetic anhydride (5 mL), at 0 °C, was prepared. Hydriodic acid 57% (10 mL) was added dropwise. The mixture was stirred, under reflux temperature, for 3 h. The solvent was evaporated under vacuum, and the dry residue was purified by crystallization (CH<sub>3</sub>CN).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Procedure for the Synthesis of Acetoxy-3-phenylcoumarins (<b>18</b>–<b>22</b>)</h4><div class="NLM_p last">Compound <b>18</b>–<b>22</b> were synthesized under anhydrous conditions, using material previously dried at 60 °C for at least 12 h and at 300 °C during few minutes immediately before use. A solution containing anhydrous CH<sub>3</sub>CO<sub>2</sub>K (2.94 mmol), phenylacetic acid (1.67 mmol), and the corresponding hydroxysalicylaldehyde (1.67 mmol), in Ac<sub>2</sub>O (1.2 mL), was refluxed for 16 h. The reaction mixture was cooled, neutralized with 10% aqueous NaHCO<sub>3</sub>, and extracted with EtOAc (3 × 30 mL). The organic layers were combined, washed with distilled water, dried (anhydrous Na<sub>2</sub>SO<sub>4</sub>), and evaporated under reduced pressure. The product was purified by recrystallization in EtOH and dried to afford the desired compound.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> General Procedure for the Synthesis of Hydroxy-3-phenylcoumarins (<b>23</b>–<b>27</b>)</h4><div class="NLM_p last">Compounds <b>23</b>–<b>27</b> were obtained by hydrolysis of their acetoxylated counterparts <b>18</b>–<b>22</b>, respectively. The appropriate acetoxylated coumarin, mixed with 2N aqueous HCl and MeOH, was refluxed during 3 h. The resulting reaction mixture was cooled in an ice-bath and the reaction product, obtained as solid, was filtered, washed with cold distilled water, and dried under vacuum to afford the desired compound.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 3-(4-Bromophenyl)-8-ethoxycoumarin (Compound <b>3</b>)</h4><div class="NLM_p last">Yield 41%; mp 162–163 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 1.52 (t, 3H, CH<sub>3</sub>, <i>J</i> = 7.0), 4.20 (q, 2H, CH<sub>2</sub>, <i>J</i> = 7.0), 7.06–7.24 (m, 3H, H-5, H-6, H-7), 7.32–7.45 (m, 4H, H-2′, H-3′, H-5′, H-6′), 7.79 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 14.8, 65.0, 114.7, 119.3, 120.2, 123.14 124.5, 127.3, 130.1, 131.6, 133.6, 140.2, 143.4, 146.4, 159.9. MS <i>m</i>/<i>z</i> (%): 347 (18), 346 (98), 345 (19), 344 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>17</sub>H<sub>13</sub>BrO<sub>3</sub>: C, 59.15; H, 3.80. Found: C 58.98, H 3.80.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 3-(4-Bromophenyl)-8-hydroxycoumarin (Compound <b>4</b>)</h4><div class="NLM_p last">Yield 42%; mp 261–217 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ (ppm), <i>J</i> (Hz): 7.05–7.16 (m, 3H, H-5, H-6, H-7), 7.56–7.71 (m, 4H, H-2′, H-3′, H-5′, H-6′), 8.22 (s, 1H, H-4), 10.27 (s, 1H, OH). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 118.2, 118.7, 120.3, 121.9, 124.6, 125.5, 130.6, 131.2, 133.9, 141.3, 141.7, 144.4, 159.5. MS <i>m</i>/<i>z</i> (%): 319 (16), 318 (98), 317 (17), 316 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>15</sub>H<sub>9</sub>BrO<sub>3</sub>: C, 56.81; H, 2.86. Found: C 56.84, H 2.87.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 8-Ethoxy-3-(3,4-dimethoxyphenyl)coumarin (Compound <b>7</b>)</h4><div class="NLM_p last">Yield 41%; mp 138–139 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 1.53 (t, 3H, CH<sub>3</sub>, <i>J</i> = 7.0), 3.90 (s, 3H, OCH<sub>3</sub>), 3.95 (s, 3H, OCH<sub>3</sub>), 4.21 (q, 2H, CH<sub>2</sub>, <i>J</i> = 7.0), 6.94 (d, 1H, H-7, <i>J</i> = 8.2), 7.02–7.09 (m, 2H, H-2′, H-6′), 7.20 (d, 1H, H-5′, <i>J</i> = 7.9), 7.28–7.33 (m, 2H, H-5, H-6), 7.77 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 14.5, 55.7, 64.6, 110.7, 111.5, 114.0, 118.9, 120.2, 121.0, 124.0, 127.1, 128.0, 138.7, 142.8, 146.0, 148.4, 149.4, 160.1. MS <i>m</i>/<i>z</i> (%): 327 (55), 326 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>19</sub>H<sub>18</sub>O<sub>5</sub>: C, 69.93; H, 5.56. Found: C, 69.91; H, 5.53.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 8-Ethoxy-3-(2,4-dimethoxyphenyl)coumarin (Compound <b>8</b>)</h4><div class="NLM_p last">Yield 36%; mp 95–96 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 1.50 (t, 3H, CH<sub>3</sub>, <i>J</i> = 7.0), 3.80 (s, 3H, OCH<sub>3</sub>), 3.82 (s, 3H, OCH<sub>3</sub>), 4.19 (q, 2H, CH<sub>2</sub>, <i>J</i> = 7.0), 6.45–6.57 (m, 2H, H-3′, H-5′), 7.03–7.09 (m, 1H, H-7), 7.14–7.19 (m, 2H, H-6, H-5), 7.30 (d, 1H, H-6′, <i>J</i> = 8.9), 7.68 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 14.8, 55.4, 55.7, 64.9, 99.0, 104.5, 114.1, 116.8, 119.1, 120.4, 124.0, 126.3, 131.4, 141.4, 146.3, 154.2, 158.3, 160.2, 161.4. MS <i>m</i>/<i>z</i> (%): 327 (12), 326 (M<sup>+</sup>, 47). Anal. Elem. Calcd. for C<sub>19</sub>H<sub>18</sub>O<sub>5</sub>: C, 69.93; H, 5.56. Found: C, 69.96; H, 5.58.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 8-Ethoxy-3-(3,4,5-trimethoxyphenyl)coumarin (Compound <b>9</b>)</h4><div class="NLM_p last">Yield 40%; mp 142–143 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 1.58 (t, 3H, CH<sub>3</sub>, <i>J</i> = 7.0), 3.94 (s, 3H, OCH<sub>3</sub>), 3.96 (s, 3H, OCH<sub>3</sub>), 3.99 (s, 3H, OCH<sub>3</sub>), 4.25 (q, 2H, CH<sub>2</sub>, <i>J</i> = 7.0), 7.0 (s, 2H, H-2′, H-6′), 7.14–7.20 (m, 1H, H-6), 7.24–7.27 (m, 1H, H-7), 7.30–7.32 (m, 1H, H-5), 7.83 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 14.8, 56.2, 56.3, 65.0, 105.9, 114.5, 119.2, 120.3, 124.4, 128.2, 130.2, 139.7, 133.8, 146.3, 153.0. MS <i>m</i>/<i>z</i> (%): 357 (23), 356 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>20</sub>H<sub>20</sub>O<sub>6</sub>: C, 67.41; H, 5.66. Found: C, 67.42; H, 5.68.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 8-Methyl-3-(4-nitrophenyl)coumarin (Compound <b>12</b>)</h4><div class="NLM_p last">Yield 61%; mp 229–230 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ (ppm), <i>J</i> (Hz): 2.38 (s, 3H, CH<sub>3</sub>), 7.28 (t, 1H, H-6, <i>J</i> = 7.4), 7.52 (d, 1H, H-7, <i>J</i> = 7.4), 7.61 (d, 1H, H-5, <i>J</i> = 7.4), 7.99 (d, 2H, H-2′, H-6′, <i>J</i> = 9.0), 8.28 (d, 2H, H-3′, H-5′, <i>J</i> = 9.0), 8.41 (s, 1H, H-4). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 15.3, 123.8, 124.8, 124.9, 125.4, 127.3, 130.2, 131.3, 134.1, 141.8, 143.4, 147.5, 152.0, 159.8. MS <i>m</i>/<i>z</i> (%): 282 (18), 281 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>16</sub>H<sub>11</sub>NO<sub>4</sub>: C, 68.33; H, 3.94. Found: C, 68.36; H, 3.93.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 3-(3,4-Dimethoxyphenyl)-8-methylcoumarin (Compound <b>13</b>)</h4><div class="NLM_p last">Yield 63%; mp 135–136 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 2.51 (s, 3H, CH<sub>3</sub>), 3.94 (s, 6H, 2 × OCH<sub>3</sub>), 6.95 (d, 1H, H-5′, <i>J</i> = 8.1), 7.16–7.39 (m, 5H, H-5, H-6, H-7, H-2′, H-6′), 7.77 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 15.4, 55.9, 110.9, 111.7, 119.4, 121.1, 124.0, 125.4, 125.8, 127.5, 127.5, 132.4, 139.2, 148.6, 149.6, 151.6, 160.9. MS <i>m</i>/<i>z</i> (%): 297 (46), 296 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>18</sub>H<sub>16</sub>O<sub>4</sub>: C, 72.96; H, 5.44. Found: C, 73.00; H, 5.49.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-(3,4,5-Trimethoxyphenyl)-8-methylcoumarin (Compound <b>14</b>)</h4><div class="NLM_p last">Yield 69%; mp 163–164 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 2.49 (s, 3H, CH<sub>3</sub>), 3.89 (s, 3H, OCH<sub>3</sub>), 3.90 (s, 3H, OCH<sub>3</sub>), 3.93 (s, 3H, OCH<sub>3</sub>), 6.95 (s, 2H, H-2′, H-6′), 7.18–7.23 (m, 2H, H-6, H-7), 7.38 (d, 1H, H-5, <i>J</i> = 7.4), 7.79 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 15.4, 56.2, 56.3, 106.0, 119.3, 124.1, 125.6, 125.9, 127.7, 130.3, 132.7, 138.7, 139.9, 151.7, 153.1, 160.7. MS <i>m</i>/<i>z</i> (%): 327 (23), 326 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>19</sub>H<sub>18</sub>O<sub>5</sub>: C, 69.93; H, 5.56. Found: C, 69.96; H, 5.59.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 8-Acetoxy-3-phenylcoumarin (Compound <b>18</b>)</h4><div class="NLM_p last">Yield 64%; mp 189–190 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 2.44 (s, 3H, CH<sub>3</sub>), 7.18–7.50 (m, 7H, H-2′, H-3′, H-4′, H-5′, H-6′, H-6, H-7), 7.66–7.71 (m, 1H, H-5), 7.83 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 20.7, 119.3, 123.0, 124.5, 124.8, 126.0, 128.2, 128.9, 129.2, 135.3, 142.1, 144.2, 149.2, 160.9, 168.5. MS <i>m</i>/<i>z</i> (%): 281 (19), 280 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>17</sub>H<sub>12</sub>O<sub>4</sub>: C, 72.85; H, 4.32. Found: C, 72.90; H, 4.30.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 7,8-Diacetoxy-3-phenylcoumarin (Compound <b>19</b>)</h4><div class="NLM_p last">Yield 81%; mp 171–172 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 2.34 (s, 3H, CH<sub>3</sub>), 2.43 (s, 3H, CH<sub>3</sub>), 7.15 (d, 1H, H-6, <i>J</i> = 8.7), 7.39–7.49 (m, 4H, H-5, H-2′, H-4′, H-6′), 7.64–7.69 (m 2H, H-3′, H-5′), 7.78 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 20.3, 20.6, 118.5, 119.1, 124.9, 128.1, 128.5, 129.0, 130.0, 134.3, 139.1, 144.9, 146.5, 159.0, 167.4, 167.8. MS <i>m</i>/<i>z</i> (%): 339 (11), 338 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>19</sub>H<sub>14</sub>O<sub>6</sub>: C, 67.45; H, 4.17. Found: C, 67.52; H, 4.20.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 7,8-Diacetoxy-3-(4-acetoxyphenyl)coumarin (Compound <b>20</b>)</h4><div class="NLM_p last">Yield 75%; mp 195–196 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 2.32 (s, 3H, CH<sub>3</sub>), 2.34 (s, 3H, CH<sub>3</sub>), 2.42 (s, 3H, CH<sub>3</sub>), 7.13–7.19 (m, 3H, H-6, H-3′, H-5′), 7.41 (d, 1H, H-5, <i>J</i> = 8.7), 7.68 (d, 2H, H-2′, H-6′, <i>J</i> = 8.6), 7.77 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 20.2, 20.5, 21.1, 118.3, 119.1, 121.6, 124.9, 127.1, 129.6, 131.8, 131.9, 139.1, 144.2, 144.92, 151.1, 161.9, 167. 3. MS <i>m</i>/<i>z</i> (%): 397 (9), 396 (M<sup>+</sup>, 93). Anal. Elem. Calcd. for C<sub>21</sub>H<sub>16</sub>O<sub>8</sub>: C, 63.64; H, 4.07. Found: C, 63.61; H, 4.09.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 8-Acetoxy-3-(3,4-diacetoxyphenyl)coumarin (Compound <b>21</b>)</h4><div class="NLM_p last">Yield 47%; mp 144–145 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 2.33 (s, 6H, 2 × CH<sub>3</sub>), 2.44 (s, 3H, CH<sub>3</sub>), 7.27–7.31 (m, 3H, H-5′, H-2′, H-6), 7.41–7.45 (m, 1H, H-7), 7.58–7.64 (m, 2H, H-6′, H-5), 7.84 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 20.6, 20.6, 20.6, 120.6, 123.4, 123.6, 124.3, 125.1, 125.4, 126.6, 127.0, 132.8, 137.5, 139.8, 139.9, 140.0, 141.9, 158.8, 168.0, 168.1, 168.5. MS <i>m</i>/<i>z</i> (%): 397 (15), 396 (M<sup>+</sup>, 89). Anal. Elem. Calcd. for C<sub>21</sub>H<sub>16</sub>O<sub>8</sub>: C, 63.64; H, 4.07. Found: C, 63.66; H, 4.10.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 7,8-Diacetoxy-3-(3,4-diacetoxyphenyl)coumarin (Compound <b>22</b>)</h4><div class="NLM_p last">Yield 54%; mp 202–203 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ (ppm), <i>J</i> (Hz): 2.35 (s, 3H, CH<sub>3</sub>), 2.37 (s, 3H, CH<sub>3</sub>), 2.39 (s, 3H, CH<sub>3</sub>), 2.46 (s, 3H, CH<sub>3</sub>), 7.20 (d, 1H, H-6′, <i>J</i> = 8.6), 7.30 (s, 1H, H-2′), 7.46 (d, 1H, H-5′, <i>J</i> = 8.6), 7.59–7.65 (m, 2H, H-5, H-6), 7.84 (s, 1H, H-4). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ (ppm): 20.1, 20.2, 20.5, 20.6, 118.1, 119.2, 122.0, 123.4, 123.6, 125.9, 126.2, 132.7, 139.5, 141.9, 142.6, 145.1, 148.9, 150.3, 160.4, 167.6. MS <i>m</i>/<i>z</i> (%): 455 (9), 454 (M<sup>+</sup>, 92). Anal. Elem. Calcd. for C<sub>23</sub>H<sub>18</sub>O<sub>10</sub>: C, 60.80; H, 3.99. Found: C, 60.82; H, 4.01.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 7,8-Dihydroxy-3-(4-hydroxyphenyl)coumarin (Compound <b>25</b>)</h4><div class="NLM_p last">Yield 91%; mp 290–291 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ (ppm), <i>J</i> (Hz): 6.78–6.81 (m, 3H, H-6, H-3′, H-5′), 7.04 (d, 1H, H-5, <i>J</i> = 8.5), 7.51–7.55 (m, 2H, H-2′, H-6′), 7.97 (s, 1H, H-4), 9.63 (s, 1H, OH), 10.05 (s, 1H, OH), 10.08 (s, 1H, OH). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 115.0, 115.2, 116.3, 126.0, 126.6, 129.8, 133.6, 139.7, 142.5, 149.0, 149.3, 157.2, 162.7. MS <i>m</i>/<i>z</i> (%): 271 (16), 270 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>15</sub>H<sub>10</sub>O<sub>5</sub>: C, 66.67; H, 3.73. Found: C, 66.65; H, 3.75.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 8-Hydroxy-3-(3,4-dihydroxyphenyl)coumarin (Compound <b>26</b>)</h4><div class="NLM_p">Yield 79%; mp 259–260 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ (ppm), <i>J</i> (Hz): 7.79 (d, 1H, H-5′, <i>J</i> = 8.3), 7.01–7.22 (m, 5H, H-5, H-6, H-7, H-2′, H-6′), 8.03 (s, 1H, H-4), 9.07 (s, 1H, OH), 9.22 (s, 1H, OH), 10.16 (s, 1H, OH). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) δ (ppm): 115.5, 116.2, 117.6, 118.5, 120.0, 120.8, 124.6, 125.9, 126.8, 138.8, 139.0, 145.0, 146.3, 155.2, 164.8. MS <i>m</i>/<i>z</i> (%): 271 (18), 270 (M<sup>+</sup>, 100). Anal. Elem. Calcd. for C<sub>15</sub>H<sub>10</sub>O<sub>5</sub>: C, 66.67; H, 3.73. Found: C, 66.66; H, 3.71.</div><div class="NLM_p last">Compounds <b>1</b>, <b>2</b>, <b>5</b>, <b>6</b>, <b>10</b>, <b>11</b>, <b>15</b>, <b>16</b>, <b>17</b>, <b>23</b>, <b>24</b>, and <b>27</b> have been previously described.<a onclick="showRef(event, 'ref23 ref24 ref25 ref41 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref41 ref42 ref43 ref44 ref45 ref46">(23−25,41−46)</a></div></div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Adenosine Receptors Affinity</h3><div class="NLM_p last">The affinity of the studied compounds for the human adenosine receptor subtypes hA<sub>1</sub>, hA<sub>2A</sub>, and hA<sub>3</sub> was determined with radioligand competition experiments in Chinese hamster ovary (CHO) cells that were stably transfected with the individual receptor subtypes. The radioligands used were 1 nM [<sup>3</sup>H]CCPA for hA<sub>1</sub>, 10 nM [<sup>3</sup>H]NECA for hA<sub>2A</sub>, and 1 nM [<sup>3</sup>H]HEMADO for hA<sub>3</sub> receptors. The results were expressed as <i>K</i><sub>i</sub> values (dissociation constants), which were calculated with the program Prism (GraphPad Software). <i>K</i><sub>i</sub> values are reported as geometric means of three independent experiments with each tested concentration of compound measured in duplicate. As an interval estimate for the dissociation constants, 95% confidence intervals are given in parentheses. Details for pharmacological experiments are described in previous works.<a onclick="showRef(event, 'ref26 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref29">(26,29)</a> Because of the lack of a suitable radioligand for hA<sub>2B</sub> receptors, the potency of antagonists at the hA<sub>2B</sub> receptor (expressed on CHO cells) was determined by inhibition of NECA-stimulated adenylyl cyclase activity.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> GloSensor cAMP Assay</h3><div class="NLM_p last">Functional A<sub>3</sub> adenosine receptor activity was determined using a biosensor technology called GloSensor cAMP assay. It consists of a mutant form of Firefly luciferase into which a cAMP-binding protein moiety has been inserted. When the cAMP binds the biosensor, there is a conformational change which induce an increase of light output that allow to evaluate the activity of ligands at the receptor under study. Briefly, cells stably expressing the hA<sub>3</sub> adenosine receptor and transiently the biosensor were harvested and incubated in equilibration medium containing a 3% v/v GloSensor cAMP reagent stock solution, 10% FBS, and 87% CO<sub>2</sub> independent medium. After 2 h of incubation at room temperature, cells were dispensed in the wells of a 384-well plate and NECA reference agonist or the understudy compounds, at different concentrations, were added. When compounds were unable to inhibit the cAMP production, they were studied as antagonists. In particular, the antagonist profile was evaluated by assessing the ability of these compounds to counteract NECA-induced decrease of cAMP accumulation. Responses were expressed as percentage of the maximal relative luminescence units (RLU). Concentration–response curves were fitted by a nonlinear regression with the Prism 5.0 program (GraphPAD Software, San Diego, CA, USA). The antagonist profile of the compounds was expressed as IC<sub>50</sub>, which is the concentration of antagonists that produces 50% inhibition of the agonist effect. Three independent experiments with each tested concentration of compound measured five times. The final values are given with 95% confidence intervals.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> hA<sub>3</sub> Homology Model</h3><div class="NLM_p">Homology model of hA<sub>3</sub> receptor along with a description of its construction was previously published by our group.<a onclick="showRef(event, 'ref21 ref32'); return false;" href="javascript:void(0);" class="ref ref21 ref32">(21,32)</a> The hA<sub>2A</sub> crystallized structure (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a>)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> was used as a template for the development of the homology model. The alignment between both proteins was reported previously and it is included in Katritch et al.,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> considering highly conserved residues in the TMs. The Homology model module in MOE software was used to develop the hA<sub>3</sub> model.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> For residues that are identical, the heavy atoms coordinates are copied to the new target from the template, whereas only the backbone is taken into account for different residues. The residues placed in the loops with no specified coordinates are constructed based on high resolution fragments available in the PDB. A Boltzmann-weighted function is used for the selection of the loops. The top hA<sub>3</sub> model according to the Generalized Born/Volume Integral (GB/VI) scoring was selected. The geometrical quality of φ–ψ dihedrals, bond lengths, bond angles, dihedrals, side chains, and nonbonded interactions was assessed with the Protein Geometry module. Protein pocket was optimized by docking high affinity ligands using the Induced Fit Docking workflow allowing flexibility in the pocket residues.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The best hA<sub>3</sub> homology models showed ROC curves greater than 0.80 in the discrimination of ligands from decoys. A detailed description of the homology modeling was provided in previous studies.<a onclick="showRef(event, 'ref21 ref32'); return false;" href="javascript:void(0);" class="ref ref21 ref32">(21,32)</a></div><div class="NLM_p last">Moreover, our hA<sub>3</sub> receptor was compared to a model generated using the protein structure homology model server SwissModel.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The server automatically detected the hA<sub>1</sub> (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UEN">5UEN</a>)<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> as the best template and generated a hA<sub>3</sub> model that is in agreement with our reported homology model using as a template the hA<sub>2A</sub> receptor (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a>). The average RMSD between both models is 2.8 Å, whereas the RMSD between both pockets is 0.9 Å. More details about homology model comparison are provided in the <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Molecular Docking</h3><div class="NLM_p last">Molecular docking simulations in the hA<sub>3</sub> and hA<sub>2A</sub> proteins were run using the Schrödinger package.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Ligands were prepared with the LigPrep module that included the next steps: generation of tautomers and different protonation states (pH = 7 ± 2) and optimization of the molecular structures. Protein structures were also prepared with the module Protein Preparation Wizard to optimize protonation states of some residues and the H-bond network of the proteins. After this step, a grid centered in the pocket was generated (van der Waals radius scaling = 1.0; partial charge cutoff = 0.25). The ligands were docked to the hA<sub>3</sub> and hA<sub>2A</sub> using Glide standard precision (SP mode). Top scoring function poses were selected as representative of the simulations.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01572" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01572?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01572</a>. <ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Rationale for this study, crystallographic data of compound <b>4</b>, docking information for compound <b>4</b>, representative hA<sub>3</sub> homology models, and HPLC trace for compound <b>4</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">A3 homology model MOE 1 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">A3 homology model MOE 2 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">A3 homology model SwissModel (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_005.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_001.pdf">jm9b01572_si_001.pdf (536.41 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_002.csv">jm9b01572_si_002.csv (1.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_003.pdb">jm9b01572_si_003.pdb (394.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_004.pdb">jm9b01572_si_004.pdb (394.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_005.pdb">jm9b01572_si_005.pdb (193.0 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01572" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria João Matos</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3470-8299" title="Orcid link">http://orcid.org/0000-0002-3470-8299</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#81ece0f3e8e0ebeee0eeafe2eef3f3e4e8e0f1e8eff5eec1f4f2e2afe4f2a1ece0f3e8e0afece0f5eef2c1e7e2aff4f1aff1f5"><span class="__cf_email__" data-cfemail="7a171b08131b10151b1554191508081f131b0a13140e153a0f0919541f09">[email protected]</span> <span class="__cf_email__" data-cfemail="fe939f8c979fd0939f8a918dbe989dd08b8ed08e8a">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernanda Borges</span> - <span class="hlFld-Affiliation affiliation">CIQUP/Department
of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1050-2402" title="Orcid link">http://orcid.org/0000-0003-1050-2402</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2f494d405d484a5c6f494c015a5f015f5b"><span class="__cf_email__" data-cfemail="096f6b667b6e6c7a496f6a277c7927797d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Santiago Vilar</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saleta Vazquez-Rodriguez</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonja Kachler</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacology and Toxicology, University
of Würzburg, 97078 Würzburg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl-Norbert Klotz</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmacology and Toxicology, University
of Würzburg, 97078 Würzburg, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3553-3205" title="Orcid link">http://orcid.org/0000-0003-3553-3205</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michela Buccioni</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Medicinal Chemistry Unit, University
of Camerino, 62032 Camerino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanna Delogu</span> - <span class="hlFld-Affiliation affiliation">Department
of Life Sciences and Environment—Section of Pharmaceutical
Sciences, University of Cagliari, 09124 Cagliari, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0307-1544" title="Orcid link">http://orcid.org/0000-0003-0307-1544</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lourdes Santana</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eugenio Uriarte</span> - <span class="hlFld-Affiliation affiliation">Department
of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782 Santiago de Compostela, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">Instituto
de Ciencias Químicas Aplicadas, Universidad
Autónoma de Chile, 7500912 Santiago, Chile</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>M.J.M., E.U., and F.B. conceived and supervised the study. M.J.M., S.V.-R., and G.D. performed the synthesis, purification, and characterization of the compounds. E.U. and L.S. cosupervised the synthetic part of the work. S.K. and M.B. performed the pharmacological assays on adenosine receptors. K.-N.K. supervised and validated the pharmacological assays. S.V. performed the docking studies. L.S. and F.B. cosupervised the modeling studies. M.J.M. wrote the manuscript with contributions from all authors. All authors approved the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3978-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was partially supported by University of Porto and University of Santiago de Compostela. We are thankful for the use of RIAIDT-USC analytical facilities. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 744389, supporting S.V.R. postdoctoral fellowship (TEDCIP). We thank Angeles Alvariño Plan Galego de Investigación, Innovación e Crecemento 2011–2015 (S.V.), and the European Social Fund, FCT, POPH, and QREN (SFRH/BPD/95345/2013, M.J.M.) for funding. This project has received funding from Xunta da Galicia and Galician Plan of Research, Innovation and Growth 2011–2015 (Plan I2C, ED481B 2014/086-0 and ED481B 2018/007, M.J.M.). This project was supported by Foundation for Science and Technology (FCT), and FEDER/COMPETE (POCI-01-0145-FEDER-006980). This article is based upon work from COST Action CA15135.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">dissociation constant</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptors</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">Ac<sub>2</sub>O</td><td class="NLM_def"><p class="first last">acetic anhydride</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">μM</td><td class="NLM_def"><p class="first last">micromolar</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">SP</td><td class="NLM_def"><p class="first last">Glide standard precision</p></td></tr><tr><td class="NLM_term">RMSD</td><td class="NLM_def"><p class="first last">root-mean-square deviation</p></td></tr><tr><td class="NLM_term">FC</td><td class="NLM_def"><p class="first last">flash chromatography</p></td></tr><tr><td class="NLM_term">CHO cells</td><td class="NLM_def"><p class="first last">Chinese hamster ovary cells</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]CCPA</td><td class="NLM_def"><p class="first last">(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-2-(2-chloro-6-cyclopentylamino-purin-9-yl)-5-hydroxymethyl-tetrahydro-3,4-diol)</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]NECA</td><td class="NLM_def"><p class="first last">(1-(6-amino-9<i>H</i>-purin-9-yl)-1-deoxy-<i>N</i>-ethyl-β-dribofuronamide)</p></td></tr><tr><td class="NLM_term">[<sup>3</sup>H]HEMADO</td><td class="NLM_def"><p class="first last">2-(1-hexynyl)-<i>N</i><sup>6</sup>-methyladenosine [3H]</p></td></tr><tr><td class="NLM_term">MOE</td><td class="NLM_def"><p class="first last">Molecular Operating Environment</p></td></tr><tr><td class="NLM_term">GB</td><td class="NLM_def"><p class="first last">Generalized Born</p></td></tr><tr><td class="NLM_term">VI</td><td class="NLM_def"><p class="first last">Volume Integral</p></td></tr><tr><td class="NLM_term">ROC</td><td class="NLM_def"><p class="first last">receiver operating characteristic</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramkumar, V.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors: Expression, Function and Regulation</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2024</span>– <span class="NLM_lpage">2052</span>, <span class="refDoi"> DOI: 10.3390/ijms15022024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.3390%2Fijms15022024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=24477263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVWktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=2024-2052&issue=2&author=S.+Shethauthor=R.+Britoauthor=D.+Mukherjeaauthor=L.+P.+Rybakauthor=V.+Ramkumar&title=Adenosine+Receptors%3A+Expression%2C+Function+and+Regulation&doi=10.3390%2Fijms15022024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors: expression, function and regulation</span></div><div class="casAuthors">Sheth, Sandeep; Brito, Rafael; Mukherjea, Debashree; Rybak, Leonard P.; Ramkumar, Vickram</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2024-2052, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors (ARs) comprise a group of G protein-coupled receptors (GPCR) which mediate the physiol. actions of adenosine.  To date, four AR subtypes have been cloned and identified in different tissues.  These receptors have distinct localization, signal transduction pathways and different means of regulation upon exposure to agonists.  This review will describe the biochem. characteristics and signaling cascade assocd. with each receptor and provide insight into how these receptors are regulated in response to agonists.  A key property of some of these receptors is their ability to serve as sensors of cellular oxidative stress, which is transmitted by transcription factors, such as nuclear factor (NF)-κB, to regulate the expression of ARs.  Recent observations of oligomerization of these receptors into homo- and hetero-dimers will be discussed.  In addn., the importance of these receptors in the regulation of normal and pathol. processes such as sleep, the development of cancers and in protection against hearing loss will be examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbxOUNcNjPxbVg90H21EOLACvtfcHk0lh0HPY7hVfoKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVWktrY%253D&md5=64774f90da385624fd6c27531e72e50c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3390%2Fijms15022024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms15022024%26sid%3Dliteratum%253Aachs%26aulast%3DSheth%26aufirst%3DS.%26aulast%3DBrito%26aufirst%3DR.%26aulast%3DMukherjea%26aufirst%3DD.%26aulast%3DRybak%26aufirst%3DL.%2BP.%26aulast%3DRamkumar%26aufirst%3DV.%26atitle%3DAdenosine%2520Receptors%253A%2520Expression%252C%2520Function%2520and%2520Regulation%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2014%26volume%3D15%26issue%3D2%26spage%3D2024%26epage%3D2052%26doi%3D10.3390%2Fijms15022024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—an Update</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1124/pr.110.003285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1124%2Fpr.110.003285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=21303899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1&issue=1&author=B.+B.+Fredholmauthor=A.+P.+IJzermanauthor=K.+A.+Jacobsonauthor=J.+Lindenauthor=C.+E.+M%C3%BCller&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXXI.+Nomenclature+and+Classification+of+Adenosine+Receptors%E2%80%94an+Update&doi=10.1124%2Fpr.110.003285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Linden, Joel; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-34</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  In the 10 years since our previous International Union of Basic and Clin. Pharmacol. report on the nomenclature and classification of adenosine receptors, no developments have led to major changes in the recommendations.  However, there have been so many other developments that an update is needed.  The fact that the structure of one of the adenosine receptors has recently been solved has already led to new ways of in silico screening of ligands.  The evidence that adenosine receptors can form homo- and hetero-multimers has accumulated, but the functional significance of such complexes remains unclear.  The availability of mice with genetic modification of all the adenosine receptors has led to a clarification of the functional roles of adenosine, and to excellent means to study the specificity of drugs.  There are also interesting assocns. between disease and structural variants in one or more of the adenosine receptors.  Several new selective agonists and antagonists have become available.  They provide improved possibilities for receptor classification.  There are also developments hinting at the usefulness of allosteric modulators.  Many drugs targeting adenosine receptors are in clin. trials, but the established therapeutic use is still very limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNqbDC-UZ5sbVg90H21EOLACvtfcHk0lgHGA2mvqTw6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D&md5=e184c127e06b800bbcf15402ed27f02a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003285%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXXI.%2520Nomenclature%2520and%2520Classification%2520of%2520Adenosine%2520Receptors%25E2%2580%2594an%2520Update%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26issue%3D1%26spage%3D1%26doi%3D10.1124%2Fpr.110.003285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verzijl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweemer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göblyös, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Functionally Biased Modulation of A3 Adenosine Receptor Agonist Efficacy and Potency by Imidazoquinolinamine Allosteric Enhancers</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">668</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.06.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bcp.2011.06.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=21718691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFCqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=658-668&issue=6&author=Z.-G.+Gaoauthor=D.+Verzijlauthor=A.+Zweemerauthor=K.+Yeauthor=A.+G%C3%B6bly%C3%B6sauthor=A.+P.+IJzermanauthor=K.+A.+Jacobson&title=Functionally+Biased+Modulation+of+A3+Adenosine+Receptor+Agonist+Efficacy+and+Potency+by+Imidazoquinolinamine+Allosteric+Enhancers&doi=10.1016%2Fj.bcp.2011.06.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally biased modulation of A3 adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers</span></div><div class="casAuthors">Gao, Zhan-Guo; Verzijl, Dennis; Zweemer, Annelien; Ye, Kai; Goeblyoes, Aniko; IJzerman, Adriaan P.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">658-668</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Allosteric modulators for the Gi-coupled A3 adenosine receptor (AR) are of considerable interest as therapeutic agents and as pharmacol. tools to probe various signaling pathways.  In this study, we initially characterized the effects of several imidazoquinolinamine allosteric modulators (LUF5999, LUF6000 and LUF6001) on the human A3 AR stably expressed in CHO cells using a cAMP functional assay.  These modulators were found to affect efficacy and potency of the agonist Cl-IB-MECA differently.  LUF5999 (2-cyclobutyl deriv.) enhanced efficacy but decreased potency.  LUF6000 (2-cyclohexyl deriv.) enhanced efficacy without affecting potency.  LUF6001 (2-H deriv.) decreased both efficacy and potency.  We further compared the agonist enhancing effects of LUF6000 in several other A3 AR-mediated events.  It was shown that although LUF6000 behaved somewhat differently in various signaling pathways, it was more effective in enhancing the effects of low-efficacy than of high-efficacy agonists.  In an assay of cAMP accumulation, LUF6000 enhanced the efficacy of all agonists examd., but in the membrane hyperpolarization assay, it only enhanced the efficacy of partial agonists.  In calcium mobilization, LUF6000 did not affect the efficacy of the full agonist NECA but was able to switch the nucleoside antagonist MRS542 into a partial agonist.  In translocation of β-arrestin2, the agonist-enhancing effect LUF6000 was not pronounced.  In an assay of ERK1/2 phosphorylation LUF6000 did not show any effect on the efficacy of Cl-IB-MECA.  The differential effects of LUF6000 on the efficacy and potency of the agonist Cl-IB-MECA in various signaling pathway were interpreted quant. using a math. model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcGTgKD_XhBLVg90H21EOLACvtfcHk0lgHGA2mvqTw6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFCqu7w%253D&md5=230c20a583d3cca93c56c56c39cb7c22</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.06.017%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DVerzijl%26aufirst%3DD.%26aulast%3DZweemer%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DG%25C3%25B6bly%25C3%25B6s%26aufirst%3DA.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFunctionally%2520Biased%2520Modulation%2520of%2520A3%2520Adenosine%2520Receptor%2520Agonist%2520Efficacy%2520and%2520Potency%2520by%2520Imidazoquinolinamine%2520Allosteric%2520Enhancers%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26issue%3D6%26spage%3D658%26epage%3D668%26doi%3D10.1016%2Fj.bcp.2011.06.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors as Drug Targets – What are the Challenges?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1038/nrd3955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1038%2Fnrd3955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=23535933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXks1Glsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=265-86&issue=4&author=J.+F.+Chenauthor=H.+K.+Eltzschigauthor=B.+B.+Fredholm&title=Adenosine+Receptors+as+Drug+Targets+%E2%80%93+What+are+the+Challenges%3F&doi=10.1038%2Fnrd3955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as drug targets - what are the challenges?</span></div><div class="casAuthors">Chen, Jiang-Fan; Eltzschig, Holger K.; Fredholm, Bertil B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-286</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adenosine signalling has long been a target for drug development, with adenosine itself or its derivs. being used clin. since the 1940s.  In addn., methylxanthines such as caffeine have profound biol. effects as antagonists at adenosine receptors.  Moreover, drugs such as dipyridamole and methotrexate act by enhancing the activation of adenosine receptors.  There is strong evidence that adenosine has a functional role in many diseases, and several pharmacol. compds. specifically targeting individual adenosine receptors - either directly or indirectly - have now entered the clinic.  However, only one adenosine receptor-specific agent - the adenosine A2A receptor agonist regadenoson (Lexiscan; Astellas Pharma) - has so far gained approval from the US Food and Drug Administration (FDA).  Here, we focus on the biol. of adenosine signalling to identify hurdles in the development of addnl. pharmacol. compds. targeting adenosine receptors and discuss strategies to overcome these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqhEzWXi1WS7Vg90H21EOLACvtfcHk0lg3sGy9xRVwIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXks1Glsrs%253D&md5=898fee7a68273ebfbd5a1d3dca307dc5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd3955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3955%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAdenosine%2520Receptors%2520as%2520Drug%2520Targets%2520%25E2%2580%2593%2520What%2520are%2520the%2520Challenges%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D4%26spage%3D265%26epage%3D86%26doi%3D10.1038%2Fnrd3955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Hilaire, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K. C.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Induction of Adenosine Receptor Genes and its Functional Significance</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>218</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1002/jcp.21579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fjcp.21579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=18767039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BD1cjgvFOmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2009&pages=35-44&author=C.+St.%0AHilaireauthor=S.+H.+Carrollauthor=H.+Chenauthor=K.+C.+Ravid&title=Mechanisms+of+Induction+of+Adenosine+Receptor+Genes+and+its+Functional+Significance&doi=10.1002%2Fjcp.21579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of induction of adenosine receptor genes and its functional significance</span></div><div class="casAuthors">St Hilaire Cynthia; Carroll Shannon H; Chen Hongjie; Ravid Katya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adenosine is a metabolite generated and released from cells, particularly under injury or stress.  It elicits protective or damaging responses via signaling through the adenosine receptors, including the adenylyl cyclase inhibitory A(1) and A(3), and the adenylyl cyclase stimulatory A(2A) and A(2B).  Multiple adenosine receptor types, including stimulatory and inhibitory, can be found in the same cell, suggesting that a careful balance of adenosine receptor expression in a particular cell is necessary for a specific adenosine-induced response.  This balance could be controlled by differential expression of the adenosine receptor genes under different stimuli.  Here, we have reviewed an array of studies that have characterized basal or induced expression of the adenosine receptors and common as well as distinct mechanisms of effect, in hopes that ongoing studies on this topic will further elucidate detailed mechanisms of adenosine receptor regulation, leading to potential therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-2wKEeHylQxLDWw4HIq2sfW6udTcc2eZxFT2y21Lp6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjgvFOmuw%253D%253D&md5=3b907b9f761a998ec478f49a2d295798</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21579%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BHilaire%26aufirst%3DC.%26aulast%3DCarroll%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRavid%26aufirst%3DK.%2BC.%26atitle%3DMechanisms%2520of%2520Induction%2520of%2520Adenosine%2520Receptor%2520Genes%2520and%2520its%2520Functional%2520Significance%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2009%26volume%3D218%26spage%3D35%26epage%3D44%26doi%3D10.1002%2Fjcp.21579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1021/cr0682195</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0682195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=238-263&author=P.+Baraldiauthor=M.+Tabriziauthor=S.+Gessiauthor=P.+Borea&title=Adenosine+Receptor+Antagonists%3A+Translating+Medicinal+Chemistry+and+Pharmacology+into+Clinical+Utility&doi=10.1021%2Fcr0682195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Gessi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">238-263</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses the chem. and pharmacol. of adenosine A1, A2A, A2B and A3 receptor antagonists and their therapeutic potential in clin. developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOXhQGKqAVLbVg90H21EOLACvtfcHk0lg3sGy9xRVwIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D&md5=1ae9e978507a1bbe7ab7aea0bdb33bb8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcr0682195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0682195%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%26aulast%3DTabrizi%26aufirst%3DM.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%26atitle%3DAdenosine%2520Receptor%2520Antagonists%253A%2520Translating%2520Medicinal%2520Chemistry%2520and%2520Pharmacology%2520into%2520Clinical%2520Utility%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D238%26epage%3D263%26doi%3D10.1021%2Fcr0682195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of Adenosine, P2Y and P2X Receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.neuropharm.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=26686393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2016&pages=31-49&author=K.+A.+Jacobsonauthor=C.+E.+M%C3%BCller&title=Medicinal+Chemistry+of+Adenosine%2C+P2Y+and+P2X+Receptors&doi=10.1016%2Fj.neuropharm.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine, P2Y and P2X receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-49</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pharmacol. tool compds. are now available to define action at the adenosine (ARs), P2Y and P2X receptors.  We present a selection of the most commonly used agents to study purines in the nervous system.  Some of these compds., including A1 and A3 AR agonists, P2Y1R and P2Y12R antagonists, and P2X3, P2X4 and P2X7 antagonists, are potentially of clin. use in treatment of disorders of the nervous system, such as chronic pain, neurodegeneration and brain injury.  Agonists of the A2AAR and P2Y2R are already used clin., P2Y12R antagonists are widely used antithrombotics and an antagonist of the A2AAR is approved in Japan for treating Parkinson's disease.  The selectivity defined for some of the previously introduced compds. has been revised with updated pharmacol. characterization, for example, various AR agonists and antagonists were deemed A1AR or A3AR selective based on human data, but species differences indicated a redn. in selectivity ratios in other species.  Also, many of the P2R ligands still lack bioavailability due to charged groups or hydrolytic (either enzymic or chem.) instability.  X-ray crystallog. structures of AR and P2YRs have shifted the mode of ligand discovery to structure-based approaches rather than previous empirical approaches.  The X-ray structures can be utilized either for in silico screening of chem. diverse libraries for the discovery of novel ligands or for enhancement of the properties of known ligands by chem. modification.  Although X-ray structures of the zebrafish P2X4R have been reported, there is scant structural information about ligand recognition in these trimeric ion channels.  In summary, there are definitive, selective agonists and antagonists for all of the ARs and some of the P2YRs; while the pharmacochem. of P2XRs is still in nascent stages.  The therapeutic potential of selectively modulating these receptors is continuing to gain interest in such fields as cancer, inflammation, pain, diabetes, ischemic protection and many other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfj6lh6K1FbLVg90H21EOLACvtfcHk0liKCqx7Mj1HUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF&md5=ffcb23c7e271df86ef6b24d88aef2d82</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Adenosine%252C%2520P2Y%2520and%2520P2X%2520Receptors%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D104%26spage%3D31%26epage%3D49%26doi%3D10.1016%2Fj.neuropharm.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Clinical Efficacy of Istradefylline (KW-6002) in Parkinson’s Disease: A Randomized, Controlled Study</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1002/mds.23107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fmds.23107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=20629136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BC3cjltVOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=1437-1443&issue=10&author=Y.+Mizunoauthor=K.+Hasegawaauthor=T.+Kondoauthor=S.+Kunoauthor=M.+Yamamoto&title=Clinical+Efficacy+of+Istradefylline+%28KW-6002%29+in+Parkinson%E2%80%99s+Disease%3A+A+Randomized%2C+Controlled+Study&doi=10.1002%2Fmds.23107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study</span></div><div class="casAuthors">Mizuno Yoshikuni; Hasegawa Kazuko; Kondo Tomoyoshi; Kuno Sadako; Yamamoto Mitsutoshi</div><div class="citationInfo"><span class="NLM_cas:title">Movement disorders : official journal of the Movement Disorder Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1437-43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The objectives of this study were to evaluate the efficacy of istradefylline at an oral dose of 20 mg or 40 mg once daily for 12 weeks in Parkinson's disease (PD) patients with motor complications on levodopa therapy based on the change in the daily OFF time compared with placebo and to assess the safety at these doses.  A total of 363 subjects were randomly assigned to receive 20 mg/day istradefylline (n = 119), 40 mg/day istradefylline (n = 125), or placebo (n = 119).  The primary outcome variable was the change from baseline at endpoint in daily OFF time based on patients' ON/OFF diaries.  At endpoint, the daily OFF time reduced from baseline by 1.31 hours for 20 mg/day istradefylline (P = 0.013 as compared to the placebo), 1.58 hours for 40 mg/day istradefylline (P < 0.001), and 0.66 hours for placebo; istradefylline significantly reduced the daily OFF time compared with placebo.  The UPDRS Part III subscale score (ON state) reduced by 5.7 at endpoint in both istradefylline groups and 3.7 in the placebo group (P = 0.006 for 20 mg/day and P = 0.006 for 40 mg/day group as compared with placebo).  The most commonly reported drug-related treatment emergent adverse event (TEAE) was dyskinesia, which occurred in 2.5% (3/119) of subjects receiving placebo, 8.5% (10/118) receiving 20 mg/day istradefylline, and 6.4% (8/125) receiving 40 mg/day istradefylline.  We conclude that istradefylline at 20 mg and 40 mg once daily is effective in relieving wearing-off fluctuations of PD patients.  In addition, istradefylline was well tolerated at both doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNnUyoaApPXjW1zwg2yUK5fW6udTcc2eYinRWgiWy3f7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjltVOgtw%253D%253D&md5=47a282eaf5cf09beba823b6dd50eeda9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmds.23107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.23107%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DKuno%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DClinical%2520Efficacy%2520of%2520Istradefylline%2520%2528KW-6002%2529%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520A%2520Randomized%252C%2520Controlled%2520Study%26jtitle%3DMov.%2520Disord.%26date%3D2010%26volume%3D25%26issue%3D10%26spage%3D1437%26epage%3D1443%26doi%3D10.1002%2Fmds.23107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diniz, C.</span></span> <span> </span><span class="NLM_article-title">The Adenosinergic System as a Therapeutic Target in The Vasculature: New Ligands and Challenges</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.3390/molecules22050752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.3390%2Fmolecules22050752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOhsLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=752-779&issue=5&author=J.+B.+Sousaauthor=C.+Diniz&title=The+Adenosinergic+System+as+a+Therapeutic+Target+in+The+Vasculature%3A+New+Ligands+and+Challenges&doi=10.3390%2Fmolecules22050752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The adenosinergic system as a therapeutic target in the vasculature: new ligands and challenges</span></div><div class="casAuthors">Sousa, Joana Beatriz; Diniz, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">752/1-752/27</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Adenosine is an adenine base purine with actions as a modulator of neurotransmission, smooth muscle contraction, and immune response in several systems of the human body, including the cardiovascular system.  In the vasculature, four P1-receptors or adenosine receptors-A, AA, AB and A-have been identified.  Adenosine receptors are membrane G-protein receptors that trigger their actions through several signaling pathways and present differential affinity requirements.  Adenosine is an endogenous ligand whose extracellular levels can reach concns. high enough to activate the adenosine receptors.  This nucleoside is a product of enzymic breakdown of extra and intracellular adenine nucleotides and also of S-adenosylhomocysteine.  Adenosine availability is also dependent on the activity of nucleoside transporters (NTs).  The interplay between NTs and adenosine receptors' activities are debated and a particular attention is given to the paramount importance of the disruption of this interplay in vascular pathophysiol., namely in hypertension., The integration of important functional aspects of individual adenosine receptor pharmacol. (such as in vasoconstriction/vasodilation) and morphol. features (within the three vascular layers) in vessels will be discussed, hopefully clarifying the importance of adenosine receptors/NTs for modulating peripheral mesenteric vascular resistance.  In recent years, an increase interest in purine physiol./pharmacol. has led to the development of new ligands for adenosine receptors.  Some of them have been patented as having promising therapeutic activities and some have been chosen to undergo on clin. trials.  Increased levels of endogenous adenosine near a specific subtype can lead to its activation, constituting an indirect receptor targeting approach either by inhibition of NT or, alternatively, by increasing the activity of enzymes responsible for ATP breakdown.  These findings highlight the putative role of adenosinergic players as attractive therapeutic targets for cardiovascular pathologies, namely hypertension, heart failure or stroke.  Nevertheless, several aspects are still to be explored, creating new challenges to be addressed in future studies, particularly the development of strategies able to circumvent the predicted side effects of these therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2JvU6wUIhV7Vg90H21EOLACvtfcHk0liKCqx7Mj1HUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOhsLzK&md5=199d3241100dc332149fb9096b9b85cf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22050752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22050752%26sid%3Dliteratum%253Aachs%26aulast%3DSousa%26aufirst%3DJ.%2BB.%26aulast%3DDiniz%26aufirst%3DC.%26atitle%3DThe%2520Adenosinergic%2520System%2520as%2520a%2520Therapeutic%2520Target%2520in%2520The%2520Vasculature%253A%2520New%2520Ligands%2520and%2520Challenges%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26issue%3D5%26spage%3D752%26epage%3D779%26doi%3D10.3390%2Fmolecules22050752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vecchio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A. T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span> <span> </span><span class="NLM_article-title">New Paradigms in Adenosine Receptor Pharmacology: Allostery, Oligomerization and Biased Agonism</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4036</span>– <span class="NLM_lpage">4046</span>, <span class="refDoi"> DOI: 10.1111/bph.14337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fbph.14337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=29679502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2jsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=4036-4046&issue=21&author=E.+A.+Vecchioauthor=J.+A.+Baltosauthor=A.+T.+N.+Nguyenauthor=A.+Christopoulosauthor=P.+J.+Whiteauthor=L.+T.+May&title=New+Paradigms+in+Adenosine+Receptor+Pharmacology%3A+Allostery%2C+Oligomerization+and+Biased+Agonism&doi=10.1111%2Fbph.14337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism</span></div><div class="casAuthors">Vecchio, Elizabeth A.; Baltos, Jo-Anne; Nguyen, Anh T. N.; Christopoulos, Arthur; White, Paul J.; May, Lauren T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4036-4046</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors are a family of GPCRs contg. four subtypes (A1, A2A, A2B and A3 receptors), all of which bind the ubiquitous nucleoside adenosine.  These receptors play an important role in physiol. and pathophysiol. and therefore represent attractive drug targets for a range of conditions.  The theor. framework surrounding drug action at adenosine receptors now extends beyond the notion of prototypical agonism and antagonism to encompass more complex pharmacol. concepts.  New paradigms include allostery, in which ligands bind a topog. distinct receptor site from that of the endogenous agonist, homomeric or heteromeric interactions across receptor oligomers and biased agonism, i.e., ligand-dependent differential intracellular signalling.  This review provides a concise overview of allostery, oligomerization and biased agonism at adenosine receptors and outlines how these paradigms may enhance future drug discovery endeavours focussed on the development of novel therapeutic agents acting at adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeQa1m_RHgirVg90H21EOLACvtfcHk0ljPmUH5c8ejZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2jsbfI&md5=2548b72a81b3e269198794a19afaf760</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fbph.14337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14337%26sid%3Dliteratum%253Aachs%26aulast%3DVecchio%26aufirst%3DE.%2BA.%26aulast%3DBaltos%26aufirst%3DJ.%2BA.%26aulast%3DNguyen%26aufirst%3DA.%2BT.%2BN.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DP.%2BJ.%26aulast%3DMay%26aufirst%3DL.%2BT.%26atitle%3DNew%2520Paradigms%2520in%2520Adenosine%2520Receptor%2520Pharmacology%253A%2520Allostery%252C%2520Oligomerization%2520and%2520Biased%2520Agonism%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26issue%3D21%26spage%3D4036%26epage%3D4046%26doi%3D10.1111%2Fbph.14337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugliese, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedata, F.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors in Cerebral Ischemia</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-801022-8.00013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2FB978-0-12-801022-8.00013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=25175971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FntlCmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2014&pages=309-348&author=A.+Melaniauthor=A.+M.+Puglieseauthor=F.+Pedata&title=Adenosine+Receptors+in+Cerebral+Ischemia&doi=10.1016%2FB978-0-12-801022-8.00013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors in cerebral ischemia</span></div><div class="casAuthors">Melani Alessia; Pugliese Anna Maria; Pedata Felicita</div><div class="citationInfo"><span class="NLM_cas:title">International review of neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">309-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ischemic stroke is a complex pathology characterized by a sequence of events that evolve over time and space.  It is the second leading cause of death and the main cause of adult long-term disability in developed countries.  At the moment, there is no promising pharmacotherapy for acute ischemic stroke.  Adenosine receptors (A1, A2A, A2B, A3) are important targets for therapeutic implementation in the treatment of stroke because extracellular adenosine concentrations increase dramatically soon after ischemia.  Adenosine receptors located both on central nervous system cells and on immune blood cells exert important roles during ischemia.  The neuroprotective role of adenosine through A1 receptor subtype during ischemia is accepted, but the use of selective A1 agonists is hampered by undesirable side effects such as sedation, bradycardia, and hypotension.  Recently, the A2A receptor subtype emerged as a potential therapeutic attractive target in ischemia.  Evidence suggests that A2A receptor has dual role: in a first phase of ischemia, it potentiates excitotoxicity, while hours and days after ischemia, A2A receptors on immune blood cells potentiate cell adhesion mechanisms and infiltration in the ischemic parenchyma.  Consistently, the use of A2A receptor agonists/antagonists (administered at doses that do not modify blood pressure and heart rate) should be carefully evaluated in function of time after ischemia.  Although much is still to be known about the role of A2B and A3 receptor subtypes in brain ischemia, most consistent information indicates their role in regulation of immunosuppression and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKgIhwf9wekBcr74wzj5o5fW6udTcc2eYXzGH-lZpP4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FntlCmsg%253D%253D&md5=6edc49f13c18f3b95e90620d9a81fc54</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-801022-8.00013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-801022-8.00013-1%26sid%3Dliteratum%253Aachs%26aulast%3DMelani%26aufirst%3DA.%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DAdenosine%2520Receptors%2520in%2520Cerebral%2520Ischemia%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2014%26volume%3D119%26spage%3D309%26epage%3D348%26doi%3D10.1016%2FB978-0-12-801022-8.00013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivkees, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thevananther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span> <span> </span><span class="NLM_article-title">Are A3 Adenosine Receptors Expressed in the Brain?</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1097/00001756-200004070-00026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1097%2F00001756-200004070-00026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10790877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFOgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=1025-1030&issue=5&author=S.+A.+Rivkeesauthor=S.+Thevanantherauthor=H.+Hao&title=Are+A3+Adenosine+Receptors+Expressed+in+the+Brain%3F&doi=10.1097%2F00001756-200004070-00026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Are A3 adenosine receptors expressed in the brain?</span></div><div class="casAuthors">Rivkees, Scott A.; Thevananther, Sundararajah; Hao, Haiping</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">An increasing no. of reports suggest a role for A3 adenosine receptors (A3ARs) in mediating adenosine action in the central nervous system.  However, studies of A3AR localization in the brain have yet to be performed.  To provide insights into the central sites of A3AR action, we compared patterns of A1 and A3AR mRNA and binding site expression in the brains of rats, mice and humans.  We also assessed whether A3 agonists are selective for A3ARs.  Whereas it was possible to detect high-level A1AR expression in many brain regions, it was not possible to detect either A3AR gene or binding site expression in the central nervous system.  When we examd. the affinities of the A3AR agonists Cl-IAB-MECA and IAB-MECA for A1ARs, we found that these compds. bound to A1ARs with high affinity.  These observations suggest that studies using A3-agonists need to consider potential effects of A1ARs activation, as A1ARs are abundantly expressed in the nervous system whereas A3AR expression in the brain cannot be directly demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFts3YxNA6urVg90H21EOLACvtfcHk0ljPmUH5c8ejZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFOgsb0%253D&md5=9f5a92a805f81c544694ea48efb2fb22</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1097%2F00001756-200004070-00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200004070-00026%26sid%3Dliteratum%253Aachs%26aulast%3DRivkees%26aufirst%3DS.%2BA.%26aulast%3DThevananther%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DH.%26atitle%3DAre%2520A3%2520Adenosine%2520Receptors%2520Expressed%2520in%2520the%2520Brain%253F%26jtitle%3DNeuroReport%26date%3D2000%26volume%3D11%26issue%3D5%26spage%3D1025%26epage%3D1030%26doi%3D10.1097%2F00001756-200004070-00026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borea, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merighi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span> <span> </span><span class="NLM_article-title">The A3 Receptor: History and Perspectives</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1124/pr.113.008540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1124%2Fpr.113.008540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=25387804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=74-102&issue=1&author=A.+P.+Boreaauthor=K.+Varaniauthor=F.+Vincenziauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Merighiauthor=S.+Gessi&title=The+A3+Receptor%3A+History+and+Perspectives&doi=10.1124%2Fpr.113.008540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor: history and perspectives</span></div><div class="casAuthors">Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Merighi, Stefania; Gessi, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-102, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  By general consensus, the omnipresent purine nucleoside adenosine is considered a major regulator of local tissue function, esp. when energy supply fails to meet cellular energy demand.  Adenosine mediation involves activation of a family of four G protein-coupled adenosine receptors (ARs): A1, A2A, A2B, and A3.  The A3 adenosine receptor (A3AR) is the only adenosine subtype to be overexpressed in inflammatory and cancer cells, thus making it a potential target for therapy.  Originally isolated as an orphan receptor, A3AR presented a twofold nature under different pathophysiol. conditions: it appeared to be protective/harmful under ischemic conditions, pro/anti-inflammatory, and pro/antitumoral depending on the systems investigated.  Until recently, the greatest and most intriguing challenge has been to understand whether, and in which cases, selective A3 agonists or antagonists would be the best choice.  Today, the choice has been made and A3AR agonists are now under clin. development for some disorders including rheumatoid arthritis, psoriasis, glaucoma, and hepatocellular carcinoma.  More specifically, the interest and relevance of these new agents derives from clin. data demonstrating that A3AR agonists are both effective and safe.  Thus, it will become apparent in the present review that purine scientists do seem to be getting closer to their goal: the incorporation of adenosine ligands into drugs with the ability to save lives and improve human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNTebUcia2x7Vg90H21EOLACvtfcHk0ljPmUH5c8ejZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D&md5=152673d44c951624ccb2ef090ffc670c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fpr.113.008540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.113.008540%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DA.%2BP.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26atitle%3DThe%2520A3%2520Receptor%253A%2520History%2520and%2520Perspectives%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26issue%3D1%26spage%3D74%26epage%3D102%26doi%3D10.1124%2Fpr.113.008540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fishman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span> <span> </span><span class="NLM_article-title">The A3 Adenosine Receptor (A3AR): Therapeutic Target and Predictive Biological Marker in Rheumatoid Arthritis</span>. <i>Clin. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2359</span>– <span class="NLM_lpage">2362</span>, <span class="refDoi"> DOI: 10.1007/s10067-016-3202-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1007%2Fs10067-016-3202-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=26886128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BC28jhsVCktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=2359-2362&issue=9&author=P.+Fishmanauthor=S.+Cohen&title=The+A3+Adenosine+Receptor+%28A3AR%29%3A+Therapeutic+Target+and+Predictive+Biological+Marker+in+Rheumatoid+Arthritis&doi=10.1007%2Fs10067-016-3202-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis</span></div><div class="casAuthors">Fishman Pnina; Cohen Shira</div><div class="citationInfo"><span class="NLM_cas:title">Clinical rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2359-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Gi protein-associated A3 adenosine receptor (A3AR) is over-expressed in inflammatory cells, and this high expression is also reflected in the peripheral blood mononuclear cells of patients with autoimmune inflammatory diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease.  CF101, a selective agonist with high affinity to the A3AR, is known to induce robust anti-inflammatory effect in experimental animal models of adjuvant-, collagen-, and tropomyosin-induced arthritis.  The effect is mediated via a definitive molecular mechanism entailing deregulation of the nuclear factor-κB (NF-κB) and the Wnt signal transduction pathways resulting in apoptosis of inflammatory cells.  CF101 was found to be safe and well tolerated in all preclinical, phase I, and phase II human clinical studies.  In two phase II clinical studies where CF101 was administered to rheumatoid arthritis (RA) patients as a stand-alone drug, a significant anti-rheumatic effect and a direct significant correlation were found between receptor expression at baseline and patients' response to the drug, suggesting that A3AR may be utilized as a predictive biomarker.  The A3AR is a promising therapeutic target in rheumatoid arthritis and can be used also as a biological marker to predict patients' response to CF101.  This is a unique type of a personalized medicine approach which may pave the way for a safe and efficacious treatment for this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeChpzptz2mVHFYivNCdPRfW6udTcc2eZurInzeZMfTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhsVCktA%253D%253D&md5=0b2af53772d34d132cc949069d6744e6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs10067-016-3202-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10067-016-3202-4%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DCohen%26aufirst%3DS.%26atitle%3DThe%2520A3%2520Adenosine%2520Receptor%2520%2528A3AR%2529%253A%2520Therapeutic%2520Target%2520and%2520Predictive%2520Biological%2520Marker%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DClin.%2520Rheumatol.%26date%3D2016%26volume%3D35%26issue%3D9%26spage%3D2359%26epage%3D2362%26doi%3D10.1007%2Fs10067-016-3202-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagatini, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mânica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reschke, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F. B.</span></span> <span> </span><span class="NLM_article-title">The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases</span>. <i>J. Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">4892473</span>, <span class="refDoi"> DOI: 10.1155/2018/4892473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1155%2F2018%2F4892473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=30159340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BB3c3jt1ersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=4892473&author=M.+D.+Bagatiniauthor=A.+A.+Dos+Santosauthor=A.+M.+Cardosoauthor=A.+M%C3%A2nicaauthor=C.+R.+Reschkeauthor=F.+B.+Carvalho&title=The+Impact+of+Purinergic+System+Enzymes+on+Noncommunicable%2C+Neurological%2C+and+Degenerative+Diseases&doi=10.1155%2F2018%2F4892473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases</span></div><div class="casAuthors">Bagatini Margarete Dulce; Cardoso Andreia Machado; Bagatini Margarete Dulce; Cardoso Andreia Machado; Manica Aline; Carvalho Fabiano Barbosa; Dos Santos Alessandra Antunes; Reschke Cristina Ruedell; Carvalho Fabiano Barbosa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4892473</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Evidences show that purinergic signaling is involved in processes associated with health and disease, including noncommunicable, neurological, and degenerative diseases.  These diseases strike from children to elderly and are generally characterized by progressive deterioration of cells, eventually leading to tissue or organ degeneration.  These pathological conditions can be associated with disturbance in the signaling mediated by nucleotides and nucleosides of adenine, in expression or activity of extracellular ectonucleotidases and in activation of P2X and P2Y receptors.  Among the best known of these diseases are atherosclerosis, hypertension, cancer, epilepsy, Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS).  The currently available treatments present limited effectiveness and are mostly palliative.  This review aims to present the role of purinergic signaling highlighting the ectonucleotidases E-NTPDase, E-NPP, E-5'-nucleotidase, and adenosine deaminase in noncommunicable, neurological, and degenerative diseases associated with the cardiovascular and central nervous systems and cancer.  In conclusion, changes in the activity of ectonucleotidases were verified in all reviewed diseases.  Although the role of ectonucleotidases still remains to be further investigated, evidences reviewed here can contribute to a better understanding of the molecular mechanisms of highly complex diseases, which majorly impact on patients' quality of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSx7jOm8URJawvupmecNw_lfW6udTcc2eZurInzeZMfTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3jt1ersA%253D%253D&md5=ab9ec1a51ba98cf1c90d5712951c00da</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1155%2F2018%2F4892473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F4892473%26sid%3Dliteratum%253Aachs%26aulast%3DBagatini%26aufirst%3DM.%2BD.%26aulast%3DDos%2BSantos%26aufirst%3DA.%2BA.%26aulast%3DCardoso%26aufirst%3DA.%2BM.%26aulast%3DM%25C3%25A2nica%26aufirst%3DA.%26aulast%3DReschke%26aufirst%3DC.%2BR.%26aulast%3DCarvalho%26aufirst%3DF.%2BB.%26atitle%3DThe%2520Impact%2520of%2520Purinergic%2520System%2520Enzymes%2520on%2520Noncommunicable%252C%2520Neurological%252C%2520and%2520Degenerative%2520Diseases%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2018%26volume%3D2018%26spage%3D4892473%26doi%3D10.1155%2F2018%2F4892473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Rodriguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span> <span> </span><span class="NLM_article-title">Chalcone-Based Derivatives as New Scaffolds for Ha3 Adenosine Receptor Antagonists</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1111/jphp.12028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fjphp.12028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=23600387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1Wks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=697-703&author=S.+Vazquez-Rodriguezauthor=M.+J.+Matosauthor=L.+Santanaauthor=E.+Uriarteauthor=F.+Borgesauthor=S.+Kachlerauthor=K.-N.+Klotz&title=Chalcone-Based+Derivatives+as+New+Scaffolds+for+Ha3+Adenosine+Receptor+Antagonists&doi=10.1111%2Fjphp.12028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists</span></div><div class="casAuthors">Vazquez-Rodriguez, Saleta; Matos, Maria Joao; Santana, Lourdes; Uriarte, Eugenio; Borges, Fernanda; Kachler, Sonja; Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">697-703</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The synthesis of a new series of coumarin-chalcone hybrids and the pharmacol. characterization of their actions at four subtypes of adenosine receptor (AR) ligands were reported.  The synthesized compds. were characterized in radioligand binding (A1, A2A, and A3) and adenylyl cyclase activity assays (A2B) to det. the affinity of the compds. for the four human AR (hAR) subtypes.  Coumarin-chalcone hybrids were ligands with a novel structure, not reported thus far, that showed varying affinity and selectivity for AR subtypes.  The coumarin-chalcone hybrids in which ring B of the chalcone scaffold was a thiophene were the most potent compds. of the series.  The compd., in which ring A of the chalcone moiety was the Ph ring of the coumarin, showed similar activity against hA1, hA2A and hA3 ARs, while the compd., in which ring A of the chalcone was substituted by the benzopyrone ring of the coumarin moiety, showed similar activity only at the hA3 AR and, therefore, was deemed to be selective (Ki (dissocn. const.) = 5160 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNJuva2zvBTrVg90H21EOLACvtfcHk0litDmjnI6ErSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1Wks78%253D&md5=6af9966f25321ae95d04443867325172</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12028%26sid%3Dliteratum%253Aachs%26aulast%3DVazquez-Rodriguez%26aufirst%3DS.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DChalcone-Based%2520Derivatives%2520as%2520New%2520Scaffolds%2520for%2520Ha3%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26spage%3D697%26epage%3D703%26doi%3D10.1111%2Fjphp.12028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Coumarins and Adenosine Receptors: New Perceptions in Structure-Affinity Relationships</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fcbdd.13075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=28734062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVamsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2018&pages=245-256&author=A.+Fonsecaauthor=M.+J.+Matosauthor=S.+Vilarauthor=S.+Kachlerauthor=K.-N.+Klotzauthor=E.+Uriarteauthor=F.+Borges&title=Coumarins+and+Adenosine+Receptors%3A+New+Perceptions+in+Structure-Affinity+Relationships&doi=10.1111%2Fcbdd.13075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Coumarins and adenosine receptors: New perceptions in structure-affinity relationships</span></div><div class="casAuthors">Fonseca, Andre; Matos, Maria Joao; Vilar, Santiago; Kachler, Sonja; Klotz, Karl-Norbert; Uriarte, Eugenio; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">245-256</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Adenosine receptor (AR) subtypes are involved in several physiol. and pharmacol. processes.  Ligands that are able to selectively modulate one receptor subtype can delay or slow down the progression of diverse diseases.  In this context, our research group focused its investigation into the discovery and development of novel, potent and selective AR ligands based on coumarin scaffold.  Therefore, a series of 3-phenylcarboxamidocoumarins were synthesized and their affinity for the human AR subtypes was screened by radioligand binding assays for A1, A2A and A3 receptors and for A2B by adenylyl cyclase assay.  Compd. I was found to be the most remarkable, with a hA1/hA3 and hA2A/hA3 selectivity of 42, for the A3 AR (Ki = 2.4 μM).  Receptor-driven mol. modeling studies have provided valuable information on the binding/selectivity data of compd. I and for the following optimization process.  Moreover, compd. I presents drug-like properties according to the general guidelines linked to the concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6JtYhlSNRa7Vg90H21EOLACvtfcHk0lj8sHLdi2Duvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVamsrzI&md5=37f108d8bd2bebea6681fba77defca1f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13075%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DCoumarins%2520and%2520Adenosine%2520Receptors%253A%2520New%2520Perceptions%2520in%2520Structure-Affinity%2520Relationships%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2018%26volume%3D91%26spage%3D245%26epage%3D256%26doi%3D10.1111%2Fcbdd.13075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogger, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Adenosine Receptors Binding Affinities of a Series of 3-Arylcoumarins</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1590</span>– <span class="NLM_lpage">1597</span>, <span class="refDoi"> DOI: 10.1111/jphp.12135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fjphp.12135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=24118065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SmurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=1590-1597&author=M.+J.+Matosauthor=V.+Hoggerauthor=A.+Gasparauthor=S.+Kachlerauthor=F.+Borgesauthor=E.+Uriarteauthor=L.+Santanaauthor=K.-N.+Klotz&title=Synthesis+and+Adenosine+Receptors+Binding+Affinities+of+a+Series+of+3-Arylcoumarins&doi=10.1111%2Fjphp.12135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins</span></div><div class="casAuthors">Matos, Maria Joao; Hogger, Veronika; Gaspar, Alexandra; Kachler, Sonja; Borges, Fernanda; Uriarte, Eugenio; Santana, Lourdes; Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1590-1597</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The authors report the synthesis, pharmacol. evaluation, theor. evaluation of absorption, distribution, metab. and excretion properties and structure-activity relationship study of a selected series of 3-arylcoumarin derivs.  Adenosine receptor (ARs) binding activity and selectivity of the synthesized compds. were evaluated in this study.  Different substituents were introduced in both benzene rings of the evaluated scaffold, at positions 6 and 3' or 4' of the moiety.  The lack of data on the 3-arylcoumarin scaffold encouraged us to explore the AR binding activity of a selected series of coumarin derivs.  A series of coumarins was synthesized and evaluated by radioligand binding studies towards ARs.  Analyzing the exptl. data, it can be obsd. that neither the simple 3-arylcoumarin nor the 4'-nitro derivs. presented detectable binding affinity for the evaluated receptors, although most of the other substituted derivs. have good binding affinity profiles, esp. against the hA1/hA3 or only hA3 AR.  One compd. presented the best affinity for hA3 AR (Ki = 2680 nM) and significant selectivity for this subtype.  The title compds. thus formed included a coumarin (benzopyran) derivs. (I) [3-(4-methylphenyl)-6-(2-oxopropoxy)-2H-1-benzopyran-2-one] and related substances, such as 6-methyl-3-(4-methylphenyl)-2H-1-benzopyran-2-one, 6-hydroxy-3-(4-methylphenyl)-2H-1-benzopyran-2-one.  The synthesis of the target compds. was achieved by a reaction of 2-hydroxybenzaldehyde derivs. with benzeneacetic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8M64me97oqLVg90H21EOLACvtfcHk0lj8sHLdi2Duvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SmurzI&md5=3ffd0aaf4891d62ee7f9aa973871dbf0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12135%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DHogger%26aufirst%3DV.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DSynthesis%2520and%2520Adenosine%2520Receptors%2520Binding%2520Affinities%2520of%2520a%2520Series%2520of%25203-Arylcoumarins%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26spage%3D1590%26epage%3D1597%26doi%3D10.1111%2Fjphp.12135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span> <span> </span><span class="NLM_article-title">Targeting Adenosine Receptors with Coumarins: Synthesis and Binding Activities of Amide and Carbamate Derivatives</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.2012.01571.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fj.2042-7158.2012.01571.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=23215685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVOh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=30-34&author=M.+J.+Matosauthor=A.+Gasparauthor=S.+Kachlerauthor=K.-N.+Klotzauthor=F.+Borgesauthor=L.+Santanaauthor=E.+Uriarte&title=Targeting+Adenosine+Receptors+with+Coumarins%3A+Synthesis+and+Binding+Activities+of+Amide+and+Carbamate+Derivatives&doi=10.1111%2Fj.2042-7158.2012.01571.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives</span></div><div class="casAuthors">Matos, Maria Joao; Gaspar, Alexandra; Kachler, Sonja; Klotz, Karl-Norbert; Borges, Fernanda; Santana, Lourdes; Uriarte, Eugenio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-34</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives With the aim of finding the structural features governing binding activity and selectivity against adenosine receptors (ARs), several 3-substituted coumarins with amide (compds. 3-6) and carbamate (7-9) functions were synthesized.  To study its possible influence on the binding activity and selectivity, a hydroxyl substituent was also introduced at position 4 of the coumarin moiety.  Methods A new series of coumarins (3-9) were synthesized and evaluated by radioligand binding studies towards ARs.  Key findings None of the 4-hydroxy derivs. (4, 8 and 9) showed binding affinity for any of the ARs.  None of the compds. interacted with the hA2B AR (Ki > 100000 nM).  Compds. 3, 5, 6 and 7 had different activity profiles with dissimilar binding affinity and selectivity towards human A1, A2A and A3 ARs.  Conclusions The most remarkable deriv. is compd. 7, which presents the best affinity and selectivity for the A3 adenosine receptor (Ki = 5500 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOL9ATbbLhZ7Vg90H21EOLACvtfcHk0lj8sHLdi2Duvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVOh&md5=2a5a569c0aa10441f4c9554b4d4e36d6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2012.01571.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2012.01571.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26atitle%3DTargeting%2520Adenosine%2520Receptors%2520with%2520Coumarins%253A%2520Synthesis%2520and%2520Binding%2520Activities%2520of%2520Amide%2520and%2520Carbamate%2520Derivatives%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26spage%3D30%26epage%3D34%26doi%3D10.1111%2Fj.2042-7158.2012.01571.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celeiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Rodriguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hripcsak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span> <span> </span><span class="NLM_article-title">Development of Novel Adenosine Receptor Ligands Based on the 3-Amidocoumarin Scaffold</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bioorg.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=26042529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=1-6&author=M.+J.+Matosauthor=S.+Vilarauthor=S.+Kachlerauthor=M.+Celeiroauthor=S.+Vazquez-Rodriguezauthor=L.+Santanaauthor=E.+Uriarteauthor=G.+Hripcsakauthor=F.+Borgesauthor=K.-N.+Klotz&title=Development+of+Novel+Adenosine+Receptor+Ligands+Based+on+the+3-Amidocoumarin+Scaffold&doi=10.1016%2Fj.bioorg.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold</span></div><div class="casAuthors">Matos, Maria J.; Vilar, Santiago; Kachler, Sonja; Celeiro, Maria; Vazquez-Rodriguez, Saleta; Santana, Lourdes; Uriarte, Eugenio; Hripcsak, George; Borges, Fernanda; Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the aim of finding new adenosine receptor (AR) ligands presenting the 3-amidocoumarin scaffold, a study focusing on the discovery of new chem. entities was carried out.  The synthesized compds. 1-8 were evaluated in radioligand binding (A1, A2A and A3) and adenylyl cyclase activity (A2B) assays in order to det. their affinity for human AR subtypes.  The 3-benzamide deriv. 4 showed the highest affinity of the whole series and was more than 30-fold selective for the A3 AR (Ki = 3.24 μM).  The current study supported that small structural changes in this scaffold allowed modulating the affinity resulting in novel promising classes of A1, A2A, and/or A3 AR ligands.  We also performed docking calcns. in hA2A and hA3 to identify the hypothetical binding mode for the most active compds.  In addn., some ADME properties were calcd. in order to better understand the potential of these compds. as drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7DQKokPB-K7Vg90H21EOLACvtfcHk0lgvplmw1ceAVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFOhtb8%253D&md5=4e178d4d19bd1fd80837ce64f5780d98</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DCeleiro%26aufirst%3DM.%26aulast%3DVazquez-Rodriguez%26aufirst%3DS.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DHripcsak%26aufirst%3DG.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DDevelopment%2520of%2520Novel%2520Adenosine%2520Receptor%2520Ligands%2520Based%2520on%2520the%25203-Amidocoumarin%2520Scaffold%26jtitle%3DBioorg.%2520Chem.%26date%3D2015%26volume%3D61%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.bioorg.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatonetti, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span> <span> </span><span class="NLM_article-title">Insight into the Interactions Between Novel Coumarin Derivatives and Human A3 Adenosine Receptors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2253</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201402205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fcmdc.201402205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=25044491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyhu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2245-2253&author=M.+J.+Matosauthor=S.+Vilarauthor=S.+Kachlerauthor=A.+Fonsecaauthor=L.+Santanaauthor=E.+Uriarteauthor=F.+Borgesauthor=N.+P.+Tatonettiauthor=K.-N.+Klotz&title=Insight+into+the+Interactions+Between+Novel+Coumarin+Derivatives+and+Human+A3+Adenosine+Receptors&doi=10.1002%2Fcmdc.201402205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into the Interactions between Novel Coumarin Derivatives and Human A3 Adenosine Receptors</span></div><div class="casAuthors">Matos, Maria Joao; Vilar, Santiago; Kachler, Sonja; Fonseca, Andre; Santana, Lourdes; Uriarte, Eugenio; Borges, Fernanda; Tatonetti, Nicholas P.; Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2245-2253</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A study focused on the discovery of new chem. entities based on the 3-arylcoumarin scaffold was performed with the aim of finding new adenosine receptor (AR) ligands.  Thirteen synthesized compds. were evaluated by radioligand binding (A1, A2A, and A3) and adenylyl cyclase activity (A2B) assays in order to study their affinity for the four human AR (hAR) subtypes.  Seven of the studied compds. proved to be selective A3AR ligands, with 3-(4'-methylphenyl)-8-(2-oxopropoxy)coumarin (12) being the most potent (Ki=634 nM).  None of the compds. showed affinity for the A2B receptor, while four compds. were found to be nonselective AR ligands for the other three subtypes.  Docking simulations were carried out to identify the hypothetical binding mode and to rationalize the interaction of these types of coumarin derivs. with the binding site of the three ARs to which binding was obsd.  The results allowed us to conclude that the 3-arylcoumarin scaffold composes a novel and promising class of A3AR ligands.  ADME properties were also calcd., with the results suggesting that these compds. are promising leads for the identification of new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs6OAyWmTkdrVg90H21EOLACvtfcHk0lgvplmw1ceAVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyhu7bI&md5=b08e49f24f95617e44de75b09e44ad26</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402205%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DTatonetti%26aufirst%3DN.%2BP.%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DInsight%2520into%2520the%2520Interactions%2520Between%2520Novel%2520Coumarin%2520Derivatives%2520and%2520Human%2520A3%2520Adenosine%2520Receptors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D2245%26epage%3D2253%26doi%3D10.1002%2Fcmdc.201402205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hripcsak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fais, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Petrillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pintus, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Era, B.</span></span> <span> </span><span class="NLM_article-title">Design and Discovery of Tyrosinase Inhibitors Based on a Coumarin Scaffold</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">94227</span>– <span class="NLM_lpage">94235</span>, <span class="refDoi"> DOI: 10.1039/C5RA14465E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1039%2FC5RA14465E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=94227-94235&author=M.+J.+Matosauthor=C.+Varelaauthor=S.+Vilarauthor=G.+Hripcsakauthor=F.+Borgesauthor=L.+Santanaauthor=E.+Uriarteauthor=A.+Faisauthor=A.+Di+Petrilloauthor=F.+Pintusauthor=B.+Era&title=Design+and+Discovery+of+Tyrosinase+Inhibitors+Based+on+a+Coumarin+Scaffold&doi=10.1039%2FC5RA14465E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of tyrosinase inhibitors based on a coumarin scaffold</span></div><div class="casAuthors">Matos, M. J.; Varela, C.; Vilar, S.; Hripcsak, G.; Borges, F.; Santana, L.; Uriarte, E.; Fais, A.; Di Petrillo, A.; Pintus, F.; Era, B.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">114</span>),
    <span class="NLM_cas:pages">94227-94235</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this manuscript we report the synthesis, pharmacol. evaluation and docking studies of a selected series of 3-aryl and 3-heteroarylcoumarins with the aim of finding structural features for the tyrosinase inhibitory activity.  The synthesized compds. were evaluated as mushroom tyrosinase inhibitors.  Compd. 12b showed the lowest IC50 (0.19 μM) of the series, being approx. 100 times more active than kojic acid, used as a ref. compd.  The kinetic studies of tyrosinase inhibition revealed that 12b acts as a competitive inhibitor of mushroom tyrosinase with L-DOPA as the substrate.  Furthermore, the absence of cytotoxicity in B16F10 melanoma cells was detd. for this compd.  The antioxidant profile of all the derivs. was evaluated by measuring radical scavenging capacity (ABTS and DPPH assays).  Docking expts. were carried out on mushroom tyrosinase structures to better understand the structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocYm7xCob9bLVg90H21EOLACvtfcHk0lgvplmw1ceAVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7rI&md5=d74af86449178b65db352238d0b57bda</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC5RA14465E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA14465E%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DVarela%26aufirst%3DC.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DHripcsak%26aufirst%3DG.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DFais%26aufirst%3DA.%26aulast%3DDi%2BPetrillo%26aufirst%3DA.%26aulast%3DPintus%26aufirst%3DF.%26aulast%3DEra%26aufirst%3DB.%26atitle%3DDesign%2520and%2520Discovery%2520of%2520Tyrosinase%2520Inhibitors%2520Based%2520on%2520a%2520Coumarin%2520Scaffold%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D94227%26epage%3D94235%26doi%3D10.1039%2FC5RA14465E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delogu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadda, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Era, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fais, A.</span></span> <span> </span><span class="NLM_article-title">New Halogenated Phenylcoumarins as Tyrosinase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3342</span>– <span class="NLM_lpage">3345</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bmcl.2011.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=21514152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVOgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3342-3345&issue=11&author=M.+J.+Matosauthor=L.+Santanaauthor=E.+Uriarteauthor=G.+Deloguauthor=M.+Cordaauthor=M.+B.+Faddaauthor=B.+Eraauthor=A.+Fais&title=New+Halogenated+Phenylcoumarins+as+Tyrosinase+Inhibitors&doi=10.1016%2Fj.bmcl.2011.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New halogenated phenylcoumarins as tyrosinase inhibitors</span></div><div class="casAuthors">Matos, Maria Joao; Santana, Lourdes; Uriarte, Eugenio; Delogu, Giovanna; Corda, Marcella; Fadda, Maria Benedetta; Era, Benedetta; Fais, Antonella</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3342-3345</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the aim of detg. structural features for tyrosinase inhibitory activity, the synthesis and pharmacol. evaluation of a new series of phenylcoumarin derivs. with different no. of hydroxyl or ether groups and bromo substituent in the scaffold is reported.  The synthesized compds. were evaluated as mushroom tyrosinase inhibitors showing, two of them, lower IC50 than the umbelliferone.  6-Bromo-8-hydroxy-3-(4-hydroxyphenyl)coumarin (IC50 = 215 μM) is the best tyrosinase inhibitor of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqftZAv6PUIH7Vg90H21EOLACvtfcHk0lhkNoEPdG6_Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVOgtr0%253D&md5=ceec63fb215c64c028c5db83bf82d0d9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DDelogu%26aufirst%3DG.%26aulast%3DCorda%26aufirst%3DM.%26aulast%3DFadda%26aufirst%3DM.%2BB.%26aulast%3DEra%26aufirst%3DB.%26aulast%3DFais%26aufirst%3DA.%26atitle%3DNew%2520Halogenated%2520Phenylcoumarins%2520as%2520Tyrosinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D11%26spage%3D3342%26epage%3D3345%26doi%3D10.1016%2Fj.bmcl.2011.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viña, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laguna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span> <span> </span><span class="NLM_article-title">8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fcmdc.201100538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=22287164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2hu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=464-470&issue=3&author=D.+Vi%C3%B1aauthor=M.+J.+Matosauthor=G.+Ferinoauthor=E.+Cadoniauthor=R.+Lagunaauthor=F.+Borgesauthor=E.+Uriarteauthor=L.+Santana&title=8-Substituted+3-Arylcoumarins+as+Potent+and+Selective+MAO-B+Inhibitors%3A+Synthesis%2C+Pharmacological+Evaluation%2C+and+Docking+Studies&doi=10.1002%2Fcmdc.201100538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies</span></div><div class="casAuthors">Vina, Dolores; Matos, Maria J.; Ferino, Giulio; Cadoni, Enzo; Laguna, Reyes; Borges, Fernanda; Uriarte, Eugenio; Santana, Lourdes</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">464-470</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Neurodegenerative disorders are becoming more prevalent given the increase in the aging population.  This has inspired active research in the development of new drugs that could mark an important advance in the treatment of complex diseases such as Alzheimer's and Parkinson's.  With the aim of finding new MAO-B-selective inhibitors, we report the synthesis, in vitro evaluation, and docking simulation of a new series of 3-arylcoumarins variously substituted at the 8-position.  Most of the studied compds. show high affinity and selectivity for the hMAO-B isoform, with IC50 values in the low micro- to nanomolar range.  Some of them have greater hMAO-B inhibitory activity and selectivity than the ref. compd., selegiline.  Compds. 7 and 8 are the most active of this series, with compd. 8 being fivefold more potent against MAO-B and severalfold more selective than selegiline.  Docking expts. were carried out with hMAO-B crystal structures, providing new information about the enzyme-inhibitor interaction and the potential therapeutic application of the new 8-substituted 3-arylcoumarins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDGolnNgSgF7Vg90H21EOLACvtfcHk0lhkNoEPdG6_Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2hu7k%253D&md5=9c309ac91ff49e2a802f25f4ad94f087</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100538%26sid%3Dliteratum%253Aachs%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DFerino%26aufirst%3DG.%26aulast%3DCadoni%26aufirst%3DE.%26aulast%3DLaguna%26aufirst%3DR.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26atitle%3D8-Substituted%25203-Arylcoumarins%2520as%2520Potent%2520and%2520Selective%2520MAO-B%2520Inhibitors%253A%2520Synthesis%252C%2520Pharmacological%2520Evaluation%252C%2520and%2520Docking%2520Studies%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26issue%3D3%26spage%3D464%26epage%3D470%26doi%3D10.1002%2Fcmdc.201100538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Cruz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Rodriguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olea-Azar, C.</span></span> <span> </span><span class="NLM_article-title">Remarkable Antioxidant Properties of a Series of Hydroxy-3-Arylcoumarins</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3900</span>– <span class="NLM_lpage">3906</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bmc.2013.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=23673214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsleqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3900-3906&issue=13&author=M.+J.+Matosauthor=F.+Perez-Cruzauthor=S.+Vazquez-Rodriguezauthor=E.+Uriarteauthor=L.+Santanaauthor=F.+Borgesauthor=C.+Olea-Azar&title=Remarkable+Antioxidant+Properties+of+a+Series+of+Hydroxy-3-Arylcoumarins&doi=10.1016%2Fj.bmc.2013.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins</span></div><div class="casAuthors">Matos, Maria Joao; Perez-Cruz, Fernanda; Vazquez-Rodriguez, Saleta; Uriarte, Eugenio; Santana, Lourdes; Borges, Fernanda; Olea-Azar, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3900-3906</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present work we synthesized a series of hydroxy-3-arylcoumarins (compds. 1-9), some of them previously described as MAO-B selective inhibitors, with the aim of evaluating their antioxidant properties.  Theor. evaluation of ADME properties of all the derivs. was also carried out.  From the ORAC-FL, ESR and CV data it was concluded that these derivs. are very good antioxidants, with a very interesting hydroxyl, DPPH and superoxide radicals scavenging profiles.  In particular compd. 9 is the most active and effective antioxidant of the series (ORAC-FL = 13.5, capacity of scavenging hydroxyl radicals = 100%, capacity of scavenging DPPH radicals = 65.9% and capacity of scavenging superoxide radicals = 71.5%).  Kinetics profile for protection fluorescein probe against peroxyl radicals by addn. of antioxidant mol. 9 was also performed.  Therefore, it can operate as a potential candidate for preventing or minimizing the free radicals overprodn. in oxidative-stress related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9NoLmbV6qLVg90H21EOLACvtfcHk0lhkNoEPdG6_Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsleqt7k%253D&md5=6c21d83cef81ccc391ad6e7a33c69089</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DPerez-Cruz%26aufirst%3DF.%26aulast%3DVazquez-Rodriguez%26aufirst%3DS.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DOlea-Azar%26aufirst%3DC.%26atitle%3DRemarkable%2520Antioxidant%2520Properties%2520of%2520a%2520Series%2520of%2520Hydroxy-3-Arylcoumarins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D13%26spage%3D3900%26epage%3D3906%26doi%3D10.1016%2Fj.bmc.2013.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span> <span> </span><span class="NLM_article-title">CCDC 1937910: Experimental Crystal Structure Determination</span>. <i>CSD Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.5517/ccdc.csd.cc231k7z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.5517%2Fccdc.csd.cc231k7z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+J.+Matos&title=CCDC+1937910%3A+Experimental+Crystal+Structure+Determination&doi=10.5517%2Fccdc.csd.cc231k7z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.5517%2Fccdc.csd.cc231k7z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5517%252Fccdc.csd.cc231k7z%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26atitle%3DCCDC%25201937910%253A%2520Experimental%2520Crystal%2520Structure%2520Determination%26jtitle%3DCSD%2520Commun.%26date%3D2019%26doi%3D10.5517%2Fccdc.csd.cc231k7z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span> <span> </span><span class="NLM_article-title">3-Phenylcoumarin</span>. <i>Acta Crystallogr., Sect. E: Struct. Rep. Online</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>E68</i></span>,  <span class="NLM_fpage">o2645</span>, <span class="refDoi"> DOI: 10.1107/S1600536812034277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1107%2FS1600536812034277" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=E68&publication_year=2012&pages=o2645&author=M.+J.+Matosauthor=L.+Santanaauthor=E.+Uriarte&title=3-Phenylcoumarin&doi=10.1107%2FS1600536812034277"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS1600536812034277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600536812034277%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26atitle%3D3-Phenylcoumarin%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Struct.%2520Rep.%2520Online%26date%3D2012%26volume%3DE68%26spage%3Do2645%26doi%3D10.1107%2FS1600536812034277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kull, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, M. J.</span></span> <span> </span><span class="NLM_article-title">Comparative Pharmacology of Human Adenosine Receptor Subtypes - Characterization of Stably Transfected Receptors in CHO Cells</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/PL00005131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1007%2FPL00005131" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1997&pages=1-9&author=K.-N.+Klotzauthor=J.+Hesslingauthor=J.+Heglerauthor=C.+Owmanauthor=B.+Kullauthor=B.+B.+Fredholmauthor=M.+J.+Lohse&title=Comparative+Pharmacology+of+Human+Adenosine+Receptor+Subtypes+-+Characterization+of+Stably+Transfected+Receptors+in+CHO+Cells&doi=10.1007%2FPL00005131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2FPL00005131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005131%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DHessling%26aufirst%3DJ.%26aulast%3DHegler%26aufirst%3DJ.%26aulast%3DOwman%26aufirst%3DC.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26atitle%3DComparative%2520Pharmacology%2520of%2520Human%2520Adenosine%2520Receptor%2520Subtypes%2520-%2520Characterization%2520of%2520Stably%2520Transfected%2520Receptors%2520in%2520CHO%2520Cells%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1997%26volume%3D357%26spage%3D1%26epage%3D9%26doi%3D10.1007%2FPL00005131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falgner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambertucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vittori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristalli, G.</span></span> <span> </span><span class="NLM_article-title">[3H]HEMADO–a novel Tritiated Agonist Selective for the Human Adenosine A3 Receptor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>556</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2006.10.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.ejphar.2006.10.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=17126322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1CrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=556&publication_year=2007&pages=14-18&author=K.-N.+Klotzauthor=N.+Falgnerauthor=S.+Kachlerauthor=C.+Lambertucciauthor=S.+Vittoriauthor=R.+Volpiniauthor=G.+Cristalli&title=%5B3H%5DHEMADO%E2%80%93a+novel+Tritiated+Agonist+Selective+for+the+Human+Adenosine+A3+Receptor&doi=10.1016%2Fj.ejphar.2006.10.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]HEMADO- a novel tritiated agonist selective for the human adenosine A3 receptor</span></div><div class="casAuthors">Klotz, Karl-Norbert; Falgner, Nico; Kachler, Sonja; Lambertucci, Catia; Vittori, Sauro; Volpini, Rosaria; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">556</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">14-18</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine A3 receptors are promising drug targets for a no. of conditions like inflammatory diseases including asthma, ischemic injury or certain types of cancer.  Consequently, intense efforts are dedicated to the development of selective A3 agonists and antagonists.  The only tritiated agonist that is available for radioligand binding is the nonselective [3H]5'-N-ethylcarboxamidoadenosine ([3H]NECA).  Based on a recently characterized series of 2-substituted adenosine receptor agonists we developed a tritiated selective A3 radioligand with high affinity.  From this series 2-hexyn-1-yl-N6-methyladenosine (HEMADO) with a Ki-value of 1.1 nM at the human A3 subtype was chosen.  HEMADO is 300-fold selective vs. the A1 subtype, and 1100-fold and more than 25,000-fold selective compared to the adenosine A2A and A2B receptors, resp.  The tritiated deriv. [3H]HEMADO exhibited the same affinity as the unlabeled precursor.  In concns. up to 10 nM no specific binding to adenosine A1, A2A or A2B receptors was obsd. confirming the high selectivity for adenosine A3 receptors.  Characterization of [3H]HEMADO in radioligand binding studies revealed reversible binding to the human adenosine A3 subtype.  In satn. binding studies for the A3 subtype a KD-value of 1.1 nM was detd.  Nonspecific binding at a radioligand concn. of 1 nM amounted to 1-2% of total binding.  Competition binding with a panel of adenosine receptor ligands clearly confirmed the correct A3 pharmacol. of the binding site labeled by [3H]HEMADO.  With [3H]HEMADO we present a tritiated agonist with high affinity and A3-selectivity and very low nonspecific binding.  [3H]HEMADO is a useful tool for specific screening for A3 receptor agonists and antagonists in improved radioligand binding assays with the human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWoJyAB1P49LVg90H21EOLACvtfcHk0lirb72xo0pifA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1CrsQ%253D%253D&md5=91eb5e9810e75d1ca825a804c767929c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.10.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.10.048%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DFalgner%26aufirst%3DN.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3D%255B3H%255DHEMADO%25E2%2580%2593a%2520novel%2520Tritiated%2520Agonist%2520Selective%2520for%2520the%2520Human%2520Adenosine%2520A3%2520Receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D556%26spage%3D14%26epage%3D18%26doi%3D10.1016%2Fj.ejphar.2006.10.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gazoni, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kron, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laubach, V. E.</span></span> <span> </span><span class="NLM_article-title">Activation of A1, A2A, or A3 Adenosine Receptors Attenuates Lung Ischemia-Reperfusion Injury</span>. <i>J. Thorac. Cardiovasc. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1016/j.jtcvs.2010.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.jtcvs.2010.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=20398911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFeluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=440-446&issue=2&author=L.+M.+Gazoniauthor=D.+M.+Waltersauthor=E.+B.+Ungerauthor=J.+Lindenauthor=I.+L.+Kronauthor=V.+E.+Laubach&title=Activation+of+A1%2C+A2A%2C+or+A3+Adenosine+Receptors+Attenuates+Lung+Ischemia-Reperfusion+Injury&doi=10.1016%2Fj.jtcvs.2010.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury</span></div><div class="casAuthors">Gazoni, Leo M.; Walters, Dustin M.; Unger, Eric B.; Linden, Joel; Kron, Irving L.; Laubach, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thoracic and Cardiovascular Surgery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">440-446</span>CODEN:
                <span class="NLM_cas:coden">JTCSAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-5223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Adenosine and the activation of specific adenosine receptors are implicated in the attenuation of inflammation and organ ischemia-reperfusion injury.  We hypothesized that activation of A1, A2A, or A3 adenosine receptors would provide protection against lung ischemia-reperfusion injury.  With the use of an isolated, ventilated, blood-perfused rabbit lung model, lungs underwent 18 h of cold ischemia followed by 2 h of reperfusion.  Lungs were administered vehicle, adenosine, or selective A1, A2A, or A3 receptor agonists (CCPA, ATL-313, or IB-MECA, resp.) alone or with their resp. antagonists (DPCPX, ZM241385, or MRS1191) during reperfusion.  Compared with the vehicle-treated control group, treatment with A1, A2A, or A3 agonists significantly improved function (increased lung compliance and oxygenation and decreased pulmonary artery pressure), decreased neutrophil infiltration by myeloperoxidase activity, decreased edema, and reduced tumor necrosis factor-α prodn.  Adenosine treatment was also protective, but not to the level of the agonists.  When each agonist was paired with its resp. antagonist, all protective effects were blocked.  The A2A agonist reduced pulmonary artery pressure and myeloperoxidase activity and increased oxygenation to a greater degree than the A1 or A3 agonists.  Selective activation of A1, A2A, or A3 adenosine receptors provides significant protection against lung ischemia-reperfusion injury.  The decreased elaboration of the potent proinflammatory cytokine tumor necrosis factor-α and decreased neutrophil sequestration likely contribute to the overall improvement in pulmonary function.  These results provide evidence for the therapeutic potential of specific adenosine receptor agonists in lung transplant recipients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGFgiNUC0CcrVg90H21EOLACvtfcHk0lh4RlsgwX5mWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFeluro%253D&md5=1a32867dc18f32ef27ec596641329a7f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jtcvs.2010.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jtcvs.2010.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DGazoni%26aufirst%3DL.%2BM.%26aulast%3DWalters%26aufirst%3DD.%2BM.%26aulast%3DUnger%26aufirst%3DE.%2BB.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DKron%26aufirst%3DI.%2BL.%26aulast%3DLaubach%26aufirst%3DV.%2BE.%26atitle%3DActivation%2520of%2520A1%252C%2520A2A%252C%2520or%2520A3%2520Adenosine%2520Receptors%2520Attenuates%2520Lung%2520Ischemia-Reperfusion%2520Injury%26jtitle%3DJ.%2520Thorac.%2520Cardiovasc.%2520Surg.%26date%3D2010%26volume%3D140%26issue%3D2%26spage%3D440%26epage%3D446%26doi%3D10.1016%2Fj.jtcvs.2010.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buccioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marucci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Ben, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacobbe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambertucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soverchia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristalli, G.</span></span> <span> </span><span class="NLM_article-title">Innovative Functional cAMP Assay for Studying G Protein-Coupled Receptors: Application to the Pharmacological Characterization of GPR17</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">468</span>, <span class="refDoi"> DOI: 10.1007/s11302-011-9245-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1007%2Fs11302-011-9245-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=21773766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=463-468&author=M.+Buccioniauthor=G.+Marucciauthor=D.+Dal+Benauthor=D.+Giacobbeauthor=C.+Lambertucciauthor=L.+Soverchiaauthor=A.+Thomasauthor=R.+Volpiniauthor=G.+Cristalli&title=Innovative+Functional+cAMP+Assay+for+Studying+G+Protein-Coupled+Receptors%3A+Application+to+the+Pharmacological+Characterization+of+GPR17&doi=10.1007%2Fs11302-011-9245-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17</span></div><div class="casAuthors">Buccioni, Michela; Marucci, Gabriella; Dal Ben, Diego; Giacobbe, Dania; Lambertucci, Catia; Soverchia, Laura; Thomas, Ajiroghene; Volpini, Rosaria; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-468</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this work, an innovative and non-radioactive functional cAMP assay was validated at the GPR17 receptor.  This assay provides a simple and powerful new system to monitor G protein-coupled receptor activity through change in the intracellular cAMP concn. by using a mutant form of Photinus pyralis luciferase into which a cAMP-binding protein moiety has been inserted.  Results, expressed as EC50 or IC50 values for agonists and antagonists, resp., showed a strong correlation with those obtained with [35S]GTPγS binding assay, thus confirming the validity of this approach in the study of new ligands for GPR17.  Moreover, this method allowed confirming that GPR17 is coupled with a Gαi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfNXVrhfnAvLVg90H21EOLACvtfcHk0lh4RlsgwX5mWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegurnO&md5=86d1de424c0c9ecbe2a59bc0247d7f3f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11302-011-9245-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-011-9245-8%26sid%3Dliteratum%253Aachs%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DGiacobbe%26aufirst%3DD.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DSoverchia%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DInnovative%2520Functional%2520cAMP%2520Assay%2520for%2520Studying%2520G%2520Protein-Coupled%2520Receptors%253A%2520Application%2520to%2520the%2520Pharmacological%2520Characterization%2520of%2520GPR17%26jtitle%3DPurinergic%2520Signalling%26date%3D2011%26volume%3D7%26spage%3D463%26epage%3D468%26doi%3D10.1007%2Fs11302-011-9245-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hripcsak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Navigating in Chromone Chemical Space: Discovery of Novel and Distinct A3 Adenosine Receptor Ligands</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">78572</span>– <span class="NLM_lpage">78585</span>, <span class="refDoi"> DOI: 10.1039/C5RA14988F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1039%2FC5RA14988F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVaisLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=78572-78585&author=F.+Cagideauthor=A.+Gasparauthor=J.+Reisauthor=D.+Chavarriaauthor=S.+Vilarauthor=G.+Hripcsakauthor=E.+Uriarteauthor=S.+Kachlerauthor=K.-N.+Klotzauthor=F.+Borges&title=Navigating+in+Chromone+Chemical+Space%3A+Discovery+of+Novel+and+Distinct+A3+Adenosine+Receptor+Ligands&doi=10.1039%2FC5RA14988F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating in chromone chemical space: discovery of novel and distinct A3 adenosine receptor ligands</span></div><div class="casAuthors">Cagide, F.; Gaspar, A.; Reis, J.; Chavarria, D.; Vilar, S.; Hripcsak, G.; Uriarte, E.; Kachler, S.; Klotz, K. N.; Borges, F.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">96</span>),
    <span class="NLM_cas:pages">78572-78585</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">One of the major hurdles in the development of safe and effective drugs targeting G-protein coupled receptors (GPCRs) is finding ligands that are highly selective for a specific receptor subtype.  The search for novel compds. with therapeutic value by targeting the A3 adenosine receptor (A3AR) is still in its early stages.  The increasing knowledge about the biol., physiol. and pathol. role of the A3AR subtype was accompanied by the design and development of the A3AR ligands, but the particular role of A3AR agonists and antagonists is still an open issue.  Among the large variety of chem. classes screened towards ARs flavonoids have been indicated as remarkable A3AR antagonists.  However, the search of A3AR ligands based on this framework seems to be discontinued.  In this context, our research group focused its investigation into the discovery and development of novel, potent and selective AR ligands based on the chem. core of flavonoids, the chromone scaffold.  The ongoing research has shown that chromone-2-phenylcarboxamide derivs. display a remarkable preference for hA3AR.  In this work we report stimulating results, supported by A2A/A3 mol. docking simulations and structure-affinity-relationship (SAR) studies by which N-(4,5-methylthiazol-2-yl)-4-oxo-4H-chromene-2-carboxamide (compd. 31) emerged as the most potent and selective compd., displaying an hA3Ki of 167 nM and a selectivity ratio of 590 vs. the hA1 and 480 vs. the hA2AAR subtypes.  The chromone-based ligand was obtained by a simple synthetic approach and will enter in a lead optimization program to enhance its potency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY2n16mvecjLVg90H21EOLACvtfcHk0lh4RlsgwX5mWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVaisLnM&md5=59048ec215cd35ec456f11c6c7b14641</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2FC5RA14988F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA14988F%26sid%3Dliteratum%253Aachs%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DHripcsak%26aufirst%3DG.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DNavigating%2520in%2520Chromone%2520Chemical%2520Space%253A%2520Discovery%2520of%2520Novel%2520and%2520Distinct%2520A3%2520Adenosine%2520Receptor%2520Ligands%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D78572%26epage%3D78585%26doi%3D10.1039%2FC5RA14988F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span> <i>Schrödinger Suite 2014-3</i>; <span class="NLM_publisher-name">Schrödinger,
LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2014</span>; <a href="http://www.schrodinger.com/" class="extLink">http://www.schrodinger.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Suite+2014-3%3B+Schr%C3%B6dinger%2C%0ALLC%3A+New+York%2C+2014%3B+http%3A%2F%2Fwww.schrodinger.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202014-3%26pub%3DSchr%25C3%25B6dinger%252C%250ALLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1126/science.1164772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1126%2Fscience.1164772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=18832607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=1211-1217&author=V.+P.+Jaakolaauthor=M.+T.+Griffithauthor=M.+A.+Hansonauthor=V.+Cherezovauthor=E.+Y.+Chienauthor=J.+R.+Laneauthor=A.+P.+Ijzermanauthor=R.+C.+Stevens&title=The+2.6+Angstrom+Crystal+Structure+of+a+Human+A2A+Adenosine+Receptor+Bound+to+an+Antagonist&doi=10.1126%2Fscience.1164772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span></div><div class="casAuthors">Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Lane, J. Robert; IJzerman, Adriaan P.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">5905</span>),
    <span class="NLM_cas:pages">1211-1217</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The adenosine class of heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) mediates the important role of extracellular adenosine in many physiol. processes and is antagonized by caffeine.  The authors have detd. the crystal structure of the human A2A adenosine receptor, in complex with a high-affinity subtype-selective antagonist, ZM241385, to 2.6 angstrom resoln.  Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helixes relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally detd. GPCRs.  The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane.  The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7QL4wN4TdhrVg90H21EOLACvtfcHk0lhAhsBg8KrfeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN&md5=5bdb862b41f345c244f3c162e058206b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164772%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.%2BP.%26aulast%3DGriffith%26aufirst%3DM.%2BT.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DThe%25202.6%2520Angstrom%2520Crystal%2520Structure%2520of%2520a%2520Human%2520A2A%2520Adenosine%2520Receptor%2520Bound%2520to%2520an%2520Antagonist%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D1211%26epage%3D1217%26doi%3D10.1126%2Fscience.1164772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurrell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhukov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists Using Structure Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1898</span>– <span class="NLM_lpage">1903</span>, <span class="refDoi"> DOI: 10.1021/jm201376w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201376w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1898-1903&author=M.+Congreveauthor=S.+P.+Andrewsauthor=A.+S.+Dor%C3%A9author=K.+Hollensteinauthor=E.+Hurrellauthor=C.+J.+Langmeadauthor=J.+S.+Masonauthor=I.+W.+Ngauthor=B.+Tehanauthor=A.+Zhukovauthor=M.+Weirauthor=F.+H.+Marshall&title=Discovery+of+1%2C2%2C4-Triazine+Derivatives+as+Adenosine+A2A+Antagonists+Using+Structure+Based+Drug+Design&doi=10.1021%2Fjm201376w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design</span></div><div class="casAuthors">Congreve, Miles; Andrews, Stephen P.; Dore, Andrew S.; Hollenstein, Kaspar; Hurrell, Edward; Langmead, Christopher J.; Mason, Jonathan S.; Ng, Irene W.; Tehan, Benjamin; Zhukov, Andrei; Weir, Malcolm; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1898-1903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, ligand efficient, selective, and orally efficacious 1,2,4-triazine derivs. have been identified using structure based drug design approaches as antagonists of the adenosine A2A receptor.  The X-ray crystal structures of compds. 4e and 4g (I) bound to the GPCR illustrate that the mols. bind deeply inside the orthosteric binding cavity.  In vivo pharmacokinetic and efficacy data for compd. 4k are presented, demonstrating the potential of this series of compds. for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpddydZvtRPv7Vg90H21EOLACvtfcHk0lhAhsBg8KrfeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D&md5=71d76db8a22bf82f11d3632d2917e155</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm201376w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201376w%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DNg%26aufirst%3DI.%2BW.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DDiscovery%2520of%25201%252C2%252C4-Triazine%2520Derivatives%2520as%2520Adenosine%2520A2A%2520Antagonists%2520Using%2520Structure%2520Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1898%26epage%3D1903%26doi%3D10.1021%2Fjm201376w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Ligand Binding and Subtype Selectivity of the Human A2A Adenosine Receptor: Identification and Characterization of Essential Amino Acid Residues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">13032</span>– <span class="NLM_lpage">13044</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.096974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1074%2Fjbc.M109.096974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=20147292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVGis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=13032-13044&author=V.+P.+Jaakolaauthor=J.+R.+Laneauthor=J.+Y.+Linauthor=V.+Katritchauthor=A.+P.+Ijzermanauthor=R.+C.+Stevens&title=Ligand+Binding+and+Subtype+Selectivity+of+the+Human+A2A+Adenosine+Receptor%3A+Identification+and+Characterization+of+Essential+Amino+Acid+Residues&doi=10.1074%2Fjbc.M109.096974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Binding and Subtype Selectivity of the Human A2A Adenosine Receptor: Identification and characterization of essential amino acid residues</span></div><div class="casAuthors">Jaakola, Veli-Pekka; Lane, J. Robert; Lin, Judy Y.; Katritch, Vsevolod; IJzerman, Adriaan P.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">13032-13044</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The crystal structure of the human A2A adenosine receptor bound to the A2A receptor-specific antagonist, ZM241385, was recently detd. at 2.6-Å resoln.  Surprisingly, the antagonist binds in an extended conformation, perpendicular to the plane of the membrane, and indicates a no. of interactions unidentified before in ZM241385 recognition.  To further understand the selectivity of ZM241385 for the human A2A adenosine receptor, we examd. the effect of mutating amino acid residues within the binding cavity likely to have key interactions and that have not been previously examd.  Mutation of Phe-168 to Ala abolishes both agonist and antagonist binding as well as receptor activity, whereas mutation of this residue to Trp or Tyr had only moderate effects.  The Met-177 Ala mutation impeded antagonist but not agonist binding.  Finally, the Leu-249 Ala mutant showed neither agonist nor antagonist binding affinity.  From our results and previously published mutagenesis data, we conclude that conserved residues Phe-168(5.29), Glu-169(5.30), Asn-253(6.55), and Leu-249(6.51) play a central role in coordinating the bicyclic core present in both agonists and antagonists.  By combining the anal. of the mutagenesis data with a comparison of the sequences of different adenosine receptor subtypes from different species, we predict that the interactions that det. subtype selectivity reside in the more divergent "upper" region of the binding cavity while the "lower" part of the binding cavity is conserved across adenosine receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQknwBFotFw7Vg90H21EOLACvtfcHk0lhAhsBg8KrfeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVGis7g%253D&md5=f8939e7b36d08e741cc9f37b90e3cd28</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.096974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.096974%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.%2BP.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DLin%26aufirst%3DJ.%2BY.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DLigand%2520Binding%2520and%2520Subtype%2520Selectivity%2520of%2520the%2520Human%2520A2A%2520Adenosine%2520Receptor%253A%2520Identification%2520and%2520Characterization%2520of%2520Essential%2520Amino%2520Acid%2520Residues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D13032%26epage%3D13044%26doi%3D10.1074%2Fjbc.M109.096974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel A3 Adenosine Receptor Ligands Based on Chromone Scaffold</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bcp.2012.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=22433284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFGis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=21-29&issue=1&author=A.+Gasparauthor=J.+Reisauthor=S.+Kachlerauthor=S.+Paolettaauthor=E.+Uriarteauthor=K.-N.+Klotzauthor=S.+Moroauthor=F.+Borges&title=Discovery+of+Novel+A3+Adenosine+Receptor+Ligands+Based+on+Chromone+Scaffold&doi=10.1016%2Fj.bcp.2012.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel A3 adenosine receptor ligands based on chromone scaffold</span></div><div class="casAuthors">Gaspar, Alexandra; Reis, Joana; Kachler, Sonja; Paoletta, Silvia; Uriarte, Eugenio; Klotz, Karl-Norbert; Moro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A project focused on the discovery of new chem. entities (NCEs) as AR ligands that incorporate a benzo-γ-pyrone [(4H)-1-benzopyran-4-one] substructure has been developed.  Accordingly, two series of novel chromone carboxamides placed at positions C2 (compds. 2-13) and C3 (compds. 15-26) of the γ-pyrone ring were synthesized using chromone carboxylic acids (chromone-2-carboxylic acid or chromone-3-carboxylic acid) as starting materials.  From this study and on the basis of the obtained structure-activity relationships it was concluded that the chromone carboxamide scaffold represent a novel class of AR ligands.  The most remarkable chromones were compds. (I) and (II) that present a better affinity for A3AR (Ki = 3680 nM and Ki = 3750 nM, resp.).  Receptor-driven mol. modeling studies provide information on the binding/selectivity data of the chromone.  The data so far acquired are instrumental for future optimization of chromone carboxamide as a selective A3AR antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK33Z9D6f08bVg90H21EOLACvtfcHk0liMK_TyFoDB-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFGis78%253D&md5=82c1e9787e3856549b59a413199293fb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520Novel%2520A3%2520Adenosine%2520Receptor%2520Ligands%2520Based%2520on%2520Chromone%2520Scaffold%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26issue%3D1%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.bcp.2012.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. S.</span></span> <span> </span><span class="NLM_article-title">A Molecular Model for DNA Cross-Linking by the Antitumor Agent Azinomycin B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">2783</span>– <span class="NLM_lpage">2788</span>, <span class="refDoi"> DOI: 10.1021/jm990362l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990362l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1els7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2783-2788&issue=15&author=S.+Alcaroauthor=R.+S.+Coleman&title=A+Molecular+Model+for+DNA+Cross-Linking+by+the+Antitumor+Agent+Azinomycin+B&doi=10.1021%2Fjm990362l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A Molecular Model for DNA Cross-Linking by the Antitumor Agent Azinomycin B</span></div><div class="casAuthors">Alcaro, Stefano; Coleman, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2783-2788</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A computational model for the covalent interstrand DNA crosslinking of the antitumor agent azinomycin B is reported and is based on Monte Carlo simulations of the four possible monoalkylation species and an examn. of the low energy conformations of the cross-linked agent.  The model was developed using a suitably modified version of the AMBER* force field with the exptl. detd. triplet DNA target sequence 5'-d(GCT)-3' in both the native B-form and contg. a preformed intercalation site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xh2VIklGybVg90H21EOLACvtfcHk0liMK_TyFoDB-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1els7s%253D&md5=d2c14d8eaf1e7f654b3a2763a6fa47b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm990362l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990362l%26sid%3Dliteratum%253Aachs%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DColeman%26aufirst%3DR.%2BS.%26atitle%3DA%2520Molecular%2520Model%2520for%2520DNA%2520Cross-Linking%2520by%2520the%2520Antitumor%2520Agent%2520Azinomycin%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D15%26spage%3D2783%26epage%3D2788%26doi%3D10.1021%2Fjm990362l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span> <span> </span><span class="NLM_article-title">Conformational Analysis of Drug-Like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization upon Binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2499</span>– <span class="NLM_lpage">2510</span>, <span class="refDoi"> DOI: 10.1021/jm030563w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030563w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2499-2510&issue=10&author=E.+Perolaauthor=P.+S.+Charifson&title=Conformational+Analysis+of+Drug-Like+Molecules+Bound+to+Proteins%3A+An+Extensive+Study+of+Ligand+Reorganization+upon+Binding&doi=10.1021%2Fjm030563w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Analysis of Drug-Like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization upon Binding</span></div><div class="casAuthors">Perola, Emanuele; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2499-2510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes a large-scale study on the nature and the energetics of the conformational changes drug-like mols. experience upon binding.  Ligand strain energies and conformational reorganization were analyzed with different computational methods on 150 crystal structures of pharmaceutically relevant protein-ligand complexes.  The common knowledge that ligands rarely bind in their lowest calcd. energy conformation was confirmed.  Addnl., the authors found that over 60% of the ligands do not bind in a local min. conformation.  While approx. 60% of the ligands were calcd. to bind with strain energies lower than 5 kcal/mol, strain energies over 9 kcal/mol were calcd. in at least 10% of the cases regardless of the method used.  A clear correlation was found between acceptable strain energy and ligand flexibility, while there was no correlation between strain energy and binding affinity, thus indicating that expensive conformational rearrangements can be tolerated in some cases without overly penalizing the tightness of binding.  On the basis of the trends obsd., thresholds for the acceptable strain energies of bioactive conformations were defined with consideration of the impact of ligand flexibility.  An anal. of the degree of folding of the bound ligands confirmed the general tendency of small mols. to bind in an extended conformation.  The results suggest that the unfolding of hydrophobic ligands during binding, which exposes hydrophobic surfaces to contact with protein residues, could be one of the factors accounting for high reorganization energies.  Finally, different methods for conformational anal. were evaluated, and guidelines were defined to maximize the prevalence of bioactive conformations in computationally generated ensembles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMrN0dFKglcbVg90H21EOLACvtfcHk0liMK_TyFoDB-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVans78%253D&md5=8f54a8285ef1ffc5e1a19f748f4674bf</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm030563w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030563w%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DConformational%2520Analysis%2520of%2520Drug-Like%2520Molecules%2520Bound%2520to%2520Proteins%253A%2520An%2520Extensive%2520Study%2520of%2520Ligand%2520Reorganization%2520upon%2520Binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D10%26spage%3D2499%26epage%3D2510%26doi%3D10.1021%2Fjm030563w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiebel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulsdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrader, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Intriguing Role of Water in Protein-Ligand Binding Studied by Neutron Crystallography on Trypsin Complexes</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3559</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05769-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1038%2Fs41467-018-05769-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=30177695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BB3c3ltVOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3559&author=J.+Schiebelauthor=R.+Gaspariauthor=T.+Wulsdorfauthor=K.+Ngoauthor=C.+Sohnauthor=T.+E.+Schraderauthor=A.+Cavalliauthor=A.+Ostermannauthor=A.+Heineauthor=G.+Klebe&title=Intriguing+Role+of+Water+in+Protein-Ligand+Binding+Studied+by+Neutron+Crystallography+on+Trypsin+Complexes&doi=10.1038%2Fs41467-018-05769-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes</span></div><div class="casAuthors">Schiebel Johannes; Wulsdorf Tobias; Ngo Khang; Sohn Christian; Heine Andreas; Klebe Gerhard; Schiebel Johannes; Gaspari Roberto; Cavalli Andrea; Schrader Tobias E; Ostermann Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3559</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hydrogen bonds are key interactions determining protein-ligand binding affinity and therefore fundamental to any biological process.  Unfortunately, explicit structural information about hydrogen positions and thus H-bonds in protein-ligand complexes is extremely rare and similarly the important role of water during binding remains poorly understood.  Here, we report on neutron structures of trypsin determined at very high resolutions ≤1.5 ÅA in uncomplexed and inhibited state complemented by X-ray and thermodynamic data and computer simulations.  Our structures show the precise geometry of H-bonds between protein and the inhibitors N-amidinopiperidine and benzamidine along with the dynamics of the residual solvation pattern.  Prior to binding, the ligand-free binding pocket is occupied by water molecules characterized by a paucity of H-bonds and high mobility resulting in an imperfect hydration of the critical residue Asp189.  This phenomenon likely constitutes a key factor fueling ligand binding via water displacement and helps improving our current view on water influencing protein-ligand recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2ZT4TkrW9o0h5eUSa2oe_fW6udTcc2ebF6HeLQezzkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3ltVOhtw%253D%253D&md5=56cfa8b99517f0da0967e3c9fbc09ac9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05769-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05769-2%26sid%3Dliteratum%253Aachs%26aulast%3DSchiebel%26aufirst%3DJ.%26aulast%3DGaspari%26aufirst%3DR.%26aulast%3DWulsdorf%26aufirst%3DT.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DSohn%26aufirst%3DC.%26aulast%3DSchrader%26aufirst%3DT.%2BE.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DA.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DIntriguing%2520Role%2520of%2520Water%2520in%2520Protein-Ligand%2520Binding%2520Studied%2520by%2520Neutron%2520Crystallography%2520on%2520Trypsin%2520Complexes%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3559%26doi%3D10.1038%2Fs41467-018-05769-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naveen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenchanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumara, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokanath, N. K.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of 8-Ethoxy-3-(4-nitrophenyl)-2<i>H</i>-chromen-2-one</span>. <i>Acta Crystallogr. E Crystallogr. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">o860</span>– <span class="NLM_lpage">o861</span>, <span class="refDoi"> DOI: 10.1107/S2056989015019325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1107%2FS2056989015019325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=26594565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOktb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=o860-o861&issue=11&author=S.+Walkiauthor=S.+Naveenauthor=S.+Kenchannaauthor=K.+M.+Mahadevanauthor=M.+N.+Kumaraauthor=N.+K.+Lokanath&title=Crystal+Structure+of+8-Ethoxy-3-%284-nitrophenyl%29-2H-chromen-2-one&doi=10.1107%2FS2056989015019325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of 8-ethoxy-3-(4-nitrophenyl)-2H-chromen-2-one</span></div><div class="casAuthors">Walki, Shashikanth; Naveen, S.; Kenchanna, S.; Mahadevan, K. M.; Kumara, M. N.; Lokanath, N. K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Crystallographic Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">o860-o861</span>CODEN:
                <span class="NLM_cas:coden">ACSECI</span>;
        ISSN:<span class="NLM_cas:issn">2056-9890</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">In the title compd., C17H13NO5, the coumarin ring system is essentially planar (r.m.s. deviation = 0.008 Å).  The nitrophenyl ring makes a dihedral angle of 25.27 (9)° with the coumarin ring plane.  The nitro group is almost coplanar with the Ph ring to which it is attached, making a dihedral angle of 4.3 (3)°.  The ethoxy group is inclined to the coumarin ring plane by 4.1 (2)°.  Electron delocalization was found at the short bridging C-C bond with a bond length of 1.354 (2) Å.  In the crystal, mols. are linked via C-H···O hydrogen bonds, forming sheets in the bc plane.  The sheets are linked via π-π stacking [centroid-centroid distances = 3.5688 (13) and 3.7514 (13) Å], forming a three-dimensional structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwHmlX590plrVg90H21EOLACvtfcHk0ljfytwM_OAjNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOktb3K&md5=257f9857750e069d68889001f79fddcd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS2056989015019325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2056989015019325%26sid%3Dliteratum%253Aachs%26aulast%3DWalki%26aufirst%3DS.%26aulast%3DNaveen%26aufirst%3DS.%26aulast%3DKenchanna%26aufirst%3DS.%26aulast%3DMahadevan%26aufirst%3DK.%2BM.%26aulast%3DKumara%26aufirst%3DM.%2BN.%26aulast%3DLokanath%26aufirst%3DN.%2BK.%26atitle%3DCrystal%2520Structure%2520of%25208-Ethoxy-3-%25284-nitrophenyl%2529-2H-chromen-2-one%26jtitle%3DActa%2520Crystallogr.%2520E%2520Crystallogr.%2520Commun.%26date%3D2015%26volume%3D71%26issue%3D11%26spage%3Do860%26epage%3Do861%26doi%3D10.1107%2FS2056989015019325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budriesi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarini, A.</span></span> <span> </span><span class="NLM_article-title">Coumarin 1,4-Dihydropyridine Derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">803</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(98)00037-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2FS0968-0896%2898%2900037-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=9681146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVOmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=803-810&author=P.+Valentiauthor=A.+Rampaauthor=R.+Budriesiauthor=A.+Bisiauthor=A.+Chiarini&title=Coumarin+1%2C4-Dihydropyridine+Derivatives&doi=10.1016%2FS0968-0896%2898%2900037-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">(Coumarinyl)-1,4-dihydropyridine derivatives</span></div><div class="casAuthors">Valenti, P.; Rampa, A.; Budriesi, R.; Bisi, A.; Chiarini, A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-810</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of 1,4-dihydropyridines bearing a coumarin moiety in 4-position was synthesized.  The compds. were evaluated for inotropic, chronotropic and calcium antagonist activities.  The replacement of the o-nitrophenyl moiety of nifedipine with a coumarin or phenylcoumarin system is accompanied by a decrease of the activity on myocardial and vascular parameters, but the synthesized compds. showed selective inhibiting effects on cardiac contractility and frequency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtObBeLhPeWLVg90H21EOLACvtfcHk0ljfytwM_OAjNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVOmtbg%253D&md5=617f47abb2b570c970234bc4ef1aee34</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2898%2900037-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252898%252900037-6%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DChiarini%26aufirst%3DA.%26atitle%3DCoumarin%25201%252C4-Dihydropyridine%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D803%26epage%3D810%26doi%3D10.1016%2FS0968-0896%2898%2900037-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nemeryuk, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrova, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedov, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anisimova, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traven, V. F.</span></span> <span> </span><span class="NLM_article-title">New Approach to the Synthesis of 3-Arylcoumarins. Reaction of 3-Acyl and 3-Ethoxycarbonyl-Coumarins with Hydrazide of <i>p</i>-Nitrophenylacetic Acid</span>. <i>Chem. Heterocycl. Compd.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1023/A:1015359830129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1023%2FA%3A1015359830129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtFalsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2002&pages=249-250&author=M.+P.+Nemeryukauthor=V.+D.+Dimitrovaauthor=A.+L.+Sedovauthor=O.+S.+Anisimovaauthor=V.+F.+Traven&title=New+Approach+to+the+Synthesis+of+3-Arylcoumarins.+Reaction+of+3-Acyl+and+3-Ethoxycarbonyl-Coumarins+with+Hydrazide+of+p-Nitrophenylacetic+Acid&doi=10.1023%2FA%3A1015359830129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New approach to the synthesis of 3-arylcoumarins. Reaction of 3-acyl- and 3-ethoxycarbonyl-coumarins with hydrazide of p-nitrophenylacetic acid</span></div><div class="casAuthors">Nemeryuk, M. P.; Dimitrova, V. D.; Sedov, A. L.; Anisimova, O. S.; Traven, V. F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Heterocyclic Compounds (New York, NY, United States)(Translation of Khimiya Geterotsiklicheskikh Soedinenii)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-250</span>CODEN:
                <span class="NLM_cas:coden">CHCCAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-3122</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">The synthesis of 3-arylcoumarins contg. electron-withdrawing substituents in the aryl ring is accomplished by the reaction of 3-acyl- or 3-ethoxycarbonyl-coumarins with derivs. of phenylacetic acid hydrazides under Michael reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9cC6VaqTCo7Vg90H21EOLACvtfcHk0ljf_WlA7My1Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtFalsbY%253D&md5=6724199a912921613dc66c90ab969559</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015359830129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015359830129%26sid%3Dliteratum%253Aachs%26aulast%3DNemeryuk%26aufirst%3DM.%2BP.%26aulast%3DDimitrova%26aufirst%3DV.%2BD.%26aulast%3DSedov%26aufirst%3DA.%2BL.%26aulast%3DAnisimova%26aufirst%3DO.%2BS.%26aulast%3DTraven%26aufirst%3DV.%2BF.%26atitle%3DNew%2520Approach%2520to%2520the%2520Synthesis%2520of%25203-Arylcoumarins.%2520Reaction%2520of%25203-Acyl%2520and%25203-Ethoxycarbonyl-Coumarins%2520with%2520Hydrazide%2520of%2520p-Nitrophenylacetic%2520Acid%26jtitle%3DChem.%2520Heterocycl.%2520Compd.%26date%3D2002%26volume%3D38%26spage%3D249%26epage%3D250%26doi%3D10.1023%2FA%3A1015359830129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jafarpour, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzegar Amiri Olia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalalimanesh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahiminejadan, S.</span></span> <span> </span><span class="NLM_article-title">Palladium-Catalyzed Decarboxylative Cross-Coupling Reactions: A Route for Regioselective Functionalization of Coumarins</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">2957</span>– <span class="NLM_lpage">2964</span>, <span class="refDoi"> DOI: 10.1021/jo302778d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo302778d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=2957-2964&author=F.+Jafarpourauthor=S.+Zareiauthor=M.+Barzegar+Amiri+Oliaauthor=N.+Jalalimaneshauthor=S.+Rahiminejadan&title=Palladium-Catalyzed+Decarboxylative+Cross-Coupling+Reactions%3A+A+Route+for+Regioselective+Functionalization+of+Coumarins&doi=10.1021%2Fjo302778d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Decarboxylative Cross-Coupling Reactions: A Route for Regioselective Functionalization of Coumarins</span></div><div class="casAuthors">Jafarpour, Farnaz; Zarei, Samaneh; Barzegar Amiri Olia, Mina; Jalalimanesh, Nafiseh; Rahiminejadan, Soraya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2957-2964</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A straightforward, regioselective, and step-economical ligand-free palladium-catalyzed decarboxylative functionalization of coumarin-3-carboxylic acids, e.g. I, is devised.  This protocol is compatible with a wide variety of electron-donating and -withdrawing substituents and allows for construction of various biol. important π-electron extended coumarins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6dCgx8n_B4LVg90H21EOLACvtfcHk0ljf_WlA7My1Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWhu7s%253D&md5=d003ddea2ccd28c2b31cddd8f11fa01d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo302778d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo302778d%26sid%3Dliteratum%253Aachs%26aulast%3DJafarpour%26aufirst%3DF.%26aulast%3DZarei%26aufirst%3DS.%26aulast%3DBarzegar%2BAmiri%2BOlia%26aufirst%3DM.%26aulast%3DJalalimanesh%26aufirst%3DN.%26aulast%3DRahiminejadan%26aufirst%3DS.%26atitle%3DPalladium-Catalyzed%2520Decarboxylative%2520Cross-Coupling%2520Reactions%253A%2520A%2520Route%2520for%2520Regioselective%2520Functionalization%2520of%2520Coumarins%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26spage%3D2957%26epage%3D2964%26doi%3D10.1021%2Fjo302778d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erk, C.</span></span> <span> </span><span class="NLM_article-title">The Synthesis of Novel Crown Ethers, Part IX, 3-Phenyl Chromenone-Crown Ethers</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.1002/jhet.5570380608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fjhet.5570380608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=1291-1295&issue=6&author=M.+Bulutauthor=C.+Erk&title=The+Synthesis+of+Novel+Crown+Ethers%2C+Part+IX%2C+3-Phenyl+Chromenone-Crown+Ethers&doi=10.1002%2Fjhet.5570380608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of novel crown ethers, part IX, 3-phenyl chromenone-crown ethers</span></div><div class="casAuthors">Bulut, M.; Erk, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1291-1295</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    
            (<span class="NLM_cas:orgname">HeteroCorporation</span>)
        </div><div class="casAbstract">3-Phenyl- and 3-(p-methoxyphenyl)-7,8-dihydroxy- and -6,7-dihydroxychromenones were prepd. from Et 3-oxo-2-phenylpropanoate, Et 3-oxo-2-(4-methoxyphenyl)propanoate and the trihydroxybenzenes in H2SO4.  3-Aryl-7,8- and 3-aryl-6,7-dihydroxy-2H-chromenones reacted with the bis-dihalides of polyglycols in DMF/MeCO3 to afford 12-crown-4-, 15-crown-5- and 18-crown-6-chromenones.  The products were identified with IR, 1H NMR, low and high resoln. mass spectroscopy and elemental anal.  Some 1:1 cation assocn. consts., Kb, of the 3-phenylchromenone crown ethers with Li+, Na+, K+ and Rb+ cations were studied by steady state emission fluorescence spectroscopy; Kb chromenone-crown complexes displayed crown ether-cation binding selectivity rules properly in MeCN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow0rmZn-Rt9bVg90H21EOLACvtfcHk0ljf_WlA7My1Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFGrtQ%253D%253D&md5=74a92e9b6e9ce13d6aa79724a5cf113c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570380608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570380608%26sid%3Dliteratum%253Aachs%26aulast%3DBulut%26aufirst%3DM.%26aulast%3DErk%26aufirst%3DC.%26atitle%3DThe%2520Synthesis%2520of%2520Novel%2520Crown%2520Ethers%252C%2520Part%2520IX%252C%25203-Phenyl%2520Chromenone-Crown%2520Ethers%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2001%26volume%3D38%26issue%3D6%26spage%3D1291%26epage%3D1295%26doi%3D10.1002%2Fjhet.5570380608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunduz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulut, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 7,8-Dihydroxy-3-(3,4-dihydroxyphenyl)-2<i>H</i>-chromen-2-one Derivatives of Crown Ethers</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1002/jhet.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fjhet.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1ajtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2009&pages=105-107&issue=1&author=C.+Gunduzauthor=M.+Bulut&title=Synthesis+of+7%2C8-Dihydroxy-3-%283%2C4-dihydroxyphenyl%29-2H-chromen-2-one+Derivatives+of+Crown+Ethers&doi=10.1002%2Fjhet.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 7,8-dihydroxy-3-(3,4-dihydroxyphenyl)-2H-chromen-2-one derivatives of crown ethers</span></div><div class="casAuthors">Gunduz, Cihan; Bulut, Mustafa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-107</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The novel 1-(3,4-dimethoxyphenyl)-2-(2,3,4-trimethoxyphenyl)acrylonitrile I was prepd. by condensation of 2,3,4-trimethoxybenzaldehyde with 3,4-dimethoxyphenylacetonitrile in ethanol at 70 °C with 20% aq. sodium hydroxide soln.  Cyclization and demethylation of the acrylacetonitrile I was performed using pyridine hydrochloride.  The obtained 7,8-dihydroxy-3-(3,4-dihydroxyphenyl)-2H-chromen-2-one II (R = H) was reacted with the poly(ethylene glycol) ditosylates in CH3CN/alkali carbonate to afford bis-[12]crown-4, -[15]crown-5, and -[18]crown-6 chromenones II [RR = CH2CH2(OCH2CH2)n; n = 2 - 4].  The chromatog. purified novel chromenone crown ethers were identified by IR, 1H NMR, 13C NMR, and MALDI-TOF mass spectrometry and elemental anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOwIcxL8r737Vg90H21EOLACvtfcHk0ljf_WlA7My1Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1ajtLk%253D&md5=7a1f78348eff1caf814c73104b2b8033</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fjhet.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.17%26sid%3Dliteratum%253Aachs%26aulast%3DGunduz%26aufirst%3DC.%26aulast%3DBulut%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25207%252C8-Dihydroxy-3-%25283%252C4-dihydroxyphenyl%2529-2H-chromen-2-one%2520Derivatives%2520of%2520Crown%2520Ethers%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2009%26volume%3D46%26issue%3D1%26spage%3D105%26epage%3D107%26doi%3D10.1002%2Fjhet.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span> <span> </span><span class="NLM_article-title">Structure Based Prediction of Subtype-Selectivity for Adenosine Receptor Antagonists</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.neuropharm.2010.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=20637786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=108-115&author=V.+Katritchauthor=I.+Kufarevaauthor=R.+Abagyan&title=Structure+Based+Prediction+of+Subtype-Selectivity+for+Adenosine+Receptor+Antagonists&doi=10.1016%2Fj.neuropharm.2010.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based prediction of subtype-selectivity for adenosine receptor antagonists</span></div><div class="casAuthors">Katritch, Vsevolod; Kufareva, Irina; Abagyan, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">108-115</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">One of the major hurdles in the development of safe and effective drugs targeting G-protein coupled receptors (GPCRs) is finding ligands that are highly selective for a specific receptor subtype.  Structural understanding of subtype-specific binding pocket variations and ligand-receptor interactions may greatly facilitate design of selective ligands.  To gain insights into the structural basis of ligand subtype selectivity within the family of adenosine receptors (AR: A1, A2A, A2B, and A3) we generated 3D models of all four subtypes using the recently detd. crystal structure of the AA2AR as a template, and employing the methodol. of ligand-guided receptor optimization for refinement.  This approach produced 3D conformational models of AR subtypes that effectively explain binding modes and subtype selectivity for a diverse set of known AR antagonists.  Anal. of the subtype-specific ligand-receptor interactions allowed identification of the major determinants of ligand selectivity, which may facilitate discovery of more efficient drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRVFATDSQWmbVg90H21EOLACvtfcHk0li0dnTmr5MEjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FP&md5=da3b83ff9b882f130e2f02071f928617</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DStructure%2520Based%2520Prediction%2520of%2520Subtype-Selectivity%2520for%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D108%26epage%3D115%26doi%3D10.1016%2Fj.neuropharm.2010.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span> <i>MOE, version 2011.10</i>; <span class="NLM_publisher-name">Chemical Computing
Group, Inc.</span>, <span class="NLM_year">2011</span>; <a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MOE%2C+version+2011.10%3B+Chemical+Computing%0AGroup%2C+Inc.%2C+2011%3B+http%3A%2F%2Fwww.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%252C%2520version%25202011.10%26pub%3DChemical%2520Computing%250AGroup%252C%2520Inc%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumienny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heer, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Beer, T. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rempfer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">SWISS-MODEL: Homology Modelling of Protein Structures and Complexes</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">W1</span>),  <span class="NLM_fpage">W296</span>– <span class="NLM_lpage">W303</span>, <span class="refDoi"> DOI: 10.1093/nar/gky427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1093%2Fnar%2Fgky427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=29788355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosVyru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=W296-W303&issue=W1&author=A.+Waterhouseauthor=M.+Bertoniauthor=S.+Bienertauthor=G.+Studerauthor=G.+Taurielloauthor=R.+Gumiennyauthor=F.+T.+Heerauthor=T.+A.+P.+de+Beerauthor=C.+Rempferauthor=L.+Bordoliauthor=R.+Leporeauthor=T.+Schwede&title=SWISS-MODEL%3A+Homology+Modelling+of+Protein+Structures+and+Complexes&doi=10.1093%2Fnar%2Fgky427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">SWISS-MODEL: homology modelling of protein structures and complexes</span></div><div class="casAuthors">Waterhouse, Andrew; Bertoni, Martino; Bienert, Stefan; Studer, Gabriel; Tauriello, Gerardo; Gumienny, Rafal; Heer, Florian T.; de Beer, Tjaart A. P.; Rempfer, Christine; Bordoli, Lorenza; Lepore, Rosalba; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W296-W303</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Homol. modeling has matured into an important technique in structural biol., significantly contributing to narrowing the gap between known protein sequences and exptl. detd. structures.  Fully automated workflows and servers simplify and streamline the homol. modeling process, also allowing users without a specific computational expertise to generate reliable protein models and have easy access to modeling results, their visualization and interpretation.  Here, we present an update to the SWISS-MODEL server, which pioneered the field of automated modeling 25 years ago and been continuously further developed.  Recently, its functionality has been extended to the modeling of homo- and heteromeric complexes.  Starting from the amino acid sequences of the interacting proteins, both the stoichiometry and the overall structure of the complex are inferred by homol. modeling.  Other major improvements include the implementation of a new modeling engine, ProMod3 and the introduction a new local model quality estn. method, QMEANDisCo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf9ZhQAzPVe7Vg90H21EOLACvtfcHk0li0dnTmr5MEjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosVyru70%253D&md5=651b55ade2d4f354f5d6699f318424d0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgky427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgky427%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DA.%26aulast%3DBertoni%26aufirst%3DM.%26aulast%3DBienert%26aufirst%3DS.%26aulast%3DStuder%26aufirst%3DG.%26aulast%3DTauriello%26aufirst%3DG.%26aulast%3DGumienny%26aufirst%3DR.%26aulast%3DHeer%26aufirst%3DF.%2BT.%26aulast%3Dde%2BBeer%26aufirst%3DT.%2BA.%2BP.%26aulast%3DRempfer%26aufirst%3DC.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DLepore%26aufirst%3DR.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DSWISS-MODEL%253A%2520Homology%2520Modelling%2520of%2520Protein%2520Structures%2520and%2520Complexes%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2018%26volume%3D46%26issue%3DW1%26spage%3DW296%26epage%3DW303%26doi%3D10.1093%2Fnar%2Fgky427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glukhova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jörg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.cell.2017.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=28235198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVWrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=867-877&issue=5&author=A.+Glukhovaauthor=D.+M.+Thalauthor=A.+T.+Nguyenauthor=E.+A.+Vecchioauthor=M.+J%C3%B6rgauthor=P.+J.+Scammellsauthor=L.+T.+Mayauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Structure+of+the+Adenosine+A1+Receptor+Reveals+the+Basis+for+Subtype+Selectivity&doi=10.1016%2Fj.cell.2017.01.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity</span></div><div class="casAuthors">Glukhova, Alisa; Thal, David M.; Nguyen, Anh T.; Vecchio, Elizabeth A.; Jorg, Manuela; Scammells, Peter J.; May, Lauren T.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">867-877.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The adenosine A1 receptor (A1-AR) is a G-protein-coupled receptor that plays a vital role in cardiac, renal, and neuronal processes but remains poorly targeted by current drugs.  We detd. a 3.2 Å crystal structure of the A1-AR bound to the selective covalent antagonist, DU172, and identified striking differences to the previously solved adenosine A2A receptor (A2A-AR) structure.  Mutational and computational anal. of A1-AR revealed a distinct conformation of the second extracellular loop and a wider extracellular cavity with a secondary binding pocket that can accommodate orthosteric and allosteric ligands.  We propose that conformational differences in these regions, rather than amino-acid divergence, underlie drug selectivity between these adenosine receptor subtypes.  Our findings provide a mol. basis for AR subtype selectivity with implications for understanding the mechanisms governing allosteric modulation of these receptors, allowing the design of more selective agents for the treatment of ischemia-reperfusion injury, renal pathologies, and neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3PS3LxJi-C7Vg90H21EOLACvtfcHk0li0dnTmr5MEjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVWrsrg%253D&md5=a5ff676cfedd6e11a899f65555a1ba62</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DGlukhova%26aufirst%3DA.%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DA.%2BT.%26aulast%3DVecchio%26aufirst%3DE.%2BA.%26aulast%3DJ%25C3%25B6rg%26aufirst%3DM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DStructure%2520of%2520the%2520Adenosine%2520A1%2520Receptor%2520Reveals%2520the%2520Basis%2520for%2520Subtype%2520Selectivity%26jtitle%3DCell%26date%3D2017%26volume%3D168%26issue%3D5%26spage%3D867%26epage%3D877%26doi%3D10.1016%2Fj.cell.2017.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chrisna  Matthee</span>, <span class="hlFld-ContribAuthor ">Gisella  Terre’Blanche</span>, <span class="hlFld-ContribAuthor ">Lesetja J.  Legoabe</span>, <span class="hlFld-ContribAuthor ">Helena D.  Janse van Rensburg</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>16 </em><a href="https://doi.org/10.1007/s11030-021-10257-9" title="DOI URL">https://doi.org/10.1007/s11030-021-10257-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-021-10257-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-021-10257-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DExploration%252Bof%252Bchalcones%252Band%252Brelated%252Bheterocycle%252Bcompounds%252Bas%252Bligands%252Bof%252Badenosine%252Breceptors%25253A%252Btherapeutics%252Bdevelopment%26aulast%3DMatthee%26aufirst%3DChrisna%26date%3D2021%26date%3D2021%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Adriaan P.  IJzerman</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>187 </em>, 114311. <a href="https://doi.org/10.1016/j.bcp.2020.114311" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114311%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DMedicinal%252Bchemistry%252Bof%252BP2%252Band%252Badenosine%252Breceptors%25253A%252BCommon%252Bscaffolds%252Badapted%252Bfor%252Bmultiple%252Btargets%26aulast%3DJacobson%26aufirst%3DKenneth%2BA.%26date%3D2021%26volume%3D187%26spage%3D114311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aitor  Carneiro</span>, <span class="hlFld-ContribAuthor ">Maria João  Matos</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Lourdes  Santana</span>. </span><span class="cited-content_cbyCitation_article-title">Trending Topics on Coumarin and Its Derivatives in 2020. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     , 501. <a href="https://doi.org/10.3390/molecules26020501" title="DOI URL">https://doi.org/10.3390/molecules26020501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26020501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26020501%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTrending%252BTopics%252Bon%252BCoumarin%252Band%252BIts%252BDerivatives%252Bin%252B2020%26aulast%3DCarneiro%26aufirst%3DAitor%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D2%26spage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julian  Breidenbach</span>, <span class="hlFld-ContribAuthor ">Ulrike  Bartz</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>. </span><span class="cited-content_cbyCitation_article-title">Coumarin as a structural component of substrates and probes for serine and cysteine proteases. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2020,</strong> <em>1868 </em>
                                    (9)
                                     , 140445. <a href="https://doi.org/10.1016/j.bbapap.2020.140445" title="DOI URL">https://doi.org/10.1016/j.bbapap.2020.140445</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2020.140445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2020.140445%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DCoumarin%252Bas%252Ba%252Bstructural%252Bcomponent%252Bof%252Bsubstrates%252Band%252Bprobes%252Bfor%252Bserine%252Band%252Bcysteine%252Bproteases%26aulast%3DBreidenbach%26aufirst%3DJulian%26date%3D2020%26volume%3D1868%26issue%3D9%26spage%3D140445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saleta  Vazquez-Rodriguez</span>, <span class="hlFld-ContribAuthor ">Santiago  Vilar</span>, <span class="hlFld-ContribAuthor ">Sonja  Kachler</span>, <span class="hlFld-ContribAuthor ">Karl-Norbert  Klotz</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Fernanda  Borges</span>, <span class="hlFld-ContribAuthor ">Maria João  Matos</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine Receptor Ligands: Coumarin–Chalcone Hybrids as Modulating Agents on the Activity of hARs. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (18)
                                     , 4306. <a href="https://doi.org/10.3390/molecules25184306" title="DOI URL">https://doi.org/10.3390/molecules25184306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25184306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25184306%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAdenosine%252BReceptor%252BLigands%25253A%252BCoumarin%2525E2%252580%252593Chalcone%252BHybrids%252Bas%252BModulating%252BAgents%252Bon%252Bthe%252BActivity%252Bof%252BhARs%26aulast%3DVazquez-Rodriguez%26aufirst%3DSaleta%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D18%26spage%3D4306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previous results from the group on the potential of 8-substituted 3-arylcoumarins as adenosine ligands at adenosine 7TM receptors. (A) Three 8-(2-oxopropoxy)-3-arylcoumarins with different affinity profiles. (B) Hypothetical binding mode for 8-(2-oxopropoxy)-3-(<i>p</i>-tolyl)coumarin in the hA<sub>3</sub> protein pocket (template for the hA<sub>3</sub> homology model: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a>). Color code: pale-orange, micromolar range; red, nanomolar range.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Scheme of the synthetic methodologies: (a) DCC, DMSO, 110 °C, 24 h; (b) HI, AcOH, Ac<sub>2</sub>O, reflux, 3 h; (c) CH<sub>3</sub>CO<sub>2</sub>K, Ac<sub>2</sub>O, reflux, 16 h; (d) HCl, MeOH, reflux, 3 h. (B) Molecular structure of compound <b>4</b>, showing the atom-numbering scheme used in the X-ray study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) General view of the hA<sub>3</sub> receptor bound to compound <b>4</b>. (b) Comparison of the cocrystallized conformations for the compounds (carbons in green) in the hA<sub>2A</sub> [<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a> (left) and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UZC">3UZC</a> (right)] with the binding mode observed by docking in hA<sub>3</sub> for compound <b>4</b> (pink carbons). Both proteins, hA<sub>2A</sub> and hA<sub>3</sub>, were superimposed. (c) Hypothetical binding mode in the hA<sub>3</sub> determined for compound <b>4</b> along with relevant residues in ligand interaction. Hydrogen bonds are colored in yellow. For clarity, protein ribbons were partially omitted. Template for the hA<sub>3</sub> homology model: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Residue contribution to the interaction with ligand <b>4</b> (including van der Waals, Coulomb, and hydrogen bond energies). (b) Differences in the residue contribution of compounds <b>4</b> and <b>23</b>. Bromine substitution in the 3-aryl ring (compound <b>4</b>) causes a higher Coulomb/van der Waals contribution in nearby residues. (c) Hydrophobic (white) and hydrophilic (red) areas inside the hA<sub>3</sub> with the binding mode detected for compound <b>4</b> (isovalues of −0.5 and −4.87 for hydrophobic and hydrophilic surfaces, respectively). The 8-hydroxyl is placed in the hydrophilic area while the 3-aryl scaffold is placed in the hydrophobic one (template for the hA<sub>3</sub> homology model: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML">3EML</a>). (d) Dihedral angle energy plot for compound <b>4</b> extracted from conformational analysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/medium/jm9b01572_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Superposition of the binding poses for compound <b>4</b> observed by docking in hA<sub>3</sub> (ligand in pink carbons) and hA<sub>2A</sub> (ligand in orange carbons). (a) Hypothetical binding mode of compound <b>4</b> buried in an area of multiple crystallographic water molecules in the hA<sub>2A</sub> (although water molecules are shown in red/white mesh, the docking was performed with no water in the cavity). This hypothetical pose would need to displace the mentioned waters. (b) Hypothetical binding mode of compound <b>4</b> in a shallower area close to the extracellular loops in the hA<sub>2A</sub> (docking performed considering the water molecules presented in the protein pocket). Disruption of the binding mode detected for compound <b>4</b> in hA<sub>3</sub> (carbons in pink) could be the cause of lack of affinity in the hA<sub>2A</sub>. (c) Key residues in ligand recognition in the hA<sub>3</sub> that are not conserved in both hA<sub>2A</sub> and hA<sub>1</sub> subtypes. Other residues that differ in the hA<sub>3</sub>, hA<sub>2A</sub>, and hA<sub>1</sub> subtypes are Leu264, Met270, and Thr270, respectively, not represented in the figure due to clarity reasons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01572/20200306/images/large/jm9b01572_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01572&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brito, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherjea, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybak, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramkumar, V.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors: Expression, Function and Regulation</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2024</span>– <span class="NLM_lpage">2052</span>, <span class="refDoi"> DOI: 10.3390/ijms15022024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.3390%2Fijms15022024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=24477263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVWktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=2024-2052&issue=2&author=S.+Shethauthor=R.+Britoauthor=D.+Mukherjeaauthor=L.+P.+Rybakauthor=V.+Ramkumar&title=Adenosine+Receptors%3A+Expression%2C+Function+and+Regulation&doi=10.3390%2Fijms15022024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors: expression, function and regulation</span></div><div class="casAuthors">Sheth, Sandeep; Brito, Rafael; Mukherjea, Debashree; Rybak, Leonard P.; Ramkumar, Vickram</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2024-2052, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors (ARs) comprise a group of G protein-coupled receptors (GPCR) which mediate the physiol. actions of adenosine.  To date, four AR subtypes have been cloned and identified in different tissues.  These receptors have distinct localization, signal transduction pathways and different means of regulation upon exposure to agonists.  This review will describe the biochem. characteristics and signaling cascade assocd. with each receptor and provide insight into how these receptors are regulated in response to agonists.  A key property of some of these receptors is their ability to serve as sensors of cellular oxidative stress, which is transmitted by transcription factors, such as nuclear factor (NF)-κB, to regulate the expression of ARs.  Recent observations of oligomerization of these receptors into homo- and hetero-dimers will be discussed.  In addn., the importance of these receptors in the regulation of normal and pathol. processes such as sleep, the development of cancers and in protection against hearing loss will be examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbxOUNcNjPxbVg90H21EOLACvtfcHk0lhqvUIz3RZY0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVWktrY%253D&md5=64774f90da385624fd6c27531e72e50c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3390%2Fijms15022024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms15022024%26sid%3Dliteratum%253Aachs%26aulast%3DSheth%26aufirst%3DS.%26aulast%3DBrito%26aufirst%3DR.%26aulast%3DMukherjea%26aufirst%3DD.%26aulast%3DRybak%26aufirst%3DL.%2BP.%26aulast%3DRamkumar%26aufirst%3DV.%26atitle%3DAdenosine%2520Receptors%253A%2520Expression%252C%2520Function%2520and%2520Regulation%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2014%26volume%3D15%26issue%3D2%26spage%3D2024%26epage%3D2052%26doi%3D10.3390%2Fijms15022024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—an Update</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1124/pr.110.003285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1124%2Fpr.110.003285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=21303899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1&issue=1&author=B.+B.+Fredholmauthor=A.+P.+IJzermanauthor=K.+A.+Jacobsonauthor=J.+Lindenauthor=C.+E.+M%C3%BCller&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXXI.+Nomenclature+and+Classification+of+Adenosine+Receptors%E2%80%94an+Update&doi=10.1124%2Fpr.110.003285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors - an update</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Linden, Joel; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-34</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  In the 10 years since our previous International Union of Basic and Clin. Pharmacol. report on the nomenclature and classification of adenosine receptors, no developments have led to major changes in the recommendations.  However, there have been so many other developments that an update is needed.  The fact that the structure of one of the adenosine receptors has recently been solved has already led to new ways of in silico screening of ligands.  The evidence that adenosine receptors can form homo- and hetero-multimers has accumulated, but the functional significance of such complexes remains unclear.  The availability of mice with genetic modification of all the adenosine receptors has led to a clarification of the functional roles of adenosine, and to excellent means to study the specificity of drugs.  There are also interesting assocns. between disease and structural variants in one or more of the adenosine receptors.  Several new selective agonists and antagonists have become available.  They provide improved possibilities for receptor classification.  There are also developments hinting at the usefulness of allosteric modulators.  Many drugs targeting adenosine receptors are in clin. trials, but the established therapeutic use is still very limited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNqbDC-UZ5sbVg90H21EOLACvtfcHk0li_M_6tr0nMYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslGisrY%253D&md5=e184c127e06b800bbcf15402ed27f02a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.110.003285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.110.003285%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXXI.%2520Nomenclature%2520and%2520Classification%2520of%2520Adenosine%2520Receptors%25E2%2580%2594an%2520Update%26jtitle%3DPharmacol.%2520Rev.%26date%3D2011%26volume%3D63%26issue%3D1%26spage%3D1%26doi%3D10.1124%2Fpr.110.003285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Z.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verzijl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zweemer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göblyös, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">IJzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span> <span> </span><span class="NLM_article-title">Functionally Biased Modulation of A3 Adenosine Receptor Agonist Efficacy and Potency by Imidazoquinolinamine Allosteric Enhancers</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">668</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.06.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bcp.2011.06.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=21718691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFCqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2011&pages=658-668&issue=6&author=Z.-G.+Gaoauthor=D.+Verzijlauthor=A.+Zweemerauthor=K.+Yeauthor=A.+G%C3%B6bly%C3%B6sauthor=A.+P.+IJzermanauthor=K.+A.+Jacobson&title=Functionally+Biased+Modulation+of+A3+Adenosine+Receptor+Agonist+Efficacy+and+Potency+by+Imidazoquinolinamine+Allosteric+Enhancers&doi=10.1016%2Fj.bcp.2011.06.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Functionally biased modulation of A3 adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers</span></div><div class="casAuthors">Gao, Zhan-Guo; Verzijl, Dennis; Zweemer, Annelien; Ye, Kai; Goeblyoes, Aniko; IJzerman, Adriaan P.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">658-668</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Allosteric modulators for the Gi-coupled A3 adenosine receptor (AR) are of considerable interest as therapeutic agents and as pharmacol. tools to probe various signaling pathways.  In this study, we initially characterized the effects of several imidazoquinolinamine allosteric modulators (LUF5999, LUF6000 and LUF6001) on the human A3 AR stably expressed in CHO cells using a cAMP functional assay.  These modulators were found to affect efficacy and potency of the agonist Cl-IB-MECA differently.  LUF5999 (2-cyclobutyl deriv.) enhanced efficacy but decreased potency.  LUF6000 (2-cyclohexyl deriv.) enhanced efficacy without affecting potency.  LUF6001 (2-H deriv.) decreased both efficacy and potency.  We further compared the agonist enhancing effects of LUF6000 in several other A3 AR-mediated events.  It was shown that although LUF6000 behaved somewhat differently in various signaling pathways, it was more effective in enhancing the effects of low-efficacy than of high-efficacy agonists.  In an assay of cAMP accumulation, LUF6000 enhanced the efficacy of all agonists examd., but in the membrane hyperpolarization assay, it only enhanced the efficacy of partial agonists.  In calcium mobilization, LUF6000 did not affect the efficacy of the full agonist NECA but was able to switch the nucleoside antagonist MRS542 into a partial agonist.  In translocation of β-arrestin2, the agonist-enhancing effect LUF6000 was not pronounced.  In an assay of ERK1/2 phosphorylation LUF6000 did not show any effect on the efficacy of Cl-IB-MECA.  The differential effects of LUF6000 on the efficacy and potency of the agonist Cl-IB-MECA in various signaling pathway were interpreted quant. using a math. model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcGTgKD_XhBLVg90H21EOLACvtfcHk0li_M_6tr0nMYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFCqu7w%253D&md5=230c20a583d3cca93c56c56c39cb7c22</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.06.017%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DVerzijl%26aufirst%3DD.%26aulast%3DZweemer%26aufirst%3DA.%26aulast%3DYe%26aufirst%3DK.%26aulast%3DG%25C3%25B6bly%25C3%25B6s%26aufirst%3DA.%26aulast%3DIJzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DFunctionally%2520Biased%2520Modulation%2520of%2520A3%2520Adenosine%2520Receptor%2520Agonist%2520Efficacy%2520and%2520Potency%2520by%2520Imidazoquinolinamine%2520Allosteric%2520Enhancers%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2011%26volume%3D82%26issue%3D6%26spage%3D658%26epage%3D668%26doi%3D10.1016%2Fj.bcp.2011.06.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors as Drug Targets – What are the Challenges?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">265</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1038/nrd3955</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1038%2Fnrd3955" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=23535933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXks1Glsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=265-86&issue=4&author=J.+F.+Chenauthor=H.+K.+Eltzschigauthor=B.+B.+Fredholm&title=Adenosine+Receptors+as+Drug+Targets+%E2%80%93+What+are+the+Challenges%3F&doi=10.1038%2Fnrd3955"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as drug targets - what are the challenges?</span></div><div class="casAuthors">Chen, Jiang-Fan; Eltzschig, Holger K.; Fredholm, Bertil B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-286</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adenosine signalling has long been a target for drug development, with adenosine itself or its derivs. being used clin. since the 1940s.  In addn., methylxanthines such as caffeine have profound biol. effects as antagonists at adenosine receptors.  Moreover, drugs such as dipyridamole and methotrexate act by enhancing the activation of adenosine receptors.  There is strong evidence that adenosine has a functional role in many diseases, and several pharmacol. compds. specifically targeting individual adenosine receptors - either directly or indirectly - have now entered the clinic.  However, only one adenosine receptor-specific agent - the adenosine A2A receptor agonist regadenoson (Lexiscan; Astellas Pharma) - has so far gained approval from the US Food and Drug Administration (FDA).  Here, we focus on the biol. of adenosine signalling to identify hurdles in the development of addnl. pharmacol. compds. targeting adenosine receptors and discuss strategies to overcome these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqhEzWXi1WS7Vg90H21EOLACvtfcHk0li_M_6tr0nMYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXks1Glsrs%253D&md5=898fee7a68273ebfbd5a1d3dca307dc5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrd3955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3955%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAdenosine%2520Receptors%2520as%2520Drug%2520Targets%2520%25E2%2580%2593%2520What%2520are%2520the%2520Challenges%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D4%26spage%3D265%26epage%3D86%26doi%3D10.1038%2Fnrd3955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Hilaire, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravid, K. C.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Induction of Adenosine Receptor Genes and its Functional Significance</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>218</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1002/jcp.21579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fjcp.21579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=18767039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BD1cjgvFOmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=218&publication_year=2009&pages=35-44&author=C.+St.%0AHilaireauthor=S.+H.+Carrollauthor=H.+Chenauthor=K.+C.+Ravid&title=Mechanisms+of+Induction+of+Adenosine+Receptor+Genes+and+its+Functional+Significance&doi=10.1002%2Fjcp.21579"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of induction of adenosine receptor genes and its functional significance</span></div><div class="casAuthors">St Hilaire Cynthia; Carroll Shannon H; Chen Hongjie; Ravid Katya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular physiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">218</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adenosine is a metabolite generated and released from cells, particularly under injury or stress.  It elicits protective or damaging responses via signaling through the adenosine receptors, including the adenylyl cyclase inhibitory A(1) and A(3), and the adenylyl cyclase stimulatory A(2A) and A(2B).  Multiple adenosine receptor types, including stimulatory and inhibitory, can be found in the same cell, suggesting that a careful balance of adenosine receptor expression in a particular cell is necessary for a specific adenosine-induced response.  This balance could be controlled by differential expression of the adenosine receptor genes under different stimuli.  Here, we have reviewed an array of studies that have characterized basal or induced expression of the adenosine receptors and common as well as distinct mechanisms of effect, in hopes that ongoing studies on this topic will further elucidate detailed mechanisms of adenosine receptor regulation, leading to potential therapeutic applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-2wKEeHylQxLDWw4HIq2sfW6udTcc2eZHpvFPaF-c-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cjgvFOmuw%253D%253D&md5=3b907b9f761a998ec478f49a2d295798</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21579%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BHilaire%26aufirst%3DC.%26aulast%3DCarroll%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DRavid%26aufirst%3DK.%2BC.%26atitle%3DMechanisms%2520of%2520Induction%2520of%2520Adenosine%2520Receptor%2520Genes%2520and%2520its%2520Functional%2520Significance%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2009%26volume%3D218%26spage%3D35%26epage%3D44%26doi%3D10.1002%2Fjcp.21579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1021/cr0682195</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr0682195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=238-263&author=P.+Baraldiauthor=M.+Tabriziauthor=S.+Gessiauthor=P.+Borea&title=Adenosine+Receptor+Antagonists%3A+Translating+Medicinal+Chemistry+and+Pharmacology+into+Clinical+Utility&doi=10.1021%2Fcr0682195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility</span></div><div class="casAuthors">Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Gessi, Stefania; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">238-263</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review discusses the chem. and pharmacol. of adenosine A1, A2A, A2B and A3 receptor antagonists and their therapeutic potential in clin. developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOXhQGKqAVLbVg90H21EOLACvtfcHk0lhHY24QQa6UYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXis1OisQ%253D%253D&md5=1ae9e978507a1bbe7ab7aea0bdb33bb8</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fcr0682195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0682195%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%26aulast%3DTabrizi%26aufirst%3DM.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%26atitle%3DAdenosine%2520Receptor%2520Antagonists%253A%2520Translating%2520Medicinal%2520Chemistry%2520and%2520Pharmacology%2520into%2520Clinical%2520Utility%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26spage%3D238%26epage%3D263%26doi%3D10.1021%2Fcr0682195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of Adenosine, P2Y and P2X Receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.neuropharm.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=26686393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2016&pages=31-49&author=K.+A.+Jacobsonauthor=C.+E.+M%C3%BCller&title=Medicinal+Chemistry+of+Adenosine%2C+P2Y+and+P2X+Receptors&doi=10.1016%2Fj.neuropharm.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine, P2Y and P2X receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-49</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pharmacol. tool compds. are now available to define action at the adenosine (ARs), P2Y and P2X receptors.  We present a selection of the most commonly used agents to study purines in the nervous system.  Some of these compds., including A1 and A3 AR agonists, P2Y1R and P2Y12R antagonists, and P2X3, P2X4 and P2X7 antagonists, are potentially of clin. use in treatment of disorders of the nervous system, such as chronic pain, neurodegeneration and brain injury.  Agonists of the A2AAR and P2Y2R are already used clin., P2Y12R antagonists are widely used antithrombotics and an antagonist of the A2AAR is approved in Japan for treating Parkinson's disease.  The selectivity defined for some of the previously introduced compds. has been revised with updated pharmacol. characterization, for example, various AR agonists and antagonists were deemed A1AR or A3AR selective based on human data, but species differences indicated a redn. in selectivity ratios in other species.  Also, many of the P2R ligands still lack bioavailability due to charged groups or hydrolytic (either enzymic or chem.) instability.  X-ray crystallog. structures of AR and P2YRs have shifted the mode of ligand discovery to structure-based approaches rather than previous empirical approaches.  The X-ray structures can be utilized either for in silico screening of chem. diverse libraries for the discovery of novel ligands or for enhancement of the properties of known ligands by chem. modification.  Although X-ray structures of the zebrafish P2X4R have been reported, there is scant structural information about ligand recognition in these trimeric ion channels.  In summary, there are definitive, selective agonists and antagonists for all of the ARs and some of the P2YRs; while the pharmacochem. of P2XRs is still in nascent stages.  The therapeutic potential of selectively modulating these receptors is continuing to gain interest in such fields as cancer, inflammation, pain, diabetes, ischemic protection and many other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfj6lh6K1FbLVg90H21EOLACvtfcHk0lhHY24QQa6UYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF&md5=ffcb23c7e271df86ef6b24d88aef2d82</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Adenosine%252C%2520P2Y%2520and%2520P2X%2520Receptors%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D104%26spage%3D31%26epage%3D49%26doi%3D10.1016%2Fj.neuropharm.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Clinical Efficacy of Istradefylline (KW-6002) in Parkinson’s Disease: A Randomized, Controlled Study</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1437</span>– <span class="NLM_lpage">1443</span>, <span class="refDoi"> DOI: 10.1002/mds.23107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fmds.23107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=20629136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BC3cjltVOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2010&pages=1437-1443&issue=10&author=Y.+Mizunoauthor=K.+Hasegawaauthor=T.+Kondoauthor=S.+Kunoauthor=M.+Yamamoto&title=Clinical+Efficacy+of+Istradefylline+%28KW-6002%29+in+Parkinson%E2%80%99s+Disease%3A+A+Randomized%2C+Controlled+Study&doi=10.1002%2Fmds.23107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study</span></div><div class="casAuthors">Mizuno Yoshikuni; Hasegawa Kazuko; Kondo Tomoyoshi; Kuno Sadako; Yamamoto Mitsutoshi</div><div class="citationInfo"><span class="NLM_cas:title">Movement disorders : official journal of the Movement Disorder Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1437-43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The objectives of this study were to evaluate the efficacy of istradefylline at an oral dose of 20 mg or 40 mg once daily for 12 weeks in Parkinson's disease (PD) patients with motor complications on levodopa therapy based on the change in the daily OFF time compared with placebo and to assess the safety at these doses.  A total of 363 subjects were randomly assigned to receive 20 mg/day istradefylline (n = 119), 40 mg/day istradefylline (n = 125), or placebo (n = 119).  The primary outcome variable was the change from baseline at endpoint in daily OFF time based on patients' ON/OFF diaries.  At endpoint, the daily OFF time reduced from baseline by 1.31 hours for 20 mg/day istradefylline (P = 0.013 as compared to the placebo), 1.58 hours for 40 mg/day istradefylline (P < 0.001), and 0.66 hours for placebo; istradefylline significantly reduced the daily OFF time compared with placebo.  The UPDRS Part III subscale score (ON state) reduced by 5.7 at endpoint in both istradefylline groups and 3.7 in the placebo group (P = 0.006 for 20 mg/day and P = 0.006 for 40 mg/day group as compared with placebo).  The most commonly reported drug-related treatment emergent adverse event (TEAE) was dyskinesia, which occurred in 2.5% (3/119) of subjects receiving placebo, 8.5% (10/118) receiving 20 mg/day istradefylline, and 6.4% (8/125) receiving 40 mg/day istradefylline.  We conclude that istradefylline at 20 mg and 40 mg once daily is effective in relieving wearing-off fluctuations of PD patients.  In addition, istradefylline was well tolerated at both doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNnUyoaApPXjW1zwg2yUK5fW6udTcc2eZHpvFPaF-c-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjltVOgtw%253D%253D&md5=47a282eaf5cf09beba823b6dd50eeda9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fmds.23107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.23107%26sid%3Dliteratum%253Aachs%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DKuno%26aufirst%3DS.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DClinical%2520Efficacy%2520of%2520Istradefylline%2520%2528KW-6002%2529%2520in%2520Parkinson%25E2%2580%2599s%2520Disease%253A%2520A%2520Randomized%252C%2520Controlled%2520Study%26jtitle%3DMov.%2520Disord.%26date%3D2010%26volume%3D25%26issue%3D10%26spage%3D1437%26epage%3D1443%26doi%3D10.1002%2Fmds.23107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diniz, C.</span></span> <span> </span><span class="NLM_article-title">The Adenosinergic System as a Therapeutic Target in The Vasculature: New Ligands and Challenges</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.3390/molecules22050752</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.3390%2Fmolecules22050752" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOhsLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=752-779&issue=5&author=J.+B.+Sousaauthor=C.+Diniz&title=The+Adenosinergic+System+as+a+Therapeutic+Target+in+The+Vasculature%3A+New+Ligands+and+Challenges&doi=10.3390%2Fmolecules22050752"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The adenosinergic system as a therapeutic target in the vasculature: new ligands and challenges</span></div><div class="casAuthors">Sousa, Joana Beatriz; Diniz, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">752/1-752/27</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Adenosine is an adenine base purine with actions as a modulator of neurotransmission, smooth muscle contraction, and immune response in several systems of the human body, including the cardiovascular system.  In the vasculature, four P1-receptors or adenosine receptors-A, AA, AB and A-have been identified.  Adenosine receptors are membrane G-protein receptors that trigger their actions through several signaling pathways and present differential affinity requirements.  Adenosine is an endogenous ligand whose extracellular levels can reach concns. high enough to activate the adenosine receptors.  This nucleoside is a product of enzymic breakdown of extra and intracellular adenine nucleotides and also of S-adenosylhomocysteine.  Adenosine availability is also dependent on the activity of nucleoside transporters (NTs).  The interplay between NTs and adenosine receptors' activities are debated and a particular attention is given to the paramount importance of the disruption of this interplay in vascular pathophysiol., namely in hypertension., The integration of important functional aspects of individual adenosine receptor pharmacol. (such as in vasoconstriction/vasodilation) and morphol. features (within the three vascular layers) in vessels will be discussed, hopefully clarifying the importance of adenosine receptors/NTs for modulating peripheral mesenteric vascular resistance.  In recent years, an increase interest in purine physiol./pharmacol. has led to the development of new ligands for adenosine receptors.  Some of them have been patented as having promising therapeutic activities and some have been chosen to undergo on clin. trials.  Increased levels of endogenous adenosine near a specific subtype can lead to its activation, constituting an indirect receptor targeting approach either by inhibition of NT or, alternatively, by increasing the activity of enzymes responsible for ATP breakdown.  These findings highlight the putative role of adenosinergic players as attractive therapeutic targets for cardiovascular pathologies, namely hypertension, heart failure or stroke.  Nevertheless, several aspects are still to be explored, creating new challenges to be addressed in future studies, particularly the development of strategies able to circumvent the predicted side effects of these therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2JvU6wUIhV7Vg90H21EOLACvtfcHk0ljMDwFpwD98TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOhsLzK&md5=199d3241100dc332149fb9096b9b85cf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22050752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22050752%26sid%3Dliteratum%253Aachs%26aulast%3DSousa%26aufirst%3DJ.%2BB.%26aulast%3DDiniz%26aufirst%3DC.%26atitle%3DThe%2520Adenosinergic%2520System%2520as%2520a%2520Therapeutic%2520Target%2520in%2520The%2520Vasculature%253A%2520New%2520Ligands%2520and%2520Challenges%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26issue%3D5%26spage%3D752%26epage%3D779%26doi%3D10.3390%2Fmolecules22050752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vecchio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltos, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A. T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span> <span> </span><span class="NLM_article-title">New Paradigms in Adenosine Receptor Pharmacology: Allostery, Oligomerization and Biased Agonism</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>175</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">4036</span>– <span class="NLM_lpage">4046</span>, <span class="refDoi"> DOI: 10.1111/bph.14337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fbph.14337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=29679502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtF2jsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2018&pages=4036-4046&issue=21&author=E.+A.+Vecchioauthor=J.+A.+Baltosauthor=A.+T.+N.+Nguyenauthor=A.+Christopoulosauthor=P.+J.+Whiteauthor=L.+T.+May&title=New+Paradigms+in+Adenosine+Receptor+Pharmacology%3A+Allostery%2C+Oligomerization+and+Biased+Agonism&doi=10.1111%2Fbph.14337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism</span></div><div class="casAuthors">Vecchio, Elizabeth A.; Baltos, Jo-Anne; Nguyen, Anh T. N.; Christopoulos, Arthur; White, Paul J.; May, Lauren T.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4036-4046</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors are a family of GPCRs contg. four subtypes (A1, A2A, A2B and A3 receptors), all of which bind the ubiquitous nucleoside adenosine.  These receptors play an important role in physiol. and pathophysiol. and therefore represent attractive drug targets for a range of conditions.  The theor. framework surrounding drug action at adenosine receptors now extends beyond the notion of prototypical agonism and antagonism to encompass more complex pharmacol. concepts.  New paradigms include allostery, in which ligands bind a topog. distinct receptor site from that of the endogenous agonist, homomeric or heteromeric interactions across receptor oligomers and biased agonism, i.e., ligand-dependent differential intracellular signalling.  This review provides a concise overview of allostery, oligomerization and biased agonism at adenosine receptors and outlines how these paradigms may enhance future drug discovery endeavours focussed on the development of novel therapeutic agents acting at adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeQa1m_RHgirVg90H21EOLACvtfcHk0ljMDwFpwD98TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtF2jsbfI&md5=2548b72a81b3e269198794a19afaf760</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fbph.14337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14337%26sid%3Dliteratum%253Aachs%26aulast%3DVecchio%26aufirst%3DE.%2BA.%26aulast%3DBaltos%26aufirst%3DJ.%2BA.%26aulast%3DNguyen%26aufirst%3DA.%2BT.%2BN.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DP.%2BJ.%26aulast%3DMay%26aufirst%3DL.%2BT.%26atitle%3DNew%2520Paradigms%2520in%2520Adenosine%2520Receptor%2520Pharmacology%253A%2520Allostery%252C%2520Oligomerization%2520and%2520Biased%2520Agonism%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2018%26volume%3D175%26issue%3D21%26spage%3D4036%26epage%3D4046%26doi%3D10.1111%2Fbph.14337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugliese, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedata, F.</span></span> <span> </span><span class="NLM_article-title">Adenosine Receptors in Cerebral Ischemia</span>. <i>Int. Rev. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">348</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-801022-8.00013-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2FB978-0-12-801022-8.00013-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=25175971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FntlCmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2014&pages=309-348&author=A.+Melaniauthor=A.+M.+Puglieseauthor=F.+Pedata&title=Adenosine+Receptors+in+Cerebral+Ischemia&doi=10.1016%2FB978-0-12-801022-8.00013-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors in cerebral ischemia</span></div><div class="casAuthors">Melani Alessia; Pugliese Anna Maria; Pedata Felicita</div><div class="citationInfo"><span class="NLM_cas:title">International review of neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">309-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Ischemic stroke is a complex pathology characterized by a sequence of events that evolve over time and space.  It is the second leading cause of death and the main cause of adult long-term disability in developed countries.  At the moment, there is no promising pharmacotherapy for acute ischemic stroke.  Adenosine receptors (A1, A2A, A2B, A3) are important targets for therapeutic implementation in the treatment of stroke because extracellular adenosine concentrations increase dramatically soon after ischemia.  Adenosine receptors located both on central nervous system cells and on immune blood cells exert important roles during ischemia.  The neuroprotective role of adenosine through A1 receptor subtype during ischemia is accepted, but the use of selective A1 agonists is hampered by undesirable side effects such as sedation, bradycardia, and hypotension.  Recently, the A2A receptor subtype emerged as a potential therapeutic attractive target in ischemia.  Evidence suggests that A2A receptor has dual role: in a first phase of ischemia, it potentiates excitotoxicity, while hours and days after ischemia, A2A receptors on immune blood cells potentiate cell adhesion mechanisms and infiltration in the ischemic parenchyma.  Consistently, the use of A2A receptor agonists/antagonists (administered at doses that do not modify blood pressure and heart rate) should be carefully evaluated in function of time after ischemia.  Although much is still to be known about the role of A2B and A3 receptor subtypes in brain ischemia, most consistent information indicates their role in regulation of immunosuppression and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTKgIhwf9wekBcr74wzj5o5fW6udTcc2eZU2gCaH_iP6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FntlCmsg%253D%253D&md5=6edc49f13c18f3b95e90620d9a81fc54</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-801022-8.00013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-801022-8.00013-1%26sid%3Dliteratum%253Aachs%26aulast%3DMelani%26aufirst%3DA.%26aulast%3DPugliese%26aufirst%3DA.%2BM.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DAdenosine%2520Receptors%2520in%2520Cerebral%2520Ischemia%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2014%26volume%3D119%26spage%3D309%26epage%3D348%26doi%3D10.1016%2FB978-0-12-801022-8.00013-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivkees, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thevananther, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span> <span> </span><span class="NLM_article-title">Are A3 Adenosine Receptors Expressed in the Brain?</span>. <i>NeuroReport</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1097/00001756-200004070-00026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1097%2F00001756-200004070-00026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10790877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivFOgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=1025-1030&issue=5&author=S.+A.+Rivkeesauthor=S.+Thevanantherauthor=H.+Hao&title=Are+A3+Adenosine+Receptors+Expressed+in+the+Brain%3F&doi=10.1097%2F00001756-200004070-00026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Are A3 adenosine receptors expressed in the brain?</span></div><div class="casAuthors">Rivkees, Scott A.; Thevananther, Sundararajah; Hao, Haiping</div><div class="citationInfo"><span class="NLM_cas:title">NeuroReport</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">NERPEZ</span>;
        ISSN:<span class="NLM_cas:issn">0959-4965</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">An increasing no. of reports suggest a role for A3 adenosine receptors (A3ARs) in mediating adenosine action in the central nervous system.  However, studies of A3AR localization in the brain have yet to be performed.  To provide insights into the central sites of A3AR action, we compared patterns of A1 and A3AR mRNA and binding site expression in the brains of rats, mice and humans.  We also assessed whether A3 agonists are selective for A3ARs.  Whereas it was possible to detect high-level A1AR expression in many brain regions, it was not possible to detect either A3AR gene or binding site expression in the central nervous system.  When we examd. the affinities of the A3AR agonists Cl-IAB-MECA and IAB-MECA for A1ARs, we found that these compds. bound to A1ARs with high affinity.  These observations suggest that studies using A3-agonists need to consider potential effects of A1ARs activation, as A1ARs are abundantly expressed in the nervous system whereas A3AR expression in the brain cannot be directly demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFts3YxNA6urVg90H21EOLACvtfcHk0livEJqyOXfIBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivFOgsb0%253D&md5=9f5a92a805f81c544694ea48efb2fb22</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1097%2F00001756-200004070-00026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00001756-200004070-00026%26sid%3Dliteratum%253Aachs%26aulast%3DRivkees%26aufirst%3DS.%2BA.%26aulast%3DThevananther%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DH.%26atitle%3DAre%2520A3%2520Adenosine%2520Receptors%2520Expressed%2520in%2520the%2520Brain%253F%26jtitle%3DNeuroReport%26date%3D2000%26volume%3D11%26issue%3D5%26spage%3D1025%26epage%3D1030%26doi%3D10.1097%2F00001756-200004070-00026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borea, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincenzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraldi, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merighi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span> <span> </span><span class="NLM_article-title">The A3 Receptor: History and Perspectives</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1124/pr.113.008540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1124%2Fpr.113.008540" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=25387804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=74-102&issue=1&author=A.+P.+Boreaauthor=K.+Varaniauthor=F.+Vincenziauthor=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Merighiauthor=S.+Gessi&title=The+A3+Receptor%3A+History+and+Perspectives&doi=10.1124%2Fpr.113.008540"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor: history and perspectives</span></div><div class="casAuthors">Borea, Pier Andrea; Varani, Katia; Vincenzi, Fabrizio; Baraldi, Pier Giovanni; Tabrizi, Mojgan Aghazadeh; Merighi, Stefania; Gessi, Stefania</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-102, 29 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  By general consensus, the omnipresent purine nucleoside adenosine is considered a major regulator of local tissue function, esp. when energy supply fails to meet cellular energy demand.  Adenosine mediation involves activation of a family of four G protein-coupled adenosine receptors (ARs): A1, A2A, A2B, and A3.  The A3 adenosine receptor (A3AR) is the only adenosine subtype to be overexpressed in inflammatory and cancer cells, thus making it a potential target for therapy.  Originally isolated as an orphan receptor, A3AR presented a twofold nature under different pathophysiol. conditions: it appeared to be protective/harmful under ischemic conditions, pro/anti-inflammatory, and pro/antitumoral depending on the systems investigated.  Until recently, the greatest and most intriguing challenge has been to understand whether, and in which cases, selective A3 agonists or antagonists would be the best choice.  Today, the choice has been made and A3AR agonists are now under clin. development for some disorders including rheumatoid arthritis, psoriasis, glaucoma, and hepatocellular carcinoma.  More specifically, the interest and relevance of these new agents derives from clin. data demonstrating that A3AR agonists are both effective and safe.  Thus, it will become apparent in the present review that purine scientists do seem to be getting closer to their goal: the incorporation of adenosine ligands into drugs with the ability to save lives and improve human health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNTebUcia2x7Vg90H21EOLACvtfcHk0livEJqyOXfIBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Omsbk%253D&md5=152673d44c951624ccb2ef090ffc670c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1124%2Fpr.113.008540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.113.008540%26sid%3Dliteratum%253Aachs%26aulast%3DBorea%26aufirst%3DA.%2BP.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DMerighi%26aufirst%3DS.%26aulast%3DGessi%26aufirst%3DS.%26atitle%3DThe%2520A3%2520Receptor%253A%2520History%2520and%2520Perspectives%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26issue%3D1%26spage%3D74%26epage%3D102%26doi%3D10.1124%2Fpr.113.008540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fishman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S.</span></span> <span> </span><span class="NLM_article-title">The A3 Adenosine Receptor (A3AR): Therapeutic Target and Predictive Biological Marker in Rheumatoid Arthritis</span>. <i>Clin. Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2359</span>– <span class="NLM_lpage">2362</span>, <span class="refDoi"> DOI: 10.1007/s10067-016-3202-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1007%2Fs10067-016-3202-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=26886128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BC28jhsVCktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=2359-2362&issue=9&author=P.+Fishmanauthor=S.+Cohen&title=The+A3+Adenosine+Receptor+%28A3AR%29%3A+Therapeutic+Target+and+Predictive+Biological+Marker+in+Rheumatoid+Arthritis&doi=10.1007%2Fs10067-016-3202-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis</span></div><div class="casAuthors">Fishman Pnina; Cohen Shira</div><div class="citationInfo"><span class="NLM_cas:title">Clinical rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2359-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Gi protein-associated A3 adenosine receptor (A3AR) is over-expressed in inflammatory cells, and this high expression is also reflected in the peripheral blood mononuclear cells of patients with autoimmune inflammatory diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease.  CF101, a selective agonist with high affinity to the A3AR, is known to induce robust anti-inflammatory effect in experimental animal models of adjuvant-, collagen-, and tropomyosin-induced arthritis.  The effect is mediated via a definitive molecular mechanism entailing deregulation of the nuclear factor-κB (NF-κB) and the Wnt signal transduction pathways resulting in apoptosis of inflammatory cells.  CF101 was found to be safe and well tolerated in all preclinical, phase I, and phase II human clinical studies.  In two phase II clinical studies where CF101 was administered to rheumatoid arthritis (RA) patients as a stand-alone drug, a significant anti-rheumatic effect and a direct significant correlation were found between receptor expression at baseline and patients' response to the drug, suggesting that A3AR may be utilized as a predictive biomarker.  The A3AR is a promising therapeutic target in rheumatoid arthritis and can be used also as a biological marker to predict patients' response to CF101.  This is a unique type of a personalized medicine approach which may pave the way for a safe and efficacious treatment for this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQeChpzptz2mVHFYivNCdPRfW6udTcc2eb1LdJcOcWkKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhsVCktA%253D%253D&md5=0b2af53772d34d132cc949069d6744e6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs10067-016-3202-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10067-016-3202-4%26sid%3Dliteratum%253Aachs%26aulast%3DFishman%26aufirst%3DP.%26aulast%3DCohen%26aufirst%3DS.%26atitle%3DThe%2520A3%2520Adenosine%2520Receptor%2520%2528A3AR%2529%253A%2520Therapeutic%2520Target%2520and%2520Predictive%2520Biological%2520Marker%2520in%2520Rheumatoid%2520Arthritis%26jtitle%3DClin.%2520Rheumatol.%26date%3D2016%26volume%3D35%26issue%3D9%26spage%3D2359%26epage%3D2362%26doi%3D10.1007%2Fs10067-016-3202-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bagatini, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dos Santos, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mânica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reschke, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, F. B.</span></span> <span> </span><span class="NLM_article-title">The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases</span>. <i>J. Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">4892473</span>, <span class="refDoi"> DOI: 10.1155/2018/4892473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1155%2F2018%2F4892473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=30159340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BB3c3jt1ersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=4892473&author=M.+D.+Bagatiniauthor=A.+A.+Dos+Santosauthor=A.+M.+Cardosoauthor=A.+M%C3%A2nicaauthor=C.+R.+Reschkeauthor=F.+B.+Carvalho&title=The+Impact+of+Purinergic+System+Enzymes+on+Noncommunicable%2C+Neurological%2C+and+Degenerative+Diseases&doi=10.1155%2F2018%2F4892473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases</span></div><div class="casAuthors">Bagatini Margarete Dulce; Cardoso Andreia Machado; Bagatini Margarete Dulce; Cardoso Andreia Machado; Manica Aline; Carvalho Fabiano Barbosa; Dos Santos Alessandra Antunes; Reschke Cristina Ruedell; Carvalho Fabiano Barbosa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of immunology research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4892473</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Evidences show that purinergic signaling is involved in processes associated with health and disease, including noncommunicable, neurological, and degenerative diseases.  These diseases strike from children to elderly and are generally characterized by progressive deterioration of cells, eventually leading to tissue or organ degeneration.  These pathological conditions can be associated with disturbance in the signaling mediated by nucleotides and nucleosides of adenine, in expression or activity of extracellular ectonucleotidases and in activation of P2X and P2Y receptors.  Among the best known of these diseases are atherosclerosis, hypertension, cancer, epilepsy, Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS).  The currently available treatments present limited effectiveness and are mostly palliative.  This review aims to present the role of purinergic signaling highlighting the ectonucleotidases E-NTPDase, E-NPP, E-5'-nucleotidase, and adenosine deaminase in noncommunicable, neurological, and degenerative diseases associated with the cardiovascular and central nervous systems and cancer.  In conclusion, changes in the activity of ectonucleotidases were verified in all reviewed diseases.  Although the role of ectonucleotidases still remains to be further investigated, evidences reviewed here can contribute to a better understanding of the molecular mechanisms of highly complex diseases, which majorly impact on patients' quality of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSx7jOm8URJawvupmecNw_lfW6udTcc2ebcMYYaHFRCUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3jt1ersA%253D%253D&md5=ab9ec1a51ba98cf1c90d5712951c00da</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1155%2F2018%2F4892473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2018%252F4892473%26sid%3Dliteratum%253Aachs%26aulast%3DBagatini%26aufirst%3DM.%2BD.%26aulast%3DDos%2BSantos%26aufirst%3DA.%2BA.%26aulast%3DCardoso%26aufirst%3DA.%2BM.%26aulast%3DM%25C3%25A2nica%26aufirst%3DA.%26aulast%3DReschke%26aufirst%3DC.%2BR.%26aulast%3DCarvalho%26aufirst%3DF.%2BB.%26atitle%3DThe%2520Impact%2520of%2520Purinergic%2520System%2520Enzymes%2520on%2520Noncommunicable%252C%2520Neurological%252C%2520and%2520Degenerative%2520Diseases%26jtitle%3DJ.%2520Immunol.%2520Res.%26date%3D2018%26volume%3D2018%26spage%3D4892473%26doi%3D10.1155%2F2018%2F4892473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Rodriguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span> <span> </span><span class="NLM_article-title">Chalcone-Based Derivatives as New Scaffolds for Ha3 Adenosine Receptor Antagonists</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">703</span>, <span class="refDoi"> DOI: 10.1111/jphp.12028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fjphp.12028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=23600387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1Wks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=697-703&author=S.+Vazquez-Rodriguezauthor=M.+J.+Matosauthor=L.+Santanaauthor=E.+Uriarteauthor=F.+Borgesauthor=S.+Kachlerauthor=K.-N.+Klotz&title=Chalcone-Based+Derivatives+as+New+Scaffolds+for+Ha3+Adenosine+Receptor+Antagonists&doi=10.1111%2Fjphp.12028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists</span></div><div class="casAuthors">Vazquez-Rodriguez, Saleta; Matos, Maria Joao; Santana, Lourdes; Uriarte, Eugenio; Borges, Fernanda; Kachler, Sonja; Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">697-703</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The synthesis of a new series of coumarin-chalcone hybrids and the pharmacol. characterization of their actions at four subtypes of adenosine receptor (AR) ligands were reported.  The synthesized compds. were characterized in radioligand binding (A1, A2A, and A3) and adenylyl cyclase activity assays (A2B) to det. the affinity of the compds. for the four human AR (hAR) subtypes.  Coumarin-chalcone hybrids were ligands with a novel structure, not reported thus far, that showed varying affinity and selectivity for AR subtypes.  The coumarin-chalcone hybrids in which ring B of the chalcone scaffold was a thiophene were the most potent compds. of the series.  The compd., in which ring A of the chalcone moiety was the Ph ring of the coumarin, showed similar activity against hA1, hA2A and hA3 ARs, while the compd., in which ring A of the chalcone was substituted by the benzopyrone ring of the coumarin moiety, showed similar activity only at the hA3 AR and, therefore, was deemed to be selective (Ki (dissocn. const.) = 5160 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNJuva2zvBTrVg90H21EOLACvtfcHk0ljEHOWYsgMFGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1Wks78%253D&md5=6af9966f25321ae95d04443867325172</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12028%26sid%3Dliteratum%253Aachs%26aulast%3DVazquez-Rodriguez%26aufirst%3DS.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DChalcone-Based%2520Derivatives%2520as%2520New%2520Scaffolds%2520for%2520Ha3%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26spage%3D697%26epage%3D703%26doi%3D10.1111%2Fjphp.12028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Coumarins and Adenosine Receptors: New Perceptions in Structure-Affinity Relationships</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1111/cbdd.13075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fcbdd.13075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=28734062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVamsrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2018&pages=245-256&author=A.+Fonsecaauthor=M.+J.+Matosauthor=S.+Vilarauthor=S.+Kachlerauthor=K.-N.+Klotzauthor=E.+Uriarteauthor=F.+Borges&title=Coumarins+and+Adenosine+Receptors%3A+New+Perceptions+in+Structure-Affinity+Relationships&doi=10.1111%2Fcbdd.13075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Coumarins and adenosine receptors: New perceptions in structure-affinity relationships</span></div><div class="casAuthors">Fonseca, Andre; Matos, Maria Joao; Vilar, Santiago; Kachler, Sonja; Klotz, Karl-Norbert; Uriarte, Eugenio; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">245-256</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Adenosine receptor (AR) subtypes are involved in several physiol. and pharmacol. processes.  Ligands that are able to selectively modulate one receptor subtype can delay or slow down the progression of diverse diseases.  In this context, our research group focused its investigation into the discovery and development of novel, potent and selective AR ligands based on coumarin scaffold.  Therefore, a series of 3-phenylcarboxamidocoumarins were synthesized and their affinity for the human AR subtypes was screened by radioligand binding assays for A1, A2A and A3 receptors and for A2B by adenylyl cyclase assay.  Compd. I was found to be the most remarkable, with a hA1/hA3 and hA2A/hA3 selectivity of 42, for the A3 AR (Ki = 2.4 μM).  Receptor-driven mol. modeling studies have provided valuable information on the binding/selectivity data of compd. I and for the following optimization process.  Moreover, compd. I presents drug-like properties according to the general guidelines linked to the concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6JtYhlSNRa7Vg90H21EOLACvtfcHk0ljEHOWYsgMFGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVamsrzI&md5=37f108d8bd2bebea6681fba77defca1f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.13075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.13075%26sid%3Dliteratum%253Aachs%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DCoumarins%2520and%2520Adenosine%2520Receptors%253A%2520New%2520Perceptions%2520in%2520Structure-Affinity%2520Relationships%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2018%26volume%3D91%26spage%3D245%26epage%3D256%26doi%3D10.1111%2Fcbdd.13075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogger, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Adenosine Receptors Binding Affinities of a Series of 3-Arylcoumarins</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1590</span>– <span class="NLM_lpage">1597</span>, <span class="refDoi"> DOI: 10.1111/jphp.12135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fjphp.12135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=24118065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SmurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=1590-1597&author=M.+J.+Matosauthor=V.+Hoggerauthor=A.+Gasparauthor=S.+Kachlerauthor=F.+Borgesauthor=E.+Uriarteauthor=L.+Santanaauthor=K.-N.+Klotz&title=Synthesis+and+Adenosine+Receptors+Binding+Affinities+of+a+Series+of+3-Arylcoumarins&doi=10.1111%2Fjphp.12135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and adenosine receptors binding affinities of a series of 3-arylcoumarins</span></div><div class="casAuthors">Matos, Maria Joao; Hogger, Veronika; Gaspar, Alexandra; Kachler, Sonja; Borges, Fernanda; Uriarte, Eugenio; Santana, Lourdes; Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1590-1597</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The authors report the synthesis, pharmacol. evaluation, theor. evaluation of absorption, distribution, metab. and excretion properties and structure-activity relationship study of a selected series of 3-arylcoumarin derivs.  Adenosine receptor (ARs) binding activity and selectivity of the synthesized compds. were evaluated in this study.  Different substituents were introduced in both benzene rings of the evaluated scaffold, at positions 6 and 3' or 4' of the moiety.  The lack of data on the 3-arylcoumarin scaffold encouraged us to explore the AR binding activity of a selected series of coumarin derivs.  A series of coumarins was synthesized and evaluated by radioligand binding studies towards ARs.  Analyzing the exptl. data, it can be obsd. that neither the simple 3-arylcoumarin nor the 4'-nitro derivs. presented detectable binding affinity for the evaluated receptors, although most of the other substituted derivs. have good binding affinity profiles, esp. against the hA1/hA3 or only hA3 AR.  One compd. presented the best affinity for hA3 AR (Ki = 2680 nM) and significant selectivity for this subtype.  The title compds. thus formed included a coumarin (benzopyran) derivs. (I) [3-(4-methylphenyl)-6-(2-oxopropoxy)-2H-1-benzopyran-2-one] and related substances, such as 6-methyl-3-(4-methylphenyl)-2H-1-benzopyran-2-one, 6-hydroxy-3-(4-methylphenyl)-2H-1-benzopyran-2-one.  The synthesis of the target compds. was achieved by a reaction of 2-hydroxybenzaldehyde derivs. with benzeneacetic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8M64me97oqLVg90H21EOLACvtfcHk0ljZjDL0d17rvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SmurzI&md5=3ffd0aaf4891d62ee7f9aa973871dbf0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12135%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DHogger%26aufirst%3DV.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DSynthesis%2520and%2520Adenosine%2520Receptors%2520Binding%2520Affinities%2520of%2520a%2520Series%2520of%25203-Arylcoumarins%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26spage%3D1590%26epage%3D1597%26doi%3D10.1111%2Fjphp.12135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span> <span> </span><span class="NLM_article-title">Targeting Adenosine Receptors with Coumarins: Synthesis and Binding Activities of Amide and Carbamate Derivatives</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">30</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.2012.01571.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1111%2Fj.2042-7158.2012.01571.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=23215685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVOh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=30-34&author=M.+J.+Matosauthor=A.+Gasparauthor=S.+Kachlerauthor=K.-N.+Klotzauthor=F.+Borgesauthor=L.+Santanaauthor=E.+Uriarte&title=Targeting+Adenosine+Receptors+with+Coumarins%3A+Synthesis+and+Binding+Activities+of+Amide+and+Carbamate+Derivatives&doi=10.1111%2Fj.2042-7158.2012.01571.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting adenosine receptors with coumarins: synthesis and binding activities of amide and carbamate derivatives</span></div><div class="casAuthors">Matos, Maria Joao; Gaspar, Alexandra; Kachler, Sonja; Klotz, Karl-Norbert; Borges, Fernanda; Santana, Lourdes; Uriarte, Eugenio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">30-34</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives With the aim of finding the structural features governing binding activity and selectivity against adenosine receptors (ARs), several 3-substituted coumarins with amide (compds. 3-6) and carbamate (7-9) functions were synthesized.  To study its possible influence on the binding activity and selectivity, a hydroxyl substituent was also introduced at position 4 of the coumarin moiety.  Methods A new series of coumarins (3-9) were synthesized and evaluated by radioligand binding studies towards ARs.  Key findings None of the 4-hydroxy derivs. (4, 8 and 9) showed binding affinity for any of the ARs.  None of the compds. interacted with the hA2B AR (Ki > 100000 nM).  Compds. 3, 5, 6 and 7 had different activity profiles with dissimilar binding affinity and selectivity towards human A1, A2A and A3 ARs.  Conclusions The most remarkable deriv. is compd. 7, which presents the best affinity and selectivity for the A3 adenosine receptor (Ki = 5500 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOL9ATbbLhZ7Vg90H21EOLACvtfcHk0ljZjDL0d17rvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVOh&md5=2a5a569c0aa10441f4c9554b4d4e36d6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2012.01571.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2012.01571.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26atitle%3DTargeting%2520Adenosine%2520Receptors%2520with%2520Coumarins%253A%2520Synthesis%2520and%2520Binding%2520Activities%2520of%2520Amide%2520and%2520Carbamate%2520Derivatives%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26spage%3D30%26epage%3D34%26doi%3D10.1111%2Fj.2042-7158.2012.01571.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celeiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Rodriguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hripcsak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span> <span> </span><span class="NLM_article-title">Development of Novel Adenosine Receptor Ligands Based on the 3-Amidocoumarin Scaffold</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2015.05.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bioorg.2015.05.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=26042529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFOhtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=1-6&author=M.+J.+Matosauthor=S.+Vilarauthor=S.+Kachlerauthor=M.+Celeiroauthor=S.+Vazquez-Rodriguezauthor=L.+Santanaauthor=E.+Uriarteauthor=G.+Hripcsakauthor=F.+Borgesauthor=K.-N.+Klotz&title=Development+of+Novel+Adenosine+Receptor+Ligands+Based+on+the+3-Amidocoumarin+Scaffold&doi=10.1016%2Fj.bioorg.2015.05.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold</span></div><div class="casAuthors">Matos, Maria J.; Vilar, Santiago; Kachler, Sonja; Celeiro, Maria; Vazquez-Rodriguez, Saleta; Santana, Lourdes; Uriarte, Eugenio; Hripcsak, George; Borges, Fernanda; Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the aim of finding new adenosine receptor (AR) ligands presenting the 3-amidocoumarin scaffold, a study focusing on the discovery of new chem. entities was carried out.  The synthesized compds. 1-8 were evaluated in radioligand binding (A1, A2A and A3) and adenylyl cyclase activity (A2B) assays in order to det. their affinity for human AR subtypes.  The 3-benzamide deriv. 4 showed the highest affinity of the whole series and was more than 30-fold selective for the A3 AR (Ki = 3.24 μM).  The current study supported that small structural changes in this scaffold allowed modulating the affinity resulting in novel promising classes of A1, A2A, and/or A3 AR ligands.  We also performed docking calcns. in hA2A and hA3 to identify the hypothetical binding mode for the most active compds.  In addn., some ADME properties were calcd. in order to better understand the potential of these compds. as drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7DQKokPB-K7Vg90H21EOLACvtfcHk0ljZjDL0d17rvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFOhtb8%253D&md5=4e178d4d19bd1fd80837ce64f5780d98</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2015.05.008%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DCeleiro%26aufirst%3DM.%26aulast%3DVazquez-Rodriguez%26aufirst%3DS.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DHripcsak%26aufirst%3DG.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DDevelopment%2520of%2520Novel%2520Adenosine%2520Receptor%2520Ligands%2520Based%2520on%2520the%25203-Amidocoumarin%2520Scaffold%26jtitle%3DBioorg.%2520Chem.%26date%3D2015%26volume%3D61%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.bioorg.2015.05.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatonetti, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span> <span> </span><span class="NLM_article-title">Insight into the Interactions Between Novel Coumarin Derivatives and Human A3 Adenosine Receptors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2245</span>– <span class="NLM_lpage">2253</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201402205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fcmdc.201402205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=25044491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyhu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2245-2253&author=M.+J.+Matosauthor=S.+Vilarauthor=S.+Kachlerauthor=A.+Fonsecaauthor=L.+Santanaauthor=E.+Uriarteauthor=F.+Borgesauthor=N.+P.+Tatonettiauthor=K.-N.+Klotz&title=Insight+into+the+Interactions+Between+Novel+Coumarin+Derivatives+and+Human+A3+Adenosine+Receptors&doi=10.1002%2Fcmdc.201402205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into the Interactions between Novel Coumarin Derivatives and Human A3 Adenosine Receptors</span></div><div class="casAuthors">Matos, Maria Joao; Vilar, Santiago; Kachler, Sonja; Fonseca, Andre; Santana, Lourdes; Uriarte, Eugenio; Borges, Fernanda; Tatonetti, Nicholas P.; Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2245-2253</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A study focused on the discovery of new chem. entities based on the 3-arylcoumarin scaffold was performed with the aim of finding new adenosine receptor (AR) ligands.  Thirteen synthesized compds. were evaluated by radioligand binding (A1, A2A, and A3) and adenylyl cyclase activity (A2B) assays in order to study their affinity for the four human AR (hAR) subtypes.  Seven of the studied compds. proved to be selective A3AR ligands, with 3-(4'-methylphenyl)-8-(2-oxopropoxy)coumarin (12) being the most potent (Ki=634 nM).  None of the compds. showed affinity for the A2B receptor, while four compds. were found to be nonselective AR ligands for the other three subtypes.  Docking simulations were carried out to identify the hypothetical binding mode and to rationalize the interaction of these types of coumarin derivs. with the binding site of the three ARs to which binding was obsd.  The results allowed us to conclude that the 3-arylcoumarin scaffold composes a novel and promising class of A3AR ligands.  ADME properties were also calcd., with the results suggesting that these compds. are promising leads for the identification of new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs6OAyWmTkdrVg90H21EOLACvtfcHk0ljZjDL0d17rvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyhu7bI&md5=b08e49f24f95617e44de75b09e44ad26</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201402205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201402205%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DTatonetti%26aufirst%3DN.%2BP.%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DInsight%2520into%2520the%2520Interactions%2520Between%2520Novel%2520Coumarin%2520Derivatives%2520and%2520Human%2520A3%2520Adenosine%2520Receptors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D2245%26epage%3D2253%26doi%3D10.1002%2Fcmdc.201402205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varela, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hripcsak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fais, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Petrillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pintus, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Era, B.</span></span> <span> </span><span class="NLM_article-title">Design and Discovery of Tyrosinase Inhibitors Based on a Coumarin Scaffold</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">94227</span>– <span class="NLM_lpage">94235</span>, <span class="refDoi"> DOI: 10.1039/C5RA14465E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1039%2FC5RA14465E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslams7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=94227-94235&author=M.+J.+Matosauthor=C.+Varelaauthor=S.+Vilarauthor=G.+Hripcsakauthor=F.+Borgesauthor=L.+Santanaauthor=E.+Uriarteauthor=A.+Faisauthor=A.+Di+Petrilloauthor=F.+Pintusauthor=B.+Era&title=Design+and+Discovery+of+Tyrosinase+Inhibitors+Based+on+a+Coumarin+Scaffold&doi=10.1039%2FC5RA14465E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and discovery of tyrosinase inhibitors based on a coumarin scaffold</span></div><div class="casAuthors">Matos, M. J.; Varela, C.; Vilar, S.; Hripcsak, G.; Borges, F.; Santana, L.; Uriarte, E.; Fais, A.; Di Petrillo, A.; Pintus, F.; Era, B.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">114</span>),
    <span class="NLM_cas:pages">94227-94235</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">In this manuscript we report the synthesis, pharmacol. evaluation and docking studies of a selected series of 3-aryl and 3-heteroarylcoumarins with the aim of finding structural features for the tyrosinase inhibitory activity.  The synthesized compds. were evaluated as mushroom tyrosinase inhibitors.  Compd. 12b showed the lowest IC50 (0.19 μM) of the series, being approx. 100 times more active than kojic acid, used as a ref. compd.  The kinetic studies of tyrosinase inhibition revealed that 12b acts as a competitive inhibitor of mushroom tyrosinase with L-DOPA as the substrate.  Furthermore, the absence of cytotoxicity in B16F10 melanoma cells was detd. for this compd.  The antioxidant profile of all the derivs. was evaluated by measuring radical scavenging capacity (ABTS and DPPH assays).  Docking expts. were carried out on mushroom tyrosinase structures to better understand the structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocYm7xCob9bLVg90H21EOLACvtfcHk0ljqBZyt31bOGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslams7rI&md5=d74af86449178b65db352238d0b57bda</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1039%2FC5RA14465E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA14465E%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DVarela%26aufirst%3DC.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DHripcsak%26aufirst%3DG.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DFais%26aufirst%3DA.%26aulast%3DDi%2BPetrillo%26aufirst%3DA.%26aulast%3DPintus%26aufirst%3DF.%26aulast%3DEra%26aufirst%3DB.%26atitle%3DDesign%2520and%2520Discovery%2520of%2520Tyrosinase%2520Inhibitors%2520Based%2520on%2520a%2520Coumarin%2520Scaffold%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D94227%26epage%3D94235%26doi%3D10.1039%2FC5RA14465E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delogu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadda, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Era, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fais, A.</span></span> <span> </span><span class="NLM_article-title">New Halogenated Phenylcoumarins as Tyrosinase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3342</span>– <span class="NLM_lpage">3345</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bmcl.2011.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=21514152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVOgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3342-3345&issue=11&author=M.+J.+Matosauthor=L.+Santanaauthor=E.+Uriarteauthor=G.+Deloguauthor=M.+Cordaauthor=M.+B.+Faddaauthor=B.+Eraauthor=A.+Fais&title=New+Halogenated+Phenylcoumarins+as+Tyrosinase+Inhibitors&doi=10.1016%2Fj.bmcl.2011.04.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">New halogenated phenylcoumarins as tyrosinase inhibitors</span></div><div class="casAuthors">Matos, Maria Joao; Santana, Lourdes; Uriarte, Eugenio; Delogu, Giovanna; Corda, Marcella; Fadda, Maria Benedetta; Era, Benedetta; Fais, Antonella</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3342-3345</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the aim of detg. structural features for tyrosinase inhibitory activity, the synthesis and pharmacol. evaluation of a new series of phenylcoumarin derivs. with different no. of hydroxyl or ether groups and bromo substituent in the scaffold is reported.  The synthesized compds. were evaluated as mushroom tyrosinase inhibitors showing, two of them, lower IC50 than the umbelliferone.  6-Bromo-8-hydroxy-3-(4-hydroxyphenyl)coumarin (IC50 = 215 μM) is the best tyrosinase inhibitor of this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqftZAv6PUIH7Vg90H21EOLACvtfcHk0ljqBZyt31bOGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVOgtr0%253D&md5=ceec63fb215c64c028c5db83bf82d0d9</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DDelogu%26aufirst%3DG.%26aulast%3DCorda%26aufirst%3DM.%26aulast%3DFadda%26aufirst%3DM.%2BB.%26aulast%3DEra%26aufirst%3DB.%26aulast%3DFais%26aufirst%3DA.%26atitle%3DNew%2520Halogenated%2520Phenylcoumarins%2520as%2520Tyrosinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D11%26spage%3D3342%26epage%3D3345%26doi%3D10.1016%2Fj.bmcl.2011.04.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Viña, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laguna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span> <span> </span><span class="NLM_article-title">8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">464</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201100538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fcmdc.201100538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=22287164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2hu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=464-470&issue=3&author=D.+Vi%C3%B1aauthor=M.+J.+Matosauthor=G.+Ferinoauthor=E.+Cadoniauthor=R.+Lagunaauthor=F.+Borgesauthor=E.+Uriarteauthor=L.+Santana&title=8-Substituted+3-Arylcoumarins+as+Potent+and+Selective+MAO-B+Inhibitors%3A+Synthesis%2C+Pharmacological+Evaluation%2C+and+Docking+Studies&doi=10.1002%2Fcmdc.201100538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies</span></div><div class="casAuthors">Vina, Dolores; Matos, Maria J.; Ferino, Giulio; Cadoni, Enzo; Laguna, Reyes; Borges, Fernanda; Uriarte, Eugenio; Santana, Lourdes</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">464-470</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Neurodegenerative disorders are becoming more prevalent given the increase in the aging population.  This has inspired active research in the development of new drugs that could mark an important advance in the treatment of complex diseases such as Alzheimer's and Parkinson's.  With the aim of finding new MAO-B-selective inhibitors, we report the synthesis, in vitro evaluation, and docking simulation of a new series of 3-arylcoumarins variously substituted at the 8-position.  Most of the studied compds. show high affinity and selectivity for the hMAO-B isoform, with IC50 values in the low micro- to nanomolar range.  Some of them have greater hMAO-B inhibitory activity and selectivity than the ref. compd., selegiline.  Compds. 7 and 8 are the most active of this series, with compd. 8 being fivefold more potent against MAO-B and severalfold more selective than selegiline.  Docking expts. were carried out with hMAO-B crystal structures, providing new information about the enzyme-inhibitor interaction and the potential therapeutic application of the new 8-substituted 3-arylcoumarins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDGolnNgSgF7Vg90H21EOLACvtfcHk0ljqBZyt31bOGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2hu7k%253D&md5=9c309ac91ff49e2a802f25f4ad94f087</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100538%26sid%3Dliteratum%253Aachs%26aulast%3DVi%25C3%25B1a%26aufirst%3DD.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DFerino%26aufirst%3DG.%26aulast%3DCadoni%26aufirst%3DE.%26aulast%3DLaguna%26aufirst%3DR.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26atitle%3D8-Substituted%25203-Arylcoumarins%2520as%2520Potent%2520and%2520Selective%2520MAO-B%2520Inhibitors%253A%2520Synthesis%252C%2520Pharmacological%2520Evaluation%252C%2520and%2520Docking%2520Studies%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26issue%3D3%26spage%3D464%26epage%3D470%26doi%3D10.1002%2Fcmdc.201100538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Cruz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez-Rodriguez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olea-Azar, C.</span></span> <span> </span><span class="NLM_article-title">Remarkable Antioxidant Properties of a Series of Hydroxy-3-Arylcoumarins</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">3900</span>– <span class="NLM_lpage">3906</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.04.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bmc.2013.04.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=23673214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsleqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3900-3906&issue=13&author=M.+J.+Matosauthor=F.+Perez-Cruzauthor=S.+Vazquez-Rodriguezauthor=E.+Uriarteauthor=L.+Santanaauthor=F.+Borgesauthor=C.+Olea-Azar&title=Remarkable+Antioxidant+Properties+of+a+Series+of+Hydroxy-3-Arylcoumarins&doi=10.1016%2Fj.bmc.2013.04.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Remarkable antioxidant properties of a series of hydroxy-3-arylcoumarins</span></div><div class="casAuthors">Matos, Maria Joao; Perez-Cruz, Fernanda; Vazquez-Rodriguez, Saleta; Uriarte, Eugenio; Santana, Lourdes; Borges, Fernanda; Olea-Azar, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3900-3906</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In the present work we synthesized a series of hydroxy-3-arylcoumarins (compds. 1-9), some of them previously described as MAO-B selective inhibitors, with the aim of evaluating their antioxidant properties.  Theor. evaluation of ADME properties of all the derivs. was also carried out.  From the ORAC-FL, ESR and CV data it was concluded that these derivs. are very good antioxidants, with a very interesting hydroxyl, DPPH and superoxide radicals scavenging profiles.  In particular compd. 9 is the most active and effective antioxidant of the series (ORAC-FL = 13.5, capacity of scavenging hydroxyl radicals = 100%, capacity of scavenging DPPH radicals = 65.9% and capacity of scavenging superoxide radicals = 71.5%).  Kinetics profile for protection fluorescein probe against peroxyl radicals by addn. of antioxidant mol. 9 was also performed.  Therefore, it can operate as a potential candidate for preventing or minimizing the free radicals overprodn. in oxidative-stress related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9NoLmbV6qLVg90H21EOLACvtfcHk0lhixOaHI-eGhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsleqt7k%253D&md5=6c21d83cef81ccc391ad6e7a33c69089</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.04.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.04.015%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DPerez-Cruz%26aufirst%3DF.%26aulast%3DVazquez-Rodriguez%26aufirst%3DS.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DBorges%26aufirst%3DF.%26aulast%3DOlea-Azar%26aufirst%3DC.%26atitle%3DRemarkable%2520Antioxidant%2520Properties%2520of%2520a%2520Series%2520of%2520Hydroxy-3-Arylcoumarins%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D13%26spage%3D3900%26epage%3D3906%26doi%3D10.1016%2Fj.bmc.2013.04.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span> <span> </span><span class="NLM_article-title">CCDC 1937910: Experimental Crystal Structure Determination</span>. <i>CSD Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="refDoi"> DOI: 10.5517/ccdc.csd.cc231k7z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.5517%2Fccdc.csd.cc231k7z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=M.+J.+Matos&title=CCDC+1937910%3A+Experimental+Crystal+Structure+Determination&doi=10.5517%2Fccdc.csd.cc231k7z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.5517%2Fccdc.csd.cc231k7z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5517%252Fccdc.csd.cc231k7z%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26atitle%3DCCDC%25201937910%253A%2520Experimental%2520Crystal%2520Structure%2520Determination%26jtitle%3DCSD%2520Commun.%26date%3D2019%26doi%3D10.5517%2Fccdc.csd.cc231k7z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span> <span> </span><span class="NLM_article-title">3-Phenylcoumarin</span>. <i>Acta Crystallogr., Sect. E: Struct. Rep. Online</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>E68</i></span>,  <span class="NLM_fpage">o2645</span>, <span class="refDoi"> DOI: 10.1107/S1600536812034277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1107%2FS1600536812034277" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=E68&publication_year=2012&pages=o2645&author=M.+J.+Matosauthor=L.+Santanaauthor=E.+Uriarte&title=3-Phenylcoumarin&doi=10.1107%2FS1600536812034277"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS1600536812034277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600536812034277%26sid%3Dliteratum%253Aachs%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26atitle%3D3-Phenylcoumarin%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520E%253A%2520Struct.%2520Rep.%2520Online%26date%3D2012%26volume%3DE68%26spage%3Do2645%26doi%3D10.1107%2FS1600536812034277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kull, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredholm, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohse, M. J.</span></span> <span> </span><span class="NLM_article-title">Comparative Pharmacology of Human Adenosine Receptor Subtypes - Characterization of Stably Transfected Receptors in CHO Cells</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1007/PL00005131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1007%2FPL00005131" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1997&pages=1-9&author=K.-N.+Klotzauthor=J.+Hesslingauthor=J.+Heglerauthor=C.+Owmanauthor=B.+Kullauthor=B.+B.+Fredholmauthor=M.+J.+Lohse&title=Comparative+Pharmacology+of+Human+Adenosine+Receptor+Subtypes+-+Characterization+of+Stably+Transfected+Receptors+in+CHO+Cells&doi=10.1007%2FPL00005131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2FPL00005131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005131%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DHessling%26aufirst%3DJ.%26aulast%3DHegler%26aufirst%3DJ.%26aulast%3DOwman%26aufirst%3DC.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26atitle%3DComparative%2520Pharmacology%2520of%2520Human%2520Adenosine%2520Receptor%2520Subtypes%2520-%2520Characterization%2520of%2520Stably%2520Transfected%2520Receptors%2520in%2520CHO%2520Cells%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1997%26volume%3D357%26spage%3D1%26epage%3D9%26doi%3D10.1007%2FPL00005131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falgner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambertucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vittori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristalli, G.</span></span> <span> </span><span class="NLM_article-title">[3H]HEMADO–a novel Tritiated Agonist Selective for the Human Adenosine A3 Receptor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>556</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2006.10.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.ejphar.2006.10.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=17126322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1CrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=556&publication_year=2007&pages=14-18&author=K.-N.+Klotzauthor=N.+Falgnerauthor=S.+Kachlerauthor=C.+Lambertucciauthor=S.+Vittoriauthor=R.+Volpiniauthor=G.+Cristalli&title=%5B3H%5DHEMADO%E2%80%93a+novel+Tritiated+Agonist+Selective+for+the+Human+Adenosine+A3+Receptor&doi=10.1016%2Fj.ejphar.2006.10.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]HEMADO- a novel tritiated agonist selective for the human adenosine A3 receptor</span></div><div class="casAuthors">Klotz, Karl-Norbert; Falgner, Nico; Kachler, Sonja; Lambertucci, Catia; Vittori, Sauro; Volpini, Rosaria; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">556</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">14-18</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine A3 receptors are promising drug targets for a no. of conditions like inflammatory diseases including asthma, ischemic injury or certain types of cancer.  Consequently, intense efforts are dedicated to the development of selective A3 agonists and antagonists.  The only tritiated agonist that is available for radioligand binding is the nonselective [3H]5'-N-ethylcarboxamidoadenosine ([3H]NECA).  Based on a recently characterized series of 2-substituted adenosine receptor agonists we developed a tritiated selective A3 radioligand with high affinity.  From this series 2-hexyn-1-yl-N6-methyladenosine (HEMADO) with a Ki-value of 1.1 nM at the human A3 subtype was chosen.  HEMADO is 300-fold selective vs. the A1 subtype, and 1100-fold and more than 25,000-fold selective compared to the adenosine A2A and A2B receptors, resp.  The tritiated deriv. [3H]HEMADO exhibited the same affinity as the unlabeled precursor.  In concns. up to 10 nM no specific binding to adenosine A1, A2A or A2B receptors was obsd. confirming the high selectivity for adenosine A3 receptors.  Characterization of [3H]HEMADO in radioligand binding studies revealed reversible binding to the human adenosine A3 subtype.  In satn. binding studies for the A3 subtype a KD-value of 1.1 nM was detd.  Nonspecific binding at a radioligand concn. of 1 nM amounted to 1-2% of total binding.  Competition binding with a panel of adenosine receptor ligands clearly confirmed the correct A3 pharmacol. of the binding site labeled by [3H]HEMADO.  With [3H]HEMADO we present a tritiated agonist with high affinity and A3-selectivity and very low nonspecific binding.  [3H]HEMADO is a useful tool for specific screening for A3 receptor agonists and antagonists in improved radioligand binding assays with the human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWoJyAB1P49LVg90H21EOLACvtfcHk0li3owToWL2a0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1CrsQ%253D%253D&md5=91eb5e9810e75d1ca825a804c767929c</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.10.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.10.048%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DFalgner%26aufirst%3DN.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3D%255B3H%255DHEMADO%25E2%2580%2593a%2520novel%2520Tritiated%2520Agonist%2520Selective%2520for%2520the%2520Human%2520Adenosine%2520A3%2520Receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D556%26spage%3D14%26epage%3D18%26doi%3D10.1016%2Fj.ejphar.2006.10.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gazoni, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kron, I. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laubach, V. E.</span></span> <span> </span><span class="NLM_article-title">Activation of A1, A2A, or A3 Adenosine Receptors Attenuates Lung Ischemia-Reperfusion Injury</span>. <i>J. Thorac. Cardiovasc. Surg.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>140</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">440</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1016/j.jtcvs.2010.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.jtcvs.2010.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=20398911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFeluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2010&pages=440-446&issue=2&author=L.+M.+Gazoniauthor=D.+M.+Waltersauthor=E.+B.+Ungerauthor=J.+Lindenauthor=I.+L.+Kronauthor=V.+E.+Laubach&title=Activation+of+A1%2C+A2A%2C+or+A3+Adenosine+Receptors+Attenuates+Lung+Ischemia-Reperfusion+Injury&doi=10.1016%2Fj.jtcvs.2010.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury</span></div><div class="casAuthors">Gazoni, Leo M.; Walters, Dustin M.; Unger, Eric B.; Linden, Joel; Kron, Irving L.; Laubach, Victor E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thoracic and Cardiovascular Surgery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">440-446</span>CODEN:
                <span class="NLM_cas:coden">JTCSAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-5223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Adenosine and the activation of specific adenosine receptors are implicated in the attenuation of inflammation and organ ischemia-reperfusion injury.  We hypothesized that activation of A1, A2A, or A3 adenosine receptors would provide protection against lung ischemia-reperfusion injury.  With the use of an isolated, ventilated, blood-perfused rabbit lung model, lungs underwent 18 h of cold ischemia followed by 2 h of reperfusion.  Lungs were administered vehicle, adenosine, or selective A1, A2A, or A3 receptor agonists (CCPA, ATL-313, or IB-MECA, resp.) alone or with their resp. antagonists (DPCPX, ZM241385, or MRS1191) during reperfusion.  Compared with the vehicle-treated control group, treatment with A1, A2A, or A3 agonists significantly improved function (increased lung compliance and oxygenation and decreased pulmonary artery pressure), decreased neutrophil infiltration by myeloperoxidase activity, decreased edema, and reduced tumor necrosis factor-α prodn.  Adenosine treatment was also protective, but not to the level of the agonists.  When each agonist was paired with its resp. antagonist, all protective effects were blocked.  The A2A agonist reduced pulmonary artery pressure and myeloperoxidase activity and increased oxygenation to a greater degree than the A1 or A3 agonists.  Selective activation of A1, A2A, or A3 adenosine receptors provides significant protection against lung ischemia-reperfusion injury.  The decreased elaboration of the potent proinflammatory cytokine tumor necrosis factor-α and decreased neutrophil sequestration likely contribute to the overall improvement in pulmonary function.  These results provide evidence for the therapeutic potential of specific adenosine receptor agonists in lung transplant recipients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGFgiNUC0CcrVg90H21EOLACvtfcHk0lgmBG2Ghz5rFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFeluro%253D&md5=1a32867dc18f32ef27ec596641329a7f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.jtcvs.2010.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jtcvs.2010.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DGazoni%26aufirst%3DL.%2BM.%26aulast%3DWalters%26aufirst%3DD.%2BM.%26aulast%3DUnger%26aufirst%3DE.%2BB.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DKron%26aufirst%3DI.%2BL.%26aulast%3DLaubach%26aufirst%3DV.%2BE.%26atitle%3DActivation%2520of%2520A1%252C%2520A2A%252C%2520or%2520A3%2520Adenosine%2520Receptors%2520Attenuates%2520Lung%2520Ischemia-Reperfusion%2520Injury%26jtitle%3DJ.%2520Thorac.%2520Cardiovasc.%2520Surg.%26date%3D2010%26volume%3D140%26issue%3D2%26spage%3D440%26epage%3D446%26doi%3D10.1016%2Fj.jtcvs.2010.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buccioni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marucci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Ben, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giacobbe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambertucci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soverchia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristalli, G.</span></span> <span> </span><span class="NLM_article-title">Innovative Functional cAMP Assay for Studying G Protein-Coupled Receptors: Application to the Pharmacological Characterization of GPR17</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">468</span>, <span class="refDoi"> DOI: 10.1007/s11302-011-9245-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1007%2Fs11302-011-9245-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=21773766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFegurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=463-468&author=M.+Buccioniauthor=G.+Marucciauthor=D.+Dal+Benauthor=D.+Giacobbeauthor=C.+Lambertucciauthor=L.+Soverchiaauthor=A.+Thomasauthor=R.+Volpiniauthor=G.+Cristalli&title=Innovative+Functional+cAMP+Assay+for+Studying+G+Protein-Coupled+Receptors%3A+Application+to+the+Pharmacological+Characterization+of+GPR17&doi=10.1007%2Fs11302-011-9245-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17</span></div><div class="casAuthors">Buccioni, Michela; Marucci, Gabriella; Dal Ben, Diego; Giacobbe, Dania; Lambertucci, Catia; Soverchia, Laura; Thomas, Ajiroghene; Volpini, Rosaria; Cristalli, Gloria</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">463-468</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In this work, an innovative and non-radioactive functional cAMP assay was validated at the GPR17 receptor.  This assay provides a simple and powerful new system to monitor G protein-coupled receptor activity through change in the intracellular cAMP concn. by using a mutant form of Photinus pyralis luciferase into which a cAMP-binding protein moiety has been inserted.  Results, expressed as EC50 or IC50 values for agonists and antagonists, resp., showed a strong correlation with those obtained with [35S]GTPγS binding assay, thus confirming the validity of this approach in the study of new ligands for GPR17.  Moreover, this method allowed confirming that GPR17 is coupled with a Gαi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfNXVrhfnAvLVg90H21EOLACvtfcHk0lgmBG2Ghz5rFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFegurnO&md5=86d1de424c0c9ecbe2a59bc0247d7f3f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11302-011-9245-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-011-9245-8%26sid%3Dliteratum%253Aachs%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DGiacobbe%26aufirst%3DD.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DSoverchia%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DInnovative%2520Functional%2520cAMP%2520Assay%2520for%2520Studying%2520G%2520Protein-Coupled%2520Receptors%253A%2520Application%2520to%2520the%2520Pharmacological%2520Characterization%2520of%2520GPR17%26jtitle%3DPurinergic%2520Signalling%26date%3D2011%26volume%3D7%26spage%3D463%26epage%3D468%26doi%3D10.1007%2Fs11302-011-9245-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cagide, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vilar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hripcsak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Navigating in Chromone Chemical Space: Discovery of Novel and Distinct A3 Adenosine Receptor Ligands</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">78572</span>– <span class="NLM_lpage">78585</span>, <span class="refDoi"> DOI: 10.1039/C5RA14988F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1039%2FC5RA14988F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVaisLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=78572-78585&author=F.+Cagideauthor=A.+Gasparauthor=J.+Reisauthor=D.+Chavarriaauthor=S.+Vilarauthor=G.+Hripcsakauthor=E.+Uriarteauthor=S.+Kachlerauthor=K.-N.+Klotzauthor=F.+Borges&title=Navigating+in+Chromone+Chemical+Space%3A+Discovery+of+Novel+and+Distinct+A3+Adenosine+Receptor+Ligands&doi=10.1039%2FC5RA14988F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Navigating in chromone chemical space: discovery of novel and distinct A3 adenosine receptor ligands</span></div><div class="casAuthors">Cagide, F.; Gaspar, A.; Reis, J.; Chavarria, D.; Vilar, S.; Hripcsak, G.; Uriarte, E.; Kachler, S.; Klotz, K. N.; Borges, F.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">96</span>),
    <span class="NLM_cas:pages">78572-78585</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">One of the major hurdles in the development of safe and effective drugs targeting G-protein coupled receptors (GPCRs) is finding ligands that are highly selective for a specific receptor subtype.  The search for novel compds. with therapeutic value by targeting the A3 adenosine receptor (A3AR) is still in its early stages.  The increasing knowledge about the biol., physiol. and pathol. role of the A3AR subtype was accompanied by the design and development of the A3AR ligands, but the particular role of A3AR agonists and antagonists is still an open issue.  Among the large variety of chem. classes screened towards ARs flavonoids have been indicated as remarkable A3AR antagonists.  However, the search of A3AR ligands based on this framework seems to be discontinued.  In this context, our research group focused its investigation into the discovery and development of novel, potent and selective AR ligands based on the chem. core of flavonoids, the chromone scaffold.  The ongoing research has shown that chromone-2-phenylcarboxamide derivs. display a remarkable preference for hA3AR.  In this work we report stimulating results, supported by A2A/A3 mol. docking simulations and structure-affinity-relationship (SAR) studies by which N-(4,5-methylthiazol-2-yl)-4-oxo-4H-chromene-2-carboxamide (compd. 31) emerged as the most potent and selective compd., displaying an hA3Ki of 167 nM and a selectivity ratio of 590 vs. the hA1 and 480 vs. the hA2AAR subtypes.  The chromone-based ligand was obtained by a simple synthetic approach and will enter in a lead optimization program to enhance its potency and drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY2n16mvecjLVg90H21EOLACvtfcHk0lgmBG2Ghz5rFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVaisLnM&md5=59048ec215cd35ec456f11c6c7b14641</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1039%2FC5RA14988F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA14988F%26sid%3Dliteratum%253Aachs%26aulast%3DCagide%26aufirst%3DF.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DVilar%26aufirst%3DS.%26aulast%3DHripcsak%26aufirst%3DG.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DNavigating%2520in%2520Chromone%2520Chemical%2520Space%253A%2520Discovery%2520of%2520Novel%2520and%2520Distinct%2520A3%2520Adenosine%2520Receptor%2520Ligands%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D78572%26epage%3D78585%26doi%3D10.1039%2FC5RA14988F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span> <i>Schrödinger Suite 2014-3</i>; <span class="NLM_publisher-name">Schrödinger,
LLC</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2014</span>; <a href="http://www.schrodinger.com/" class="extLink">http://www.schrodinger.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Suite+2014-3%3B+Schr%C3%B6dinger%2C%0ALLC%3A+New+York%2C+2014%3B+http%3A%2F%2Fwww.schrodinger.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202014-3%26pub%3DSchr%25C3%25B6dinger%252C%250ALLC%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>322</i></span>,  <span class="NLM_fpage">1211</span>– <span class="NLM_lpage">1217</span>, <span class="refDoi"> DOI: 10.1126/science.1164772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1126%2Fscience.1164772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=18832607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=1211-1217&author=V.+P.+Jaakolaauthor=M.+T.+Griffithauthor=M.+A.+Hansonauthor=V.+Cherezovauthor=E.+Y.+Chienauthor=J.+R.+Laneauthor=A.+P.+Ijzermanauthor=R.+C.+Stevens&title=The+2.6+Angstrom+Crystal+Structure+of+a+Human+A2A+Adenosine+Receptor+Bound+to+an+Antagonist&doi=10.1126%2Fscience.1164772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span></div><div class="casAuthors">Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Lane, J. Robert; IJzerman, Adriaan P.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">5905</span>),
    <span class="NLM_cas:pages">1211-1217</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The adenosine class of heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) mediates the important role of extracellular adenosine in many physiol. processes and is antagonized by caffeine.  The authors have detd. the crystal structure of the human A2A adenosine receptor, in complex with a high-affinity subtype-selective antagonist, ZM241385, to 2.6 angstrom resoln.  Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helixes relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally detd. GPCRs.  The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane.  The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7QL4wN4TdhrVg90H21EOLACvtfcHk0lgi-vlBje38mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN&md5=5bdb862b41f345c244f3c162e058206b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164772%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.%2BP.%26aulast%3DGriffith%26aufirst%3DM.%2BT.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DThe%25202.6%2520Angstrom%2520Crystal%2520Structure%2520of%2520a%2520Human%2520A2A%2520Adenosine%2520Receptor%2520Bound%2520to%2520an%2520Antagonist%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D1211%26epage%3D1217%26doi%3D10.1126%2Fscience.1164772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Congreve, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenstein, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurrell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langmead, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhukov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists Using Structure Based Drug Design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1898</span>– <span class="NLM_lpage">1903</span>, <span class="refDoi"> DOI: 10.1021/jm201376w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201376w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1898-1903&author=M.+Congreveauthor=S.+P.+Andrewsauthor=A.+S.+Dor%C3%A9author=K.+Hollensteinauthor=E.+Hurrellauthor=C.+J.+Langmeadauthor=J.+S.+Masonauthor=I.+W.+Ngauthor=B.+Tehanauthor=A.+Zhukovauthor=M.+Weirauthor=F.+H.+Marshall&title=Discovery+of+1%2C2%2C4-Triazine+Derivatives+as+Adenosine+A2A+Antagonists+Using+Structure+Based+Drug+Design&doi=10.1021%2Fjm201376w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design</span></div><div class="casAuthors">Congreve, Miles; Andrews, Stephen P.; Dore, Andrew S.; Hollenstein, Kaspar; Hurrell, Edward; Langmead, Christopher J.; Mason, Jonathan S.; Ng, Irene W.; Tehan, Benjamin; Zhukov, Andrei; Weir, Malcolm; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1898-1903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, ligand efficient, selective, and orally efficacious 1,2,4-triazine derivs. have been identified using structure based drug design approaches as antagonists of the adenosine A2A receptor.  The X-ray crystal structures of compds. 4e and 4g (I) bound to the GPCR illustrate that the mols. bind deeply inside the orthosteric binding cavity.  In vivo pharmacokinetic and efficacy data for compd. 4k are presented, demonstrating the potential of this series of compds. for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpddydZvtRPv7Vg90H21EOLACvtfcHk0lgi-vlBje38mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D&md5=71d76db8a22bf82f11d3632d2917e155</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm201376w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201376w%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DNg%26aufirst%3DI.%2BW.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DDiscovery%2520of%25201%252C2%252C4-Triazine%2520Derivatives%2520as%2520Adenosine%2520A2A%2520Antagonists%2520Using%2520Structure%2520Based%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1898%26epage%3D1903%26doi%3D10.1021%2Fjm201376w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaakola, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ijzerman, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Ligand Binding and Subtype Selectivity of the Human A2A Adenosine Receptor: Identification and Characterization of Essential Amino Acid Residues</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">13032</span>– <span class="NLM_lpage">13044</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.096974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1074%2Fjbc.M109.096974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=20147292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVGis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=13032-13044&author=V.+P.+Jaakolaauthor=J.+R.+Laneauthor=J.+Y.+Linauthor=V.+Katritchauthor=A.+P.+Ijzermanauthor=R.+C.+Stevens&title=Ligand+Binding+and+Subtype+Selectivity+of+the+Human+A2A+Adenosine+Receptor%3A+Identification+and+Characterization+of+Essential+Amino+Acid+Residues&doi=10.1074%2Fjbc.M109.096974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand Binding and Subtype Selectivity of the Human A2A Adenosine Receptor: Identification and characterization of essential amino acid residues</span></div><div class="casAuthors">Jaakola, Veli-Pekka; Lane, J. Robert; Lin, Judy Y.; Katritch, Vsevolod; IJzerman, Adriaan P.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">13032-13044</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The crystal structure of the human A2A adenosine receptor bound to the A2A receptor-specific antagonist, ZM241385, was recently detd. at 2.6-Å resoln.  Surprisingly, the antagonist binds in an extended conformation, perpendicular to the plane of the membrane, and indicates a no. of interactions unidentified before in ZM241385 recognition.  To further understand the selectivity of ZM241385 for the human A2A adenosine receptor, we examd. the effect of mutating amino acid residues within the binding cavity likely to have key interactions and that have not been previously examd.  Mutation of Phe-168 to Ala abolishes both agonist and antagonist binding as well as receptor activity, whereas mutation of this residue to Trp or Tyr had only moderate effects.  The Met-177 Ala mutation impeded antagonist but not agonist binding.  Finally, the Leu-249 Ala mutant showed neither agonist nor antagonist binding affinity.  From our results and previously published mutagenesis data, we conclude that conserved residues Phe-168(5.29), Glu-169(5.30), Asn-253(6.55), and Leu-249(6.51) play a central role in coordinating the bicyclic core present in both agonists and antagonists.  By combining the anal. of the mutagenesis data with a comparison of the sequences of different adenosine receptor subtypes from different species, we predict that the interactions that det. subtype selectivity reside in the more divergent "upper" region of the binding cavity while the "lower" part of the binding cavity is conserved across adenosine receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQknwBFotFw7Vg90H21EOLACvtfcHk0lgi-vlBje38mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVGis7g%253D&md5=f8939e7b36d08e741cc9f37b90e3cd28</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.096974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.096974%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.%2BP.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DLin%26aufirst%3DJ.%2BY.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DLigand%2520Binding%2520and%2520Subtype%2520Selectivity%2520of%2520the%2520Human%2520A2A%2520Adenosine%2520Receptor%253A%2520Identification%2520and%2520Characterization%2520of%2520Essential%2520Amino%2520Acid%2520Residues%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D13032%26epage%3D13044%26doi%3D10.1074%2Fjbc.M109.096974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kachler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klotz, K.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel A3 Adenosine Receptor Ligands Based on Chromone Scaffold</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2012.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.bcp.2012.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=22433284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFGis78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=21-29&issue=1&author=A.+Gasparauthor=J.+Reisauthor=S.+Kachlerauthor=S.+Paolettaauthor=E.+Uriarteauthor=K.-N.+Klotzauthor=S.+Moroauthor=F.+Borges&title=Discovery+of+Novel+A3+Adenosine+Receptor+Ligands+Based+on+Chromone+Scaffold&doi=10.1016%2Fj.bcp.2012.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel A3 adenosine receptor ligands based on chromone scaffold</span></div><div class="casAuthors">Gaspar, Alexandra; Reis, Joana; Kachler, Sonja; Paoletta, Silvia; Uriarte, Eugenio; Klotz, Karl-Norbert; Moro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A project focused on the discovery of new chem. entities (NCEs) as AR ligands that incorporate a benzo-γ-pyrone [(4H)-1-benzopyran-4-one] substructure has been developed.  Accordingly, two series of novel chromone carboxamides placed at positions C2 (compds. 2-13) and C3 (compds. 15-26) of the γ-pyrone ring were synthesized using chromone carboxylic acids (chromone-2-carboxylic acid or chromone-3-carboxylic acid) as starting materials.  From this study and on the basis of the obtained structure-activity relationships it was concluded that the chromone carboxamide scaffold represent a novel class of AR ligands.  The most remarkable chromones were compds. (I) and (II) that present a better affinity for A3AR (Ki = 3680 nM and Ki = 3750 nM, resp.).  Receptor-driven mol. modeling studies provide information on the binding/selectivity data of the chromone.  The data so far acquired are instrumental for future optimization of chromone carboxamide as a selective A3AR antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK33Z9D6f08bVg90H21EOLACvtfcHk0li3hLNRwoJ_qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFGis78%253D&md5=82c1e9787e3856549b59a413199293fb</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DReis%26aufirst%3DJ.%26aulast%3DKachler%26aufirst%3DS.%26aulast%3DPaoletta%26aufirst%3DS.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DMoro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DDiscovery%2520of%2520Novel%2520A3%2520Adenosine%2520Receptor%2520Ligands%2520Based%2520on%2520Chromone%2520Scaffold%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26issue%3D1%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.bcp.2012.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. S.</span></span> <span> </span><span class="NLM_article-title">A Molecular Model for DNA Cross-Linking by the Antitumor Agent Azinomycin B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">2783</span>– <span class="NLM_lpage">2788</span>, <span class="refDoi"> DOI: 10.1021/jm990362l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990362l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1els7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2783-2788&issue=15&author=S.+Alcaroauthor=R.+S.+Coleman&title=A+Molecular+Model+for+DNA+Cross-Linking+by+the+Antitumor+Agent+Azinomycin+B&doi=10.1021%2Fjm990362l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A Molecular Model for DNA Cross-Linking by the Antitumor Agent Azinomycin B</span></div><div class="casAuthors">Alcaro, Stefano; Coleman, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2783-2788</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A computational model for the covalent interstrand DNA crosslinking of the antitumor agent azinomycin B is reported and is based on Monte Carlo simulations of the four possible monoalkylation species and an examn. of the low energy conformations of the cross-linked agent.  The model was developed using a suitably modified version of the AMBER* force field with the exptl. detd. triplet DNA target sequence 5'-d(GCT)-3' in both the native B-form and contg. a preformed intercalation site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3xh2VIklGybVg90H21EOLACvtfcHk0li3hLNRwoJ_qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1els7s%253D&md5=d2c14d8eaf1e7f654b3a2763a6fa47b2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm990362l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990362l%26sid%3Dliteratum%253Aachs%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DColeman%26aufirst%3DR.%2BS.%26atitle%3DA%2520Molecular%2520Model%2520for%2520DNA%2520Cross-Linking%2520by%2520the%2520Antitumor%2520Agent%2520Azinomycin%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D15%26spage%3D2783%26epage%3D2788%26doi%3D10.1021%2Fjm990362l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charifson, P. S.</span></span> <span> </span><span class="NLM_article-title">Conformational Analysis of Drug-Like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization upon Binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2499</span>– <span class="NLM_lpage">2510</span>, <span class="refDoi"> DOI: 10.1021/jm030563w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030563w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2499-2510&issue=10&author=E.+Perolaauthor=P.+S.+Charifson&title=Conformational+Analysis+of+Drug-Like+Molecules+Bound+to+Proteins%3A+An+Extensive+Study+of+Ligand+Reorganization+upon+Binding&doi=10.1021%2Fjm030563w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Analysis of Drug-Like Molecules Bound to Proteins: An Extensive Study of Ligand Reorganization upon Binding</span></div><div class="casAuthors">Perola, Emanuele; Charifson, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2499-2510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes a large-scale study on the nature and the energetics of the conformational changes drug-like mols. experience upon binding.  Ligand strain energies and conformational reorganization were analyzed with different computational methods on 150 crystal structures of pharmaceutically relevant protein-ligand complexes.  The common knowledge that ligands rarely bind in their lowest calcd. energy conformation was confirmed.  Addnl., the authors found that over 60% of the ligands do not bind in a local min. conformation.  While approx. 60% of the ligands were calcd. to bind with strain energies lower than 5 kcal/mol, strain energies over 9 kcal/mol were calcd. in at least 10% of the cases regardless of the method used.  A clear correlation was found between acceptable strain energy and ligand flexibility, while there was no correlation between strain energy and binding affinity, thus indicating that expensive conformational rearrangements can be tolerated in some cases without overly penalizing the tightness of binding.  On the basis of the trends obsd., thresholds for the acceptable strain energies of bioactive conformations were defined with consideration of the impact of ligand flexibility.  An anal. of the degree of folding of the bound ligands confirmed the general tendency of small mols. to bind in an extended conformation.  The results suggest that the unfolding of hydrophobic ligands during binding, which exposes hydrophobic surfaces to contact with protein residues, could be one of the factors accounting for high reorganization energies.  Finally, different methods for conformational anal. were evaluated, and guidelines were defined to maximize the prevalence of bioactive conformations in computationally generated ensembles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMrN0dFKglcbVg90H21EOLACvtfcHk0li3hLNRwoJ_qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVans78%253D&md5=8f54a8285ef1ffc5e1a19f748f4674bf</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm030563w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030563w%26sid%3Dliteratum%253Aachs%26aulast%3DPerola%26aufirst%3DE.%26aulast%3DCharifson%26aufirst%3DP.%2BS.%26atitle%3DConformational%2520Analysis%2520of%2520Drug-Like%2520Molecules%2520Bound%2520to%2520Proteins%253A%2520An%2520Extensive%2520Study%2520of%2520Ligand%2520Reorganization%2520upon%2520Binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D10%26spage%3D2499%26epage%3D2510%26doi%3D10.1021%2Fjm030563w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schiebel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wulsdorf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrader, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebe, G.</span></span> <span> </span><span class="NLM_article-title">Intriguing Role of Water in Protein-Ligand Binding Studied by Neutron Crystallography on Trypsin Complexes</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3559</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-05769-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1038%2Fs41467-018-05769-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=30177695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A280%3ADC%252BB3c3ltVOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=3559&author=J.+Schiebelauthor=R.+Gaspariauthor=T.+Wulsdorfauthor=K.+Ngoauthor=C.+Sohnauthor=T.+E.+Schraderauthor=A.+Cavalliauthor=A.+Ostermannauthor=A.+Heineauthor=G.+Klebe&title=Intriguing+Role+of+Water+in+Protein-Ligand+Binding+Studied+by+Neutron+Crystallography+on+Trypsin+Complexes&doi=10.1038%2Fs41467-018-05769-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes</span></div><div class="casAuthors">Schiebel Johannes; Wulsdorf Tobias; Ngo Khang; Sohn Christian; Heine Andreas; Klebe Gerhard; Schiebel Johannes; Gaspari Roberto; Cavalli Andrea; Schrader Tobias E; Ostermann Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3559</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hydrogen bonds are key interactions determining protein-ligand binding affinity and therefore fundamental to any biological process.  Unfortunately, explicit structural information about hydrogen positions and thus H-bonds in protein-ligand complexes is extremely rare and similarly the important role of water during binding remains poorly understood.  Here, we report on neutron structures of trypsin determined at very high resolutions ≤1.5 ÅA in uncomplexed and inhibited state complemented by X-ray and thermodynamic data and computer simulations.  Our structures show the precise geometry of H-bonds between protein and the inhibitors N-amidinopiperidine and benzamidine along with the dynamics of the residual solvation pattern.  Prior to binding, the ligand-free binding pocket is occupied by water molecules characterized by a paucity of H-bonds and high mobility resulting in an imperfect hydration of the critical residue Asp189.  This phenomenon likely constitutes a key factor fueling ligand binding via water displacement and helps improving our current view on water influencing protein-ligand recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2ZT4TkrW9o0h5eUSa2oe_fW6udTcc2eaViPy7EbMw4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3ltVOhtw%253D%253D&md5=56cfa8b99517f0da0967e3c9fbc09ac9</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-05769-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-05769-2%26sid%3Dliteratum%253Aachs%26aulast%3DSchiebel%26aufirst%3DJ.%26aulast%3DGaspari%26aufirst%3DR.%26aulast%3DWulsdorf%26aufirst%3DT.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DSohn%26aufirst%3DC.%26aulast%3DSchrader%26aufirst%3DT.%2BE.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DA.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DIntriguing%2520Role%2520of%2520Water%2520in%2520Protein-Ligand%2520Binding%2520Studied%2520by%2520Neutron%2520Crystallography%2520on%2520Trypsin%2520Complexes%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D3559%26doi%3D10.1038%2Fs41467-018-05769-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naveen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenchanna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahadevan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumara, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokanath, N. K.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of 8-Ethoxy-3-(4-nitrophenyl)-2<i>H</i>-chromen-2-one</span>. <i>Acta Crystallogr. E Crystallogr. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">o860</span>– <span class="NLM_lpage">o861</span>, <span class="refDoi"> DOI: 10.1107/S2056989015019325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1107%2FS2056989015019325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=26594565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOktb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2015&pages=o860-o861&issue=11&author=S.+Walkiauthor=S.+Naveenauthor=S.+Kenchannaauthor=K.+M.+Mahadevanauthor=M.+N.+Kumaraauthor=N.+K.+Lokanath&title=Crystal+Structure+of+8-Ethoxy-3-%284-nitrophenyl%29-2H-chromen-2-one&doi=10.1107%2FS2056989015019325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of 8-ethoxy-3-(4-nitrophenyl)-2H-chromen-2-one</span></div><div class="casAuthors">Walki, Shashikanth; Naveen, S.; Kenchanna, S.; Mahadevan, K. M.; Kumara, M. N.; Lokanath, N. K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section E: Crystallographic Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">o860-o861</span>CODEN:
                <span class="NLM_cas:coden">ACSECI</span>;
        ISSN:<span class="NLM_cas:issn">2056-9890</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">In the title compd., C17H13NO5, the coumarin ring system is essentially planar (r.m.s. deviation = 0.008 Å).  The nitrophenyl ring makes a dihedral angle of 25.27 (9)° with the coumarin ring plane.  The nitro group is almost coplanar with the Ph ring to which it is attached, making a dihedral angle of 4.3 (3)°.  The ethoxy group is inclined to the coumarin ring plane by 4.1 (2)°.  Electron delocalization was found at the short bridging C-C bond with a bond length of 1.354 (2) Å.  In the crystal, mols. are linked via C-H···O hydrogen bonds, forming sheets in the bc plane.  The sheets are linked via π-π stacking [centroid-centroid distances = 3.5688 (13) and 3.7514 (13) Å], forming a three-dimensional structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwHmlX590plrVg90H21EOLACvtfcHk0lh2eU2e5J3t9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOktb3K&md5=257f9857750e069d68889001f79fddcd</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS2056989015019325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2056989015019325%26sid%3Dliteratum%253Aachs%26aulast%3DWalki%26aufirst%3DS.%26aulast%3DNaveen%26aufirst%3DS.%26aulast%3DKenchanna%26aufirst%3DS.%26aulast%3DMahadevan%26aufirst%3DK.%2BM.%26aulast%3DKumara%26aufirst%3DM.%2BN.%26aulast%3DLokanath%26aufirst%3DN.%2BK.%26atitle%3DCrystal%2520Structure%2520of%25208-Ethoxy-3-%25284-nitrophenyl%2529-2H-chromen-2-one%26jtitle%3DActa%2520Crystallogr.%2520E%2520Crystallogr.%2520Commun.%26date%3D2015%26volume%3D71%26issue%3D11%26spage%3Do860%26epage%3Do861%26doi%3D10.1107%2FS2056989015019325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budriesi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiarini, A.</span></span> <span> </span><span class="NLM_article-title">Coumarin 1,4-Dihydropyridine Derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">803</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1016/S0968-0896(98)00037-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2FS0968-0896%2898%2900037-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=9681146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADyaK1cXkvVOmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=803-810&author=P.+Valentiauthor=A.+Rampaauthor=R.+Budriesiauthor=A.+Bisiauthor=A.+Chiarini&title=Coumarin+1%2C4-Dihydropyridine+Derivatives&doi=10.1016%2FS0968-0896%2898%2900037-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">(Coumarinyl)-1,4-dihydropyridine derivatives</span></div><div class="casAuthors">Valenti, P.; Rampa, A.; Budriesi, R.; Bisi, A.; Chiarini, A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-810</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of 1,4-dihydropyridines bearing a coumarin moiety in 4-position was synthesized.  The compds. were evaluated for inotropic, chronotropic and calcium antagonist activities.  The replacement of the o-nitrophenyl moiety of nifedipine with a coumarin or phenylcoumarin system is accompanied by a decrease of the activity on myocardial and vascular parameters, but the synthesized compds. showed selective inhibiting effects on cardiac contractility and frequency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtObBeLhPeWLVg90H21EOLACvtfcHk0lh2eU2e5J3t9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvVOmtbg%253D&md5=617f47abb2b570c970234bc4ef1aee34</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2898%2900037-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252898%252900037-6%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DChiarini%26aufirst%3DA.%26atitle%3DCoumarin%25201%252C4-Dihydropyridine%2520Derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1998%26volume%3D6%26spage%3D803%26epage%3D810%26doi%3D10.1016%2FS0968-0896%2898%2900037-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nemeryuk, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrova, V. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedov, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anisimova, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traven, V. F.</span></span> <span> </span><span class="NLM_article-title">New Approach to the Synthesis of 3-Arylcoumarins. Reaction of 3-Acyl and 3-Ethoxycarbonyl-Coumarins with Hydrazide of <i>p</i>-Nitrophenylacetic Acid</span>. <i>Chem. Heterocycl. Compd.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1023/A:1015359830129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1023%2FA%3A1015359830129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtFalsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2002&pages=249-250&author=M.+P.+Nemeryukauthor=V.+D.+Dimitrovaauthor=A.+L.+Sedovauthor=O.+S.+Anisimovaauthor=V.+F.+Traven&title=New+Approach+to+the+Synthesis+of+3-Arylcoumarins.+Reaction+of+3-Acyl+and+3-Ethoxycarbonyl-Coumarins+with+Hydrazide+of+p-Nitrophenylacetic+Acid&doi=10.1023%2FA%3A1015359830129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New approach to the synthesis of 3-arylcoumarins. Reaction of 3-acyl- and 3-ethoxycarbonyl-coumarins with hydrazide of p-nitrophenylacetic acid</span></div><div class="casAuthors">Nemeryuk, M. P.; Dimitrova, V. D.; Sedov, A. L.; Anisimova, O. S.; Traven, V. F.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Heterocyclic Compounds (New York, NY, United States)(Translation of Khimiya Geterotsiklicheskikh Soedinenii)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-250</span>CODEN:
                <span class="NLM_cas:coden">CHCCAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-3122</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">The synthesis of 3-arylcoumarins contg. electron-withdrawing substituents in the aryl ring is accomplished by the reaction of 3-acyl- or 3-ethoxycarbonyl-coumarins with derivs. of phenylacetic acid hydrazides under Michael reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9cC6VaqTCo7Vg90H21EOLACvtfcHk0lgh1a_IXaS6yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtFalsbY%253D&md5=6724199a912921613dc66c90ab969559</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1023%2FA%3A1015359830129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1015359830129%26sid%3Dliteratum%253Aachs%26aulast%3DNemeryuk%26aufirst%3DM.%2BP.%26aulast%3DDimitrova%26aufirst%3DV.%2BD.%26aulast%3DSedov%26aufirst%3DA.%2BL.%26aulast%3DAnisimova%26aufirst%3DO.%2BS.%26aulast%3DTraven%26aufirst%3DV.%2BF.%26atitle%3DNew%2520Approach%2520to%2520the%2520Synthesis%2520of%25203-Arylcoumarins.%2520Reaction%2520of%25203-Acyl%2520and%25203-Ethoxycarbonyl-Coumarins%2520with%2520Hydrazide%2520of%2520p-Nitrophenylacetic%2520Acid%26jtitle%3DChem.%2520Heterocycl.%2520Compd.%26date%3D2002%26volume%3D38%26spage%3D249%26epage%3D250%26doi%3D10.1023%2FA%3A1015359830129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jafarpour, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barzegar Amiri Olia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalalimanesh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahiminejadan, S.</span></span> <span> </span><span class="NLM_article-title">Palladium-Catalyzed Decarboxylative Cross-Coupling Reactions: A Route for Regioselective Functionalization of Coumarins</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">2957</span>– <span class="NLM_lpage">2964</span>, <span class="refDoi"> DOI: 10.1021/jo302778d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo302778d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2013&pages=2957-2964&author=F.+Jafarpourauthor=S.+Zareiauthor=M.+Barzegar+Amiri+Oliaauthor=N.+Jalalimaneshauthor=S.+Rahiminejadan&title=Palladium-Catalyzed+Decarboxylative+Cross-Coupling+Reactions%3A+A+Route+for+Regioselective+Functionalization+of+Coumarins&doi=10.1021%2Fjo302778d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Decarboxylative Cross-Coupling Reactions: A Route for Regioselective Functionalization of Coumarins</span></div><div class="casAuthors">Jafarpour, Farnaz; Zarei, Samaneh; Barzegar Amiri Olia, Mina; Jalalimanesh, Nafiseh; Rahiminejadan, Soraya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2957-2964</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A straightforward, regioselective, and step-economical ligand-free palladium-catalyzed decarboxylative functionalization of coumarin-3-carboxylic acids, e.g. I, is devised.  This protocol is compatible with a wide variety of electron-donating and -withdrawing substituents and allows for construction of various biol. important π-electron extended coumarins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6dCgx8n_B4LVg90H21EOLACvtfcHk0lgh1a_IXaS6yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWhu7s%253D&md5=d003ddea2ccd28c2b31cddd8f11fa01d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo302778d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo302778d%26sid%3Dliteratum%253Aachs%26aulast%3DJafarpour%26aufirst%3DF.%26aulast%3DZarei%26aufirst%3DS.%26aulast%3DBarzegar%2BAmiri%2BOlia%26aufirst%3DM.%26aulast%3DJalalimanesh%26aufirst%3DN.%26aulast%3DRahiminejadan%26aufirst%3DS.%26atitle%3DPalladium-Catalyzed%2520Decarboxylative%2520Cross-Coupling%2520Reactions%253A%2520A%2520Route%2520for%2520Regioselective%2520Functionalization%2520of%2520Coumarins%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2013%26volume%3D78%26spage%3D2957%26epage%3D2964%26doi%3D10.1021%2Fjo302778d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bulut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erk, C.</span></span> <span> </span><span class="NLM_article-title">The Synthesis of Novel Crown Ethers, Part IX, 3-Phenyl Chromenone-Crown Ethers</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1291</span>– <span class="NLM_lpage">1295</span>, <span class="refDoi"> DOI: 10.1002/jhet.5570380608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fjhet.5570380608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFGrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2001&pages=1291-1295&issue=6&author=M.+Bulutauthor=C.+Erk&title=The+Synthesis+of+Novel+Crown+Ethers%2C+Part+IX%2C+3-Phenyl+Chromenone-Crown+Ethers&doi=10.1002%2Fjhet.5570380608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of novel crown ethers, part IX, 3-phenyl chromenone-crown ethers</span></div><div class="casAuthors">Bulut, M.; Erk, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1291-1295</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    
            (<span class="NLM_cas:orgname">HeteroCorporation</span>)
        </div><div class="casAbstract">3-Phenyl- and 3-(p-methoxyphenyl)-7,8-dihydroxy- and -6,7-dihydroxychromenones were prepd. from Et 3-oxo-2-phenylpropanoate, Et 3-oxo-2-(4-methoxyphenyl)propanoate and the trihydroxybenzenes in H2SO4.  3-Aryl-7,8- and 3-aryl-6,7-dihydroxy-2H-chromenones reacted with the bis-dihalides of polyglycols in DMF/MeCO3 to afford 12-crown-4-, 15-crown-5- and 18-crown-6-chromenones.  The products were identified with IR, 1H NMR, low and high resoln. mass spectroscopy and elemental anal.  Some 1:1 cation assocn. consts., Kb, of the 3-phenylchromenone crown ethers with Li+, Na+, K+ and Rb+ cations were studied by steady state emission fluorescence spectroscopy; Kb chromenone-crown complexes displayed crown ether-cation binding selectivity rules properly in MeCN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow0rmZn-Rt9bVg90H21EOLACvtfcHk0lgh1a_IXaS6yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFGrtQ%253D%253D&md5=74a92e9b6e9ce13d6aa79724a5cf113c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570380608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570380608%26sid%3Dliteratum%253Aachs%26aulast%3DBulut%26aufirst%3DM.%26aulast%3DErk%26aufirst%3DC.%26atitle%3DThe%2520Synthesis%2520of%2520Novel%2520Crown%2520Ethers%252C%2520Part%2520IX%252C%25203-Phenyl%2520Chromenone-Crown%2520Ethers%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2001%26volume%3D38%26issue%3D6%26spage%3D1291%26epage%3D1295%26doi%3D10.1002%2Fjhet.5570380608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunduz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulut, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 7,8-Dihydroxy-3-(3,4-dihydroxyphenyl)-2<i>H</i>-chromen-2-one Derivatives of Crown Ethers</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1002/jhet.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1002%2Fjhet.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjs1ajtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2009&pages=105-107&issue=1&author=C.+Gunduzauthor=M.+Bulut&title=Synthesis+of+7%2C8-Dihydroxy-3-%283%2C4-dihydroxyphenyl%29-2H-chromen-2-one+Derivatives+of+Crown+Ethers&doi=10.1002%2Fjhet.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 7,8-dihydroxy-3-(3,4-dihydroxyphenyl)-2H-chromen-2-one derivatives of crown ethers</span></div><div class="casAuthors">Gunduz, Cihan; Bulut, Mustafa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-107</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The novel 1-(3,4-dimethoxyphenyl)-2-(2,3,4-trimethoxyphenyl)acrylonitrile I was prepd. by condensation of 2,3,4-trimethoxybenzaldehyde with 3,4-dimethoxyphenylacetonitrile in ethanol at 70 °C with 20% aq. sodium hydroxide soln.  Cyclization and demethylation of the acrylacetonitrile I was performed using pyridine hydrochloride.  The obtained 7,8-dihydroxy-3-(3,4-dihydroxyphenyl)-2H-chromen-2-one II (R = H) was reacted with the poly(ethylene glycol) ditosylates in CH3CN/alkali carbonate to afford bis-[12]crown-4, -[15]crown-5, and -[18]crown-6 chromenones II [RR = CH2CH2(OCH2CH2)n; n = 2 - 4].  The chromatog. purified novel chromenone crown ethers were identified by IR, 1H NMR, 13C NMR, and MALDI-TOF mass spectrometry and elemental anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOwIcxL8r737Vg90H21EOLACvtfcHk0lhO92p5ZLQFgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjs1ajtLk%253D&md5=7a1f78348eff1caf814c73104b2b8033</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fjhet.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.17%26sid%3Dliteratum%253Aachs%26aulast%3DGunduz%26aufirst%3DC.%26aulast%3DBulut%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25207%252C8-Dihydroxy-3-%25283%252C4-dihydroxyphenyl%2529-2H-chromen-2-one%2520Derivatives%2520of%2520Crown%2520Ethers%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D2009%26volume%3D46%26issue%3D1%26spage%3D105%26epage%3D107%26doi%3D10.1002%2Fjhet.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufareva, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span> <span> </span><span class="NLM_article-title">Structure Based Prediction of Subtype-Selectivity for Adenosine Receptor Antagonists</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.neuropharm.2010.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=20637786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2011&pages=108-115&author=V.+Katritchauthor=I.+Kufarevaauthor=R.+Abagyan&title=Structure+Based+Prediction+of+Subtype-Selectivity+for+Adenosine+Receptor+Antagonists&doi=10.1016%2Fj.neuropharm.2010.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based prediction of subtype-selectivity for adenosine receptor antagonists</span></div><div class="casAuthors">Katritch, Vsevolod; Kufareva, Irina; Abagyan, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">108-115</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">One of the major hurdles in the development of safe and effective drugs targeting G-protein coupled receptors (GPCRs) is finding ligands that are highly selective for a specific receptor subtype.  Structural understanding of subtype-specific binding pocket variations and ligand-receptor interactions may greatly facilitate design of selective ligands.  To gain insights into the structural basis of ligand subtype selectivity within the family of adenosine receptors (AR: A1, A2A, A2B, and A3) we generated 3D models of all four subtypes using the recently detd. crystal structure of the AA2AR as a template, and employing the methodol. of ligand-guided receptor optimization for refinement.  This approach produced 3D conformational models of AR subtypes that effectively explain binding modes and subtype selectivity for a diverse set of known AR antagonists.  Anal. of the subtype-specific ligand-receptor interactions allowed identification of the major determinants of ligand selectivity, which may facilitate discovery of more efficient drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRVFATDSQWmbVg90H21EOLACvtfcHk0lhO92p5ZLQFgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaitL%252FP&md5=da3b83ff9b882f130e2f02071f928617</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DStructure%2520Based%2520Prediction%2520of%2520Subtype-Selectivity%2520for%2520Adenosine%2520Receptor%2520Antagonists%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D60%26spage%3D108%26epage%3D115%26doi%3D10.1016%2Fj.neuropharm.2010.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span> <i>MOE, version 2011.10</i>; <span class="NLM_publisher-name">Chemical Computing
Group, Inc.</span>, <span class="NLM_year">2011</span>; <a href="http://www.chemcomp.com" class="extLink">http://www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+MOE%2C+version+2011.10%3B+Chemical+Computing%0AGroup%2C+Inc.%2C+2011%3B+http%3A%2F%2Fwww.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%252C%2520version%25202011.10%26pub%3DChemical%2520Computing%250AGroup%252C%2520Inc%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Studer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tauriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumienny, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heer, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Beer, T. A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rempfer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordoli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, T.</span></span> <span> </span><span class="NLM_article-title">SWISS-MODEL: Homology Modelling of Protein Structures and Complexes</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">W1</span>),  <span class="NLM_fpage">W296</span>– <span class="NLM_lpage">W303</span>, <span class="refDoi"> DOI: 10.1093/nar/gky427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1093%2Fnar%2Fgky427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=29788355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC1MXosVyru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=W296-W303&issue=W1&author=A.+Waterhouseauthor=M.+Bertoniauthor=S.+Bienertauthor=G.+Studerauthor=G.+Taurielloauthor=R.+Gumiennyauthor=F.+T.+Heerauthor=T.+A.+P.+de+Beerauthor=C.+Rempferauthor=L.+Bordoliauthor=R.+Leporeauthor=T.+Schwede&title=SWISS-MODEL%3A+Homology+Modelling+of+Protein+Structures+and+Complexes&doi=10.1093%2Fnar%2Fgky427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">SWISS-MODEL: homology modelling of protein structures and complexes</span></div><div class="casAuthors">Waterhouse, Andrew; Bertoni, Martino; Bienert, Stefan; Studer, Gabriel; Tauriello, Gerardo; Gumienny, Rafal; Heer, Florian T.; de Beer, Tjaart A. P.; Rempfer, Christine; Bordoli, Lorenza; Lepore, Rosalba; Schwede, Torsten</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W296-W303</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">1362-4962</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Homol. modeling has matured into an important technique in structural biol., significantly contributing to narrowing the gap between known protein sequences and exptl. detd. structures.  Fully automated workflows and servers simplify and streamline the homol. modeling process, also allowing users without a specific computational expertise to generate reliable protein models and have easy access to modeling results, their visualization and interpretation.  Here, we present an update to the SWISS-MODEL server, which pioneered the field of automated modeling 25 years ago and been continuously further developed.  Recently, its functionality has been extended to the modeling of homo- and heteromeric complexes.  Starting from the amino acid sequences of the interacting proteins, both the stoichiometry and the overall structure of the complex are inferred by homol. modeling.  Other major improvements include the implementation of a new modeling engine, ProMod3 and the introduction a new local model quality estn. method, QMEANDisCo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqf9ZhQAzPVe7Vg90H21EOLACvtfcHk0lhO92p5ZLQFgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXosVyru70%253D&md5=651b55ade2d4f354f5d6699f318424d0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgky427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgky427%26sid%3Dliteratum%253Aachs%26aulast%3DWaterhouse%26aufirst%3DA.%26aulast%3DBertoni%26aufirst%3DM.%26aulast%3DBienert%26aufirst%3DS.%26aulast%3DStuder%26aufirst%3DG.%26aulast%3DTauriello%26aufirst%3DG.%26aulast%3DGumienny%26aufirst%3DR.%26aulast%3DHeer%26aufirst%3DF.%2BT.%26aulast%3Dde%2BBeer%26aufirst%3DT.%2BA.%2BP.%26aulast%3DRempfer%26aufirst%3DC.%26aulast%3DBordoli%26aufirst%3DL.%26aulast%3DLepore%26aufirst%3DR.%26aulast%3DSchwede%26aufirst%3DT.%26atitle%3DSWISS-MODEL%253A%2520Homology%2520Modelling%2520of%2520Protein%2520Structures%2520and%2520Complexes%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2018%26volume%3D46%26issue%3DW1%26spage%3DW296%26epage%3DW303%26doi%3D10.1093%2Fnar%2Fgky427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glukhova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vecchio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jörg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scammells, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.01.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=10.1016%2Fj.cell.2017.01.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=28235198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVWrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=867-877&issue=5&author=A.+Glukhovaauthor=D.+M.+Thalauthor=A.+T.+Nguyenauthor=E.+A.+Vecchioauthor=M.+J%C3%B6rgauthor=P.+J.+Scammellsauthor=L.+T.+Mayauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Structure+of+the+Adenosine+A1+Receptor+Reveals+the+Basis+for+Subtype+Selectivity&doi=10.1016%2Fj.cell.2017.01.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity</span></div><div class="casAuthors">Glukhova, Alisa; Thal, David M.; Nguyen, Anh T.; Vecchio, Elizabeth A.; Jorg, Manuela; Scammells, Peter J.; May, Lauren T.; Sexton, Patrick M.; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">867-877.e13</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The adenosine A1 receptor (A1-AR) is a G-protein-coupled receptor that plays a vital role in cardiac, renal, and neuronal processes but remains poorly targeted by current drugs.  We detd. a 3.2 Å crystal structure of the A1-AR bound to the selective covalent antagonist, DU172, and identified striking differences to the previously solved adenosine A2A receptor (A2A-AR) structure.  Mutational and computational anal. of A1-AR revealed a distinct conformation of the second extracellular loop and a wider extracellular cavity with a secondary binding pocket that can accommodate orthosteric and allosteric ligands.  We propose that conformational differences in these regions, rather than amino-acid divergence, underlie drug selectivity between these adenosine receptor subtypes.  Our findings provide a mol. basis for AR subtype selectivity with implications for understanding the mechanisms governing allosteric modulation of these receptors, allowing the design of more selective agents for the treatment of ischemia-reperfusion injury, renal pathologies, and neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3PS3LxJi-C7Vg90H21EOLACvtfcHk0lj45iUEBh-OYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVWrsrg%253D&md5=a5ff676cfedd6e11a899f65555a1ba62</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.01.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.01.042%26sid%3Dliteratum%253Aachs%26aulast%3DGlukhova%26aufirst%3DA.%26aulast%3DThal%26aufirst%3DD.%2BM.%26aulast%3DNguyen%26aufirst%3DA.%2BT.%26aulast%3DVecchio%26aufirst%3DE.%2BA.%26aulast%3DJ%25C3%25B6rg%26aufirst%3DM.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DMay%26aufirst%3DL.%2BT.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DStructure%2520of%2520the%2520Adenosine%2520A1%2520Receptor%2520Reveals%2520the%2520Basis%2520for%2520Subtype%2520Selectivity%26jtitle%3DCell%26date%3D2017%26volume%3D168%26issue%3D5%26spage%3D867%26epage%3D877%26doi%3D10.1016%2Fj.cell.2017.01.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EML','PDB','3EML'); return false;">PDB: 3EML</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UZC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3UZC','PDB','3UZC'); return false;">PDB: 3UZC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UEN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5UEN','PDB','5UEN'); return false;">PDB: 5UEN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01572">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_17110"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01572?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01572</a>. <ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Rationale for this study, crystallographic data of compound <b>4</b>, docking information for compound <b>4</b>, representative hA<sub>3</sub> homology models, and HPLC trace for compound <b>4</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_002.csv">CSV</a>)</p></li><li><p class="inline">A3 homology model MOE 1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_003.pdb">PDB</a>)</p></li><li><p class="inline">A3 homology model MOE 2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_004.pdb">PDB</a>)</p></li><li><p class="inline">A3 homology model SwissModel (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_005.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_001.pdf">jm9b01572_si_001.pdf (536.41 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_002.csv">jm9b01572_si_002.csv (1.72 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_003.pdb">jm9b01572_si_003.pdb (394.77 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_004.pdb">jm9b01572_si_004.pdb (394.69 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01572/suppl_file/jm9b01572_si_005.pdb">jm9b01572_si_005.pdb (193.0 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01572&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01572%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01572" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ab3554ac13291","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
